Abstract_ID,Entities
0,"['Non-alcoholic Fatty Liver Disease', 'Prevalent', 'Condition', 'status - In progress', 'Fibrosis', 'Risk', 'Liver carcinoma', 'Effectiveness', 'Therapeutic procedure', 'glutathione', 'Protoplasm', 'glutathione biosynthetic process', 'Oxidative Stress', 'Fibrosis', 'Non-alcoholic Fatty Liver Disease', 'Impact food supplement', 'Induce (action)', 'Hepatocyte', 'Hep G2 Cells', ""Dulbecco's Modified Eagle Medium"", 'Plant seeds', 'density']"
1,"['removal technique', 'Secondary malignant neoplasm of liver', 'Race:Type:Point in time:^Patient:Nominal', 'Health Insurance', 'Healthcare Disparities', 'Clinical Research', 'Evaluation', 'Effect', 'Health Insurance', 'removal technique']"
2,"['Case-Control Studies', 'Social Determinants of Health', 'Health', 'Hematoma, Subdural', 'Cholangiocarcinoma', 'Cholangiocarcinoma', 'Risk', 'Incidence', 'Replication Origin', 'Thailand']"
3,"['Dipeptidyl-Peptidase IV Inhibitors', 'Antidiabetics', 'Effect', 'Patients', 'Diabetes Mellitus, Non-Insulin-Dependent', 'Non-alcoholic Fatty Liver Disease', 'Non-alcoholic Fatty Liver Disease']"
4,"['Coffee', 'Tea', 'World', 'Quantity', 'caffeine', 'Daily', 'Persons', 'Large', 'Quantity', 'Liver', 'Clinical Research', 'Relationships', 'Coffee', 'Tea', 'Consumption of goods', 'Diet', 'Intake', 'caffeine', 'Finding of liver enzyme levels', 'Profiling (action)', 'Clinical Research', 'control act - information', 'Participant', 'Age', 'year', 'Cohort Studies', 'ARPP21 gene', 'geographic population', 'Epidemiologic Studies', 'Persian language', 'demographic characteristics', 'Medical History', 'Consumption of goods', 'Coffee', 'Tea', 'caffeine', 'Intake', 'Laboratory Procedures', 'Investigates', 'Relationships', 'Coffee', 'Tea', 'Consumption of goods', 'caffeine', 'Intake', 'Finding of liver enzyme levels', 'Profiling (action)', 'Participant', 'Woman', 'Males', 'Older people', 'Male population group', 'Consumption of goods', 'Increased', 'Relationships', 'CD55 gene', 'Curie', 'Increased', 'Abnormal', 'Alkaline Phosphatase', 'Alkaline Phosphatase', 'Curie', 'Decreased', 'Abnormal', 'SGOT - Glutamate oxaloacetate transaminase', 'Curie', 'High', 'Intake', 'caffeine', 'Variable (uniformity)', 'Profiling (action)', 'Finding of liver enzyme levels', 'Increased', 'Increasing (qualifier value)', 'Consumption of goods', 'Coffee', 'Tea', 'Intake', 'Increase', 'High', 'Intake', 'caffeine', 'Coffee', 'Tea', 'Adverse event', 'Effect', 'Liver', 'Enzymes', 'Blood Coagulation Factor', 'care activity', 'Materials']"
5,"['Investigates', 'California', 'Mortality Vital Statistics', 'Social', 'Factor', 'History of present illness (finding)', 'Composite', 'Measures', 'Indicators', 'Neighborhood', 'Censuses', 'Tract', 'Transportation', 'Housing', 'Environmental Pollution', 'Aggregation', 'Census tract', 'COVID19 (disease)', 'Cessation of life', 'geographic population', 'Community Surveys', 'History of present illness (finding)', 'Age', 'History of present illness (finding)', 'Cardiovascular Diseases', 'COVID19 (disease)', 'Diabetes', 'Liver Cirrhosis', 'Injury of liver', ""Alzheimer's Disease"", 'Glycation End Products, Advanced', 'year', 'Mortality Vital Statistics', 'History of present illness (finding)', 'Etiology aspects', 'Mortality Vital Statistics', 'COVID19 (disease)', 'Rating (action)', 'geographic population', 'Fraction of', 'COVID19 (disease)', 'Age', 'Gender', 'Ethnicity', 'Shapes', 'findings aspects', 'Contracting', 'public health medicine (field)', 'Reduced', 'Health Inequities']"
6,"['Evaluation', 'Statistical Prevalence', 'Food Insecurity', 'CFI gene', 'Community', 'Pediatric brand name', 'Services Utilization']"
7,"['Clinical Research', 'Evaluation', 'Impact food supplement', 'lidocaine', 'Solutions', 'Saline Solution', 'Wash (cleansing action)', 'Lumpectomy of breast', 'Dental caries', 'Visual Accommodation', 'Pain, Postoperative', 'Concern', 'Patients', 'Breast surgery specialty']"
8,"['Liver and Intrahepatic Biliary Tract Carcinoma', 'Liver carcinoma', 'altretamine/cisplatin/cyclophosphamide protocol', 'second (number)', 'Cancer-Related Death', 'Pancreatic carcinoma', 'Overall Publication Type', 'Survival Rate', 'altretamine/cisplatin/cyclophosphamide protocol', 'low', 'Numerous', 'treatment options', 'altretamine/cisplatin/cyclophosphamide protocol', 'Systemic', 'Radiofrequency Ablation', 'Transarterial Chemoembolization', 'Transarterial Radioembolization', 'Operative Surgical Procedures', 'Transplantation of liver', 'Effectiveness', 'Drug Delivery Systems', 'Liver and Intrahepatic Biliary Tract Carcinoma', 'Physiological', 'Changing', 'Organ', 'Artificial nanoparticles', 'Vibration Therapy Units, Whole Body', 'Therapeutic procedure', 'Structure', 'With configuration', 'Stable status', 'Degree or extent', 'Hydrophobicity', 'Comprehensive', 'Therapeutic procedure', 'research', 'Potential']"
9,"['Alcohol Related Disorders', 'Mortality Vital Statistics', 'Cessation of life', 'chronic', 'Etiology aspects', 'ethanol', 'Increasing (qualifier value)', 'United States', 'geographic population', 'Subgroup A Nepoviruses', 'Review [Publication Type]', 'Mental association', 'Social Determinants of Health', 'Social Control Policies', 'Health Care', 'Availability of', 'Social Environment', 'Numerous', 'Geographic', 'Social Determinants of Health', 'Local', 'Context', 'Alcohol Related Disorders', 'Mortality Vital Statistics', 'Interventional procedure', 'Social Determinants of Health', 'Alcohol Related Disorders', 'Mortality Vital Statistics', 'Improved', 'Community', 'Health']"
10,"['Noncommunicable Diseases', 'Cessation of life', 'World', 'International', 'Indicators', 'Changing', 'Diet', 'Mental association', 'Clinical Research', 'Measures', 'Mental association', 'Metabolic', 'risk factors']"
11,"['Impact food supplement', 'Social Determinants of Health', 'Health', 'Social Determinants of Health', 'Pediatric brand name', 'Transplantation of liver', 'Outcome Measures', 'Clinical Research', 'Effect', 'Deprivation', 'Graft material', 'Pediatric brand name', 'Transplantation of liver', 'Recipient']"
12,"['Social Determinants of Health', 'Social Determinants of Health', 'Impact food supplement', 'Chronic liver disease', 'Chloride Anion Exchanger', 'Outcome Measures', 'Systematic Review', 'Mental association', 'Social Determinants of Health', 'Mortality Vital Statistics', 'Hospitalization', 'Hospital admission', 'Patients', 'Chloride Anion Exchanger']"
13,"['Open', 'Transplantation of liver', 'Tumor Necrosis Factor-Beta', 'trends qualifier', 'Out of Specification', 'Recipient', 'Characteristics', 'Organ', 'Quantitation', 'Out of Specification', 'Impact food supplement', 'Visual Accommodation', 'Social Determinants of Health', 'Health', 'Hematoma, Subdural', 'Financial cost', 'Associated with', 'Risk']"
14,"['Clinical Research', 'Burden', 'Burden', 'Traumatic AND/OR non-traumatic injury', 'risk factors', 'Global Burden of Disease', 'trauma qualifier', 'risk factors', 'Clinical Research']"
15,"['Hepatitis C', 'Hepatitis C', 'Hepatitis C', 'Prevalent', 'Liver diseases', 'Severe (severity modifier)', 'Outcome Measures', 'Liver Cirrhosis', 'Liver carcinoma', 'Traditional origin', 'diagnostic procedure', 'Detected (finding)', 'Antibodies, Viral', 'RNA, Viral', 'Limitation', 'Antibodies', 'week', 'acute', 'Case (situation)', 'Absent', 'Persons', 'Undiagnosed', 'Infection of ear', 'public health medicine (field)', 'Article', 'Biosensors', 'Engineer', 'Detected (finding)', 'Hepatitis C', 'Surface Antigens', 'Proteins', 'Biosensors', 'Accurate (qualifier)', 'Diagnosis', 'Viral Components', 'Communicable Diseases', 'Detection', 'Antigens, Viral', 'Diffusion of Innovation', 'Early', 'Diagnosis', 'Interventional procedure', 'viral transmission', 'Evaluation', 'Potential', 'Improved', 'Hepatitis C', 'Detection', 'Clinical', 'Hepatitis C', 'Serious Public Health Threat']"
16,"['Statistical Prevalence', 'Relationships', 'Smoking', 'Potential', 'risk factors', 'Cataract']"
17,"['Transplantation', 'Neoplasms', 'Transplantation of liver', 'Tumor Necrosis Factor-Beta', 'Combined', 'cancer care', 'Improved', 'Patients', 'Liver and Intrahepatic Biliary Tract Carcinoma', 'Patients', 'Access', 'Tumor Necrosis Factor-Beta', 'Social Determinants of Health', 'Negative', 'Impact food supplement', 'Patients', 'Ability', 'Review [Publication Type]', 'Tumor Necrosis Factor-Beta', 'Transplantation', 'Nursing interventions', 'Vision Disparity']"
18,"['Malignant Neoplasms', 'Etiology aspects', 'Cessation of life', 'Tumor Microenvironment', 'Malignant Neoplasms', 'Effectiveness', 'Therapeutic procedure', 'development aspects', 'Methods', 'Treatment intent', 'Malignant Neoplasms', 'Technology', 'Drug Industry', 'Research and Development', 'TBATA gene', 'Technology', 'Achievement', 'research', 'Tumor cells, malignant', 'Simulate composite resin', '3 Days', 'Cell Microenvironment', 'Technology', 'Hernandez Fragoso syndrome', 'System', 'findings aspects', 'Tumor cells, malignant', 'Techniques', 'Modeling', 'therapeutic aspects', 'Tumor cells, malignant', 'Limitation', 'Clinical Research']"
19,"['Impact food supplement', 'Clinical', 'Social', 'Factor', 'Mental health treatment', 'Patterns', 'Health Care Costs', 'Patients', 'altretamine/cisplatin/cyclophosphamide protocol']"
20,"['Hip Fractures', 'Disability', 'Elderly (population group)', 'Scientific Study', 'World', 'Identified', 'risk factors', 'Hip Fractures', 'Clinical Research', 'Investigates', 'risk factors', 'Hip Fractures', 'Systematic Review', 'risk factors', 'Hip Fractures', 'Publishing', 'Languages', 'Patients', 'Country', 'Examined', 'Keyword', 'MATCHING', 'Predictor', 'Hip Fractures', 'Particle', 'International', 'PubMed', 'Assessed', 'Clinical Research', 'Colicin Plasmids', 'Correlation', 'Risk', 'Hip Fractures', 'Alcohol consumption', 'Encounter due to problems with hearing', 'Low BMI', 'Cerebrovascular accident', 'Cardiovascular Diseases', 'Presenile dementia', ""Alzheimer's Disease"", 'Parkinson Disease', 'hepato-renal', 'Disease', 'Bone Density', 'Osteoporosis', 'Spinal Fractures', 'Clinical Research', 'Correlation', 'Consumption of goods', 'calcium', 'Cognition Disorders', 'Schizophrenia', 'Households', 'Income', 'Risk', 'Hip Fractures', 'risk factors', 'Hip Fractures', 'Persons', 'Recommendation', 'Health Policy', 'Interventional procedure', 'Mood swings', 'Colicin Plasmids']"
21,"['Evaluation', 'Changing', 'Age', 'Asian Americans', 'geographic population']"
22,"['Smoking', 'Mortality Vital Statistics', 'Cessation of life', 'Billion per Dose', 'year', 'Life', 'Lost', 'Refused', 'Smoking', 'Statistical Prevalence', 'year', 'Country', 'Generations', 'trends qualifier', 'Smoking', 'Statistical Prevalence', 'Smoking', 'Statistical Prevalence', 'Reduction (chemical)', 'Communicating', 'Effect', 'Potential', 'Tobacco Policy']"
23,"['Alcohol Use Disorder', 'Medical Condition', 'Persons', 'Billion per Dose', 'Health Care Costs', 'Statistical Prevalence', 'Young Adult', 'Males', 'Sexual and Gender Disorders', 'American Indians', 'Uninsured', 'High Prevalence', 'Impact food supplement', 'Health Care', 'Inadequate (qualifier)', 'Implementation', 'Screening for cancer', 'low', 'Levels (qualifier value)', 'therapeutic aspects', 'Uptake', 'Recognition, Psychology', 'Epidemiology', 'Social Determinants of Health']"
24,"['Investigates', 'Persons', 'Social Determinants of Health', 'Health', 'Social Determinants of Health', 'Cumulative', 'Cat-Scratch Disease', 'Continuance of life', 'Receipt Date', 'Transplantation of liver', 'Tumor Necrosis Factor-Beta', 'Patients', 'Liver carcinoma', 'altretamine/cisplatin/cyclophosphamide protocol']"
25,"['Mental association', 'Social Determinants of Health', 'Transplantation of liver', 'Data Listing', 'Health Care', 'Policy', 'Nursing interventions', 'Health Services Accessibility', 'Analysis', 'Recipient', 'Databases', 'Merge', 'Social Deprivation Index', 'residence', 'Study models', 'End Stage Liver Disease', 'sodium', 'Waiting Lists (patient)', 'Implantation procedure', 'Outcome Measures', 'Waiting Lists (patient)', 'Sociodemographic Factors', 'Comparison', 'Candidate', 'selective dissemination of information', 'High', 'selective dissemination of information', 'socioeconomic', 'Curie', 'Curie', 'Model for end-stage liver disease sodium score:Score:Pt:^Patient:Qn', 'Statistical Significance', 'Ethnicity', 'Analyzers, Physiologic, Middle Ear, Acoustic Reflectometry', 'Score', 'Time', 'Waiting Lists (patient)', 'Analyzers, Physiologic, Middle Ear, Acoustic Reflectometry', 'Curie', 'Candidate', 'selective dissemination of information', 'Hazard Ratio', 'Transplantation of liver', 'High', 'Cessation of life', 'High', 'Risk', 'removal technique', 'Independence', 'Race:Type:Point in time:^Patient:Nominal', 'Coitus', 'United States', 'residence', 'High', 'socioeconomic', 'High', 'Time', 'Waiting Lists (patient)', 'residence', 'High', 'Socioeconomic Disadvantage', 'High', 'Cessation of life', 'removal technique', 'Lower - spatial qualifier', 'Chance', 'Transplantation of liver', 'Waiting Lists (patient)', 'Implantation procedure']"
26,"['Statistical Prevalence', 'Inflammatory Bowel Diseases', 'Inflammatory Bowel Diseases', 'Increased', 'Disadvantaged Populations', 'Community', 'Complex', 'Cumulative', 'Effect', 'Racism', 'Sexism', 'Social Determinants of Health', 'Influence', 'Patients', 'Experience', 'Medication Systems', 'Navigation', 'Disease', 'Culturally Sensitive Care', 'Characterization', 'Ability', 'DELIVER (veterinary product)', 'Patient-Centered Care', 'care activity', 'Intersectional Framework', 'Persons', 'Sense of identity (observable entity)', 'Anthropogenic Effects', 'Disease', 'intent', 'Impact food supplement', 'Disadvantaged Populations', 'Persons', 'Household composition', 'Inflammatory Bowel Diseases', 'Health Inequities', 'Inflammatory Bowel Diseases', 'Anthropological Culture', 'Competence', 'Follow', 'Comprehension', 'Beliefs', 'Anthropological Culture', 'Procedural learning', 'Patients', 'Experience', 'patient care', 'Cultural Competency', 'Cultural Sensitivity', 'Health Personnel', 'Time Perception', 'Caring', 'Patients', 'Groups', 'Diversity', 'Array', 'Sense of identity (observable entity)', 'Anthropological Culture', 'No status change', 'Bias, Implicit', 'Bias (Epidemiology)', 'Obstetric Delivery', 'Quality', 'Inflammatory Bowel Diseases', 'care activity', 'Review Literature', 'Inflammatory Bowel Diseases', 'care activity', 'Disadvantaged Populations', 'Community', 'Anthropological Culture', 'Sensitive', 'care activity', 'trust framework', 'Inflammatory Bowel Diseases', 'Practice Experience', 'research']"
27,"['Primary Malignant Liver Neoplasm', 'Liver carcinoma', 'intrahepatic', 'Cancer-Related Death', 'United States', 'Hispanic or Latino', 'Nation', 'Ultrasonography', 'Censuses', 'Hispanics', 'Patients', 'Incidence Rate', 'Liver and Intrahepatic Biliary Tract Carcinoma', 'Hispanic or Latino', 'Caucasian', 'Hispanic or Latino', 'Black Populations', 'Vision Disparity', 'Cancer Research', 'Analyzer, device', 'Potential', 'Representation Component', 'Hispanics', 'Persons', 'Liver and Intrahepatic Biliary Tract Carcinoma', 'Databases', 'Databases', 'Liver', 'United States', 'search - EntityNameUse', 'Malignant Neoplasms', 'Databases, Genetic', 'Analysis', 'Ethnicity', 'Categories', 'Patients', 'Patients', 'Specimen', 'Persons', 'Hispanic or Latino', 'Race:Type:Point in time:^Patient:Nominal', 'Hispanic or Latino', 'Caucasian', 'Asian Americans', 'Hispanic or Latino', 'Black Populations', 'Native (qualifier value)', 'Americas Ethnicity', 'Native (qualifier value)', 'Pacific Islander Americans', 'Hawaiian language', 'findings aspects', 'Vision Disparity', 'Ethnic Groups', 'Hispanics', 'geographic population', 'Hispanic or Latino', 'year', 'Addresses (publication format)', 'health disparity', 'Worsening pattern', 'Enhance (action)', 'Inclusion', 'research']"
28,"['Social Determinants of Health', 'Transplantation of liver', 'Tumor Necrosis Factor-Beta', 'Evaluation', 'Mental association', 'Structure', 'Social Determinants of Health', 'Health', 'Persons', 'Psychosocial Factors', 'Measured', 'Integrated', 'Psychosocial assessment (procedure)', 'Score', 'Failure (biologic function)', 'Waiting Lists (patient)', 'Retrospective Cohort Study', 'Patients', 'Tumor Necrosis Factor-Beta', 'Injury due to exposure to external cause', 'Social Deprivation Index', 'Proportion', 'Households', 'Cash', 'public entity', 'Helping Behavior', 'Supplement', 'Helping Behavior', 'public entity', 'Score', 'Quartile', 'Curie', 'public entity', 'Helping Behavior', 'Quartile', 'Curie', 'Increased', 'Odds Ratio', 'Tumor Necrosis Factor-Beta', 'Mental association', 'Psychosocial assessment (procedure)', 'Score', 'Psychosocial assessment (procedure)', 'Highest', 'Quartile', 'Neighborhood', 'selective dissemination of information', 'Curie', 'Quartile', 'public entity', 'Helping Behavior', 'Curie', 'Increased', 'Failure', 'Waiting Lists (patient)', 'Psychosocial', 'Indication of (contextual qualifier)', 'Mental association', 'Quartile', 'Measures', 'Transplantation', 'Persons', 'Psychosocial care (regime/therapy)', 'Impact food supplement', 'structural barriers']"
29,"['Estimated', 'Cerebrovascular accident', 'Burden', 'Risk', 'Generalized', 'Resource Allocation', 'Estimated', 'Menstruation']"
30,"['Orthotopic liver transplant', 'Patients', 'Limited stage (cancer stage)', 'Liver carcinoma', 'Simultaneous', 'Liver Cirrhosis', 'Waiting Lists (patient)', 'Candida (fungus)', 'Affecting', 'Social Determinants of Health', 'Races (activity)', 'Ethnicity', 'Clinical Research', 'Evaluation', 'Orthotopic liver transplant', 'Patients', 'Liver carcinoma']"
31,"['Genus: Coronavirus', 'Disease', 'COVID19 (disease)', 'Pandemics', 'Psychologic', 'Complication', 'Pandemics', 'Biomechanical compliance', 'Protocols documentation', 'standards characteristics', 'research', 'Psychologic', 'COVID19 (disease)', 'Prophylactic behavior', 'Elderly (population group)', 'Clinical Research', 'Variable (uniformity)', 'Relationships', 'Associated with', 'Colicin Plasmids']"
32,"['propolis', 'Natural', 'Bees', 'Potential', 'Effect', 'Liver', 'Enzymes', 'Obesity', 'Meta Analysis (statistical procedure)', 'Impact food supplement', 'propolis', 'Obesity', 'Liver function']"
33,"['High', 'Statistical Prevalence', 'Inappropriate', 'Antibiotics', 'Sector', 'Community', 'Influence', 'Social Environment', 'Influence', 'Social Determinants of Health', 'Health', 'Affecting', 'Persons', 'Health behavior', 'Antibiotics', 'utilization qualifier', 'Health behavior', 'Persons', 'Health Literacy']"
34,['Variation (Genetics)']
35,"['Social Determinants of Health', 'gastrointestinal', 'Malignant neoplasm of gastrointestinal tract', 'Mortality Vital Statistics', 'Persons', 'Ultrasonography', 'Effect', 'Mortality Vital Statistics', 'Assessed', 'Mental association', 'County', 'Social vulnerability', 'Malignant neoplasm of gastrointestinal tract']"
36,"['Alcohol consumption', 'Transplantation of liver', 'Tumor Necrosis Factor-Beta', 'High', 'graft loss', 'Increased', 'Mortality Vital Statistics', 'Data', 'evaluation/testing', 'Predictor', 'Alcohol consumption', 'Biochemical Marker', 'phosphatidylethanol']"
37,"['Clinical Research', 'COVID19 (disease)', 'Vaccines', 'Effectiveness', 'Hospitals', 'Hospital admission', 'Severe (severity modifier)', 'COVID19 (disease)']"
38,"['Nutrients', 'Metabolism', 'Colicin Plasmids', 'Social Determinants of Health', 'Science of genetics', 'Regulators (device)', 'Metabolism', 'Healthy', 'Life Style', 'Mediator brand of benfluorex hydrochloride', 'Acclimatization', 'Cell physiology', 'Fatty Liver', 'Providing presence (regime/therapy)', 'Hepatocyte', 'Hepatocyte', 'Storage', 'Triglycerides', 'Lipids', 'Lipid droplet', 'Fatty Liver', 'Protoplasm', 'Mental Processes', 'Healthy', 'Nutrients', 'Metabolism', 'Range', 'Supermarkets', 'Several', 'Hormones', 'Peptides', 'Genes', 'Participation', 'Nutrients', 'Enzymes', 'Participation', 'Nutrients', 'Metabolism', 'Ingestion', 'Generations', 'adenosine triphosphate', 'Publications', 'Regulation', 'Nutrients', 'Metabolism', 'Regulatory Factor X1', 'Bidirectional', 'Regulators (device)', 'Nutrients', 'Metabolism', 'Fasting', 'Insulin', 'Exertion', 'Effect', 'Enzymes', 'Cell physiology', 'Metabolic', 'Inflammation', 'cell wall repair', 'End-stage', 'Regulators (device)', 'Visual Suppression', 'Receptors, Nuclear', 'NR1H4 gene', 'peroxisome', 'Receptors, Adiponectin', 'leptin', 'adiponutrin', 'Effect', 'Modulator Device', 'Incretins', 'Bile Acids', 'Intermediate', 'Players', 'Pathogenesis', 'Metabolic', 'Liver diseases', 'Disease Progression', 'Risk', 'Stratification', 'Pharmacotherapy', 'Persons', 'Patients', 'Personalized', 'Precision - characteristic', 'PubMed', 'Publications', 'Metabolism', 'Carbohydrates', 'Adipose tissue', 'Geographic state', 'health and disease', 'Cardiovascular Diseases', 'Publications', 'Peer Review, Research', 'Paper', 'Review [Publication Type]']"
39,"['Metabolic', 'Liver diseases', 'Administration occupational activities', 'Guidelines', 'Publishing', 'categorizing', 'Comparison', 'Life Style', 'Interventional procedure', 'Recommendation']"
40,"['year', 'Therapeutic procedure', 'Randomized Controlled Trials as Topic', 'Raspberries', 'Consumption of goods', 'Liver function', 'Laboratory Procedures', 'Review [Publication Type]', 'Investigates', 'Effectiveness', 'Meta Analysis (statistical procedure)']"
41,"['Publications', 'Particle', 'Manuscripts', 'Graft acceptance', 'Accepted', 'Manuscripts', 'Author', 'Style']"
42,"['polyphenols', 'Natural', 'Micronutrients', 'Plants', 'Anti-Inflammatory Agents', 'Antioxidants', 'Generalized', 'Non-alcoholic Fatty Liver Disease', 'Non-alcoholic Fatty Liver Disease', 'chronic', 'Progressive', 'Intestinal Microbiome', 'Congenital glucose-galactose malabsorption', 'Disease Progression', 'Non-alcoholic Fatty Liver Disease', 'Clinical action', 'Metabolite', 'Bile Acids', 'Lipopolysaccharides', 'Lipopolysaccharides', 'choline', 'Fatty Acids, Volatile', 'Additional', 'Influence', 'Intact', 'Intestines', 'Review [Publication Type]', 'Evaluation', 'Potential', 'polyphenols', 'Congenital glucose-galactose malabsorption', 'Intestines', 'physiological aspects', 'Impact food supplement', 'Non-alcoholic Fatty Liver Disease', 'Search - action', 'PubMed', 'Scopus', 'Systematic Review', 'Literature', 'Function (attribute)', 'Composition', 'chlorogenic acid', 'epigallocatechin gallate', 'naringenin', 'Composition', 'Improved', 'Non-alcoholic Fatty Liver Disease', 'Inflammation', 'Liver', 'Adipose tissue', 'Accumulation', 'Finding of liver enzyme levels', 'BARRIER', 'Intact', 'Component object', 'Non-alcoholic Fatty Liver Disease', 'Metabolite', 'Congenital glucose-galactose malabsorption', 'choline', 'Lipopolysaccharides', 'Evidence', 'curcumin', 'Modulated', 'Congenital glucose-galactose malabsorption', 'Improving (qualifier value)', 'Intestines', 'Intact', 'Positive', 'Non-alcoholic Fatty Liver Disease', 'Scientific Study', 'Evaluation', 'Safety', 'Effectiveness', 'naringenin', 'sulforafan', 'catechin']"
43,"['Emergency Situation', 'remdesivir', 'COVID19 (disease)', 'Country', 'aspects of adverse effects', 'Nausea', 'Worsening pattern', 'Respiratory Failure', 'Increased', 'Alanine Transaminase', 'Incidence', 'High', 'Finding of liver enzyme levels', 'Patients', 'COVID19 (disease)', 'remdesivir']"
44,"['Variable (uniformity)', 'Primary', 'Malignant neoplasm of liver', 'United States', 'Colicin Plasmids', 'Social Determinants of Health', 'Educational Status', 'regional', 'Variant', 'Outcome Measures', 'Clinical Research', 'Analysis', 'Cell cluster', 'High', 'Mortality Vital Statistics', 'Malignant neoplasm of liver', 'Mental association', 'Factor', 'Mortality Vital Statistics', 'Contiguous', 'United States']"
45,"['Early', 'Detection', 'Liver carcinoma', 'altretamine/cisplatin/cyclophosphamide protocol', 'Improved', 'Continuance of life', 'Proportion', 'Patients', 'Treating', 'Safety-net Hospitals', 'Terminal illness', 'Academic Medical Centers', 'Clinical Research', 'Diagnosis', 'altretamine/cisplatin/cyclophosphamide protocol']"
46,"['High Prevalence', 'Non-alcoholic Fatty Liver Disease', 'Complication', 'Comparison', 'silymarin', 'Non-alcoholic Fatty Liver Disease', 'Rattus norvegicus']"
47,"['Diabetes with coma (disorder)', 'Metabolic Diseases', 'Characterization', 'Hyperglycemia', 'Complication', 'Reduced', 'Quality', 'Life', 'Increase', 'Mortality Vital Statistics', 'Diabetes', 'physiopathological', 'physiopathological', 'Structure of beta Cell of islet', 'Adipose tissue', 'Skeletal muscle structure', 'Liver', 'Diabetes Mellitus, Insulin-Dependent', 'Diabetes Mellitus, Insulin-Dependent', 'Test Result', 'Destructive procedure (surgical)', 'Diabetes Mellitus, Non-Insulin-Dependent', 'Diabetes Mellitus, Non-Insulin-Dependent', 'Characterization', 'Degree or extent', 'Impaired T cell function', 'Insulin Resistance', 'Mental association', 'Obesity', 'Diabetes Mellitus, Non-Insulin-Dependent', 'Biochemical Pathway', 'CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS', 'Eating', 'Energy Metabolism', 'Input', 'Peripheral', 'Organ', 'Environment', 'Risk', 'Complications of Diabetes Mellitus', 'Social Interaction', 'Genetic Predisposition to Disease', 'Exogenous Factors', 'Availability of', 'Nutritious food', 'Social', 'Factor', 'physiopathological', 'therapeutic aspects', 'Diabetes', 'Complication', 'Course', 'Disease']"
48,"['Asian Americans', 'Pacific Islander Americans', 'Increased', 'Risk', 'Liver and Intrahepatic Biliary Tract Carcinoma', 'High', 'Cessation of life', 'Hispanic or Latino', 'Caucasian', 'Persons', 'Persons', 'risk factors', 'Social Determinants of Health', 'Navigation', 'Health system plans', 'Unique', 'Challenge', 'Liver and Intrahepatic Biliary Tract Carcinoma', 'care activity', 'Patients', 'Asian Americans', 'Pacific Islander Americans', 'geographic population', 'Heterogenous', 'Different', 'Country', 'Speaking (activity)', 'Languages', 'Challenge', 'Asian Americans', 'Pacific Islander Americans', 'Patients', 'Liver and Intrahepatic Biliary Tract Carcinoma', 'Clinician', 'research', 'Patient advocacy', 'cellular targeting', 'Solutions', 'Healthcare Disparities', 'Groups']"
49,"['Clinical Research', 'Assessed', 'Statistical Prevalence', 'Gastroesophageal reflux disease', 'Gastroesophageal reflux disease', 'Iran', 'Gastroesophageal reflux disease', 'Colicin Plasmids', 'Evaluation']"
50,"['Persons', 'Household composition', 'HIV', 'Predisposition -- attribute', 'Metabolic Diseases', 'Metabolic', 'Liver diseases', 'SLC17A5 gene', 'Persons', 'Household composition', 'HIV', 'Clinical Trials', 'Cohort Studies', 'risk factors', 'Natural History', 'SLC17A5 gene', 'geographic population', 'Poverty', 'Relevance', 'Knowledge', 'ras GTPase-Activating Proteins', 'Epidemiology', 'Health Care', 'Hamper', 'Sufficient', 'Response process', 'HIV', 'SLC17A5 gene', 'Syndemic', 'Comprehensive', 'SLC17A5 gene', 'Persons', 'Household composition', 'HIV', 'Social Determinants of Health', 'Fetal Health and Development', 'Liver diseases', 'Metabolic Syndrome X', 'Comorbidity', 'geographic population', 'SLC17A5 gene', 'Administration occupational activities', 'Recommendation', 'research', 'Data', 'Liver', 'Health', 'Persons', 'Household composition', 'HIV']"
51,"['Premature Birth', 'Process', 'week', 'Pregnancy', 'Providing presence (regime/therapy)', 'Microorganism', 'Fetal Membranes', 'Increase', 'production', 'Prostaglandins', 'Colicin Plasmids', 'Associated with', 'Premature Birth', 'Tumor Cell Invasion', 'Microorganism', 'production', 'Stimulation (motivation)', 'Birth', 'Investigates', 'Genital infection', 'Premature Birth']"
52,"['Mental association', 'Red Meat', 'Process', 'Meat', 'Consumption of goods', 'Malignant neoplasm of gastrointestinal tract', 'Indeterminate', 'Evaluation procedure', 'Systematic Review', 'Meta Analysis (statistical procedure)', 'Science']"
53,"['Relationships', 'Climate Change', 'Food Serving Systems', 'Noncommunicable Diseases', 'Africa South of the Sahara', 'anti-Ro (SSA) measurement', 'Concept (Terminology Entity)', 'anti-Ro (SSA) measurement']"
54,"['Evaluation', 'systematic', 'Social Determinants of Health', 'Health', 'Demography', 'Socioeconomic Factors', 'Comparison', 'Groups', 'Inaccurate', 'Clinical Research', 'Evaluation', 'Prediction', 'Mortality Vital Statistics', 'Patients', 'Chronic disease', 'Method of detection', 'Consideration', 'systematic']"
55,"['Non-alcoholic Fatty Liver Disease', 'Non-alcoholic Fatty Liver Disease', 'Chronic liver disease', 'Estimated', 'Statistical Prevalence', 'Variant', 'PNPLA3 gene', 'HSD17B1 gene', 'Evaluation procedure', 'Etiology aspects', 'Disease Progression', 'Non-alcoholic Fatty Liver Disease', 'Cost of Illness', 'Hispanic Americans', 'Socioeconomic Factors', 'Non-alcoholic Fatty Liver Disease', 'Disease Progression', 'Increased', 'Statistical Prevalence', 'Hispanics']"
56,"['Organ Transplantation', 'Southern Sotho language', 'Optimum', 'therapeutic aspects', 'Child', 'Single organ dysfunction', 'Increased', 'Access', 'Health', 'Southern Sotho language', 'Review [Publication Type]', 'Literature', 'Access', 'Health Outcomes', 'Pediatric brand name', 'Southern Sotho language', 'Canada', 'Aotearoa', 'New Zealand', 'Australia', 'United States', 'search - EntityNameUse', 'Clinical Trial Eligibility Criteria', 'Preliminary', 'Gray Literature', 'Scientific Study', 'United States', 'Canada', 'Aotearoa', 'Australia', 'findings aspects', 'Preemptive Analgesia', 'Living Donors', 'Patients', 'Kidney Transplantation', 'Transplantation of liver', 'findings aspects', 'Graft material', 'Patients', 'Transplantation of liver', 'Social Determinants of Health', 'Living Donors', 'Traditional origin', 'Southern Sotho language', 'Access', 'Evidence', 'ras GTPase-Activating Proteins', 'Southern Sotho language', 'research', 'research', 'Planning Techniques', 'Local', 'Community', 'Context', 'Reporting', 'Anthropological Culture', 'SAFE-Biopharma Standard', 'care activity']"
57,"['Impact food supplement', 'Social Determinants of Health', 'Older Adult Health', 'Transplantation of liver', 'Recipient', 'Outcome Measures', 'Federal Government', 'Impact food supplement', 'Social Determinants of Health', 'Health', 'Effectiveness', 'Health Care', 'Obstetric Delivery', 'Analyzer, device', 'Recipient', 'Evaluation', 'Mental association', 'Social Deprivation Index', 'Transplantation of liver', 'Recipient', 'Patients', 'Continuance of life', 'Adult', 'Recipient', 'Patients', 'Continuance of life', 'Lower - spatial qualifier', 'Adult', 'Score', 'Midline (qualifier value)', 'Patients', 'Continuance of life', 'Midline (qualifier value)', 'selective dissemination of information', 'Comparison', 'Recipient', 'Assisted Living', 'selective dissemination of information', 'Cohort', 'Mortality Vital Statistics', 'Hazard Ratio', 'Curie', 'High', 'Failure (biologic function)', 'Hazard Ratio', 'Curie', 'Increased', 'Risk', 'Vulnerable Populations', 'Hazard Ratio', 'year', 'Transplantation', 'Loss', 'selective dissemination of information', 'Linear', 'Midline (qualifier value)', 'Deprivation', 'United States', 'Social Determinants of Health', 'Anthropogenic Effects', 'Patients', 'Continuance of life', 'Overall Publication Type', 'Effect', 'follow-up', 'High', 'Deprivation', 'Evaluation', 'Effectiveness', 'Nursing interventions', 'Policy', 'Attenuation', 'Vision Disparity', 'Outcome Measures', 'Recipient', 'Disadvantaged Populations', 'Area']"
58,"['COVID19 (disease)', 'Pandemics', 'Clinical Research', 'Oral cavity', 'Fungi', 'Impact food supplement', 'Fungi', 'Environment', 'Colicin Plasmids', 'Changing', 'Structure of respiratory epithelium', 'Increased', 'Pathogenic organism', 'Local', 'Inflammation', 'Virulence', 'Colicin Plasmids', 'COVID19 (disease)', 'Severities', 'Author', 'Clinical Research', 'Fungi', 'COVID19 (disease)', 'Patients', 'Healthy Control']"
59,"['Social Determinants of Health', 'Associated with', 'Outcome Measures', 'Metabolic', 'Liver diseases', 'risk factors', 'Social Determinants of Health', 'geographic population', 'Social Determinants of Health', 'Screening for cancer', 'Induction Clinical Trial Setting', 'Optimum', 'Screening Method', 'Review [Publication Type]', 'Social Determinants of Health', 'Screening for cancer', 'Clinical setting', 'Persons', 'risk factors']"
60,"['Multimorbidity', 'Prevalent', 'Elderly (population group)', 'Adverse event', 'Health Outcomes', 'Accident and Emergency department', 'Erectile dysfunction', 'utilization qualifier', 'Social Determinants of Health', 'Associated with', 'Erectile dysfunction', 'Visit', 'Elderly (population group)', 'Multimorbidity', 'Clinical Research', 'Examined', 'Mental association', 'Social Determinants of Health', 'Erectile dysfunction', 'Visit', 'Elderly (population group)', 'Multimorbidity']"
61,"['Road', 'Traffic', 'Accidents', 'World', 'Cessation of life', 'Significant', 'Impact food supplement', 'Readiness', 'Mitigate', 'Evaluation', 'Readiness', 'Hospitals', 'West (direction)', 'Iran', 'Handle - program access', 'Road', 'Traffic', 'Accidents', 'Mass Casualties']"
62,"['Social Conditions', 'Behavioral Dietary Intervention', 'Burden', 'Malignant neoplasm of gastrointestinal tract', 'Environment', 'Influence', 'Community', 'Food', 'Availability of', 'Nutritional', 'Helping Behavior', 'Social Determinants of Health', 'United States Department of Agriculture', 'F9 EMBRYONIC ANTIGEN GENE', 'Mental association', 'Environment']"
63,"['Clinical Research', 'Epidemiologic Studies', 'Iran', 'Persian language', 'Clinical Research', 'Estimated', 'Statistical Prevalence', 'risk factors', 'Mental association', 'Incidence', 'Noncommunicable Diseases']"
64,"['Clinical Research', 'Social', 'Preventable']"
65,"['Food Insecurity', 'CFI gene', 'risk factors', 'Non-alcoholic Fatty Liver Disease', 'Non-alcoholic Fatty Liver Disease', 'Fibrosis', 'Liver diseases', 'Persons', 'HIV']"
66,"['Assessed', 'Mental association', 'Transplantation of liver', 'Tumor Necrosis Factor-Beta', 'Ethnicity']"
67,"['Clinical Research', 'Assessed', 'Severities', 'Colicin Plasmids', 'Symptomatic', 'COVID19 (disease)', 'Kidney Failure, Chronic', 'Kidney Failure, Chronic', 'Patients', 'Central', 'East']"
68,"['Clinical Research', 'Examined', 'Mortality Vital Statistics', 'Rating (action)', 'trend', 'Malignant neoplasm of gastrointestinal tract', 'Malignant neoplasm of stomach', 'Cessation of life', 'Incidence', 'Mortality Vital Statistics', 'Malignant Neoplasms', 'Iran', 'Disease', 'Persons', 'Preventive monitoring', 'trend', 'Cancer Death Rate', 'Report (document)', 'Mortality Vital Statistics', 'trend', 'Malignant neoplasm of gastrointestinal tract']"
69,"['Malignant Neoplasms', 'Upper', 'Malignant neoplasm of gastrointestinal tract', 'Nation', 'Iran']"
70,"['Liver and Intrahepatic Biliary Tract Carcinoma', 'Incidence', 'Increased', 'Ultrasonography', 'Heterogeneity', 'Population Group', 'Colicin Plasmids', 'Impact food supplement', 'Liver and Intrahepatic Biliary Tract Carcinoma', 'Risk']"
71,"['Progressive', 'Increase', 'Mortality, Premature', 'Suicide', 'Alcoholic Liver Diseases', 'Impact food supplement', 'Life Expectancy', 'Relationships', 'Social and Contextual Areas', 'Effect', 'Evidence', 'Country', 'Peripheral', 'Case (situation)', 'Brazil', 'Analysis of substances', 'Relationships', 'Feeling despair', 'brazilian', 'Cities', 'County', 'Data', 'Cell cluster', 'Economic Development', 'Analysis', 'Corrected Age', 'Mortality Vital Statistics', 'Comparison', 'statistical cluster', 'Groups', 'brazilian', 'municipality', 'PIN1 gene', 'High', 'Groups', 'Experience', 'Deprivation', 'Increase', 'High', 'Groups', 'Less Than', 'Deprivation', 'Practice Experience', 'Cell cluster', 'Groups', 'conjunctiva', 'Economics', 'Creation', 'Population Group', 'Unequal', 'Cessation of life', 'Feeling despair', 'Population Group', 'Assessed', 'Checking (action)', 'Different', 'Ecosystem', 'Levels (qualifier value)', 'Public Policy', 'Reduced', 'Lower - spatial qualifier', 'Socioeconomic Status']"
72,"['Hepatitis B, Chronic', 'risk factors', 'Malignant Neoplasms', 'Autophagy', 'Essential', 'Elements', 'Human cells', 'Scientific Study', 'Autophagy', 'Liver and Intrahepatic Biliary Tract Carcinoma', 'Different', 'Stage', 'Systematic Review', 'Investigates', 'Genetic Polymorphism', 'Mutation', 'ATG5 gene', 'Pathogenesis', 'Carcinogenesis', 'hepatitis B virus']"
73,"['Social Determinants of Health', 'Social Determinants of Health', 'Predictor', 'Poverty', 'Chronic disease', 'Mental association', 'Liver Cirrhosis', 'geographic population', 'Transplantation of liver', 'Tumor Necrosis Factor-Beta', 'Limited (extensiveness)', 'Retrospective Studies', 'Adult', 'Patients', 'Liver Cirrhosis', 'metropolitan', 'Chicago', 'Mental association', 'Social Determinants of Health', 'Decompensation', 'Complication', 'Mortality Vital Statistics', 'Waiting Lists (patient)', 'Social Deprivation Index', 'Social Determinants of Health', 'Investigates', 'Patients', 'Liver Cirrhosis', 'Age', 'year', 'Woman', 'Hispanic or Latino', 'parent deprivation', 'Hazard Ratio', 'Curie', 'Curie', 'Mortality Vital Statistics', 'Curie', 'Pleckstrin Homology Domains', 'Social Determinants of Health', 'Associated with', 'Lower - spatial qualifier', 'Probability', 'Poverty', 'Housing Quality', 'Social support', 'Liver Cirrhosis', 'Social Determinants of Health', 'High', 'Decompensation', 'Mortality Vital Statistics', 'Tumor Necrosis Factor-Beta', 'Exploration procedure', 'BARRIER', 'Tumor Necrosis Factor-Beta', 'Health Outcomes']"
74,"['Cancer-Related Death', 'Malignant neoplasm of gastrointestinal tract', 'Environment', 'Genetic Vectors', 'Effectiveness', 'occurrence characteristics', 'Malignant neoplasm of gastrointestinal tract', 'Esophageal', 'Colorectal Carcinoma', 'risk factors', 'Life Style', 'Reactive Oxygen Species', 'Reactive Oxygen Species', 'Malignant neoplasm of gastrointestinal tract', 'Oxidative Stress', 'Increase', 'Malignant Neoplasms', 'NQO1 gene', 'Antioxidants', 'CD59 Antigen', 'Mutagenesis Process', 'Carcinogenesis', 'NQO1 gene', 'Reduced', 'Quinones', 'hydroquinone', 'Prophylactic treatment', 'Reactive Oxygen Species', 'Single Nucleotide Polymorphism', 'NAD(P)H dehydrogenase (quinone) 1, human', 'NQO1 gene', 'NQO1 gene', 'Reduced', 'NQO1 gene', 'enzyme activity', 'NQO1 gene', 'Genetic Polymorphism', 'Increase', 'Risk', 'Malignant neoplasm of gastrointestinal tract', 'NQO1*2 Allele', 'Genetic Polymorphism', 'NQO1 gene', 'Effectiveness', 'Malignant neoplasm of gastrointestinal tract', 'Social Role', 'Biological Markers', 'Forecast of outcome', 'Administration occupational activities', 'Cancer Therapeutic Procedure', 'Clinical Research', 'Investigates', 'NQO1 gene', 'Biological Markers', 'Administration occupational activities', 'Malignant neoplasm of gastrointestinal tract', 'Prophylactic treatment', 'therapeutic aspects']"
75,"['Pediatric brand name', 'Liver Failure, Acute', 'Emergency Situation', 'Administration occupational activities', 'Experience', 'Transplantation of liver', 'Social Determinants of Health', 'Social Determinants of Health', 'Healthcare Disparities', 'Disease', 'Health Services Accessibility', 'Mental association', 'Social Determinants of Health', 'Outcome Measures', 'Tumor Necrosis Factor-Beta', 'Cessation of life', 'Clinical Research', 'Investigates', 'Social Determinants of Health', 'Area', 'Interventional procedure', 'Unrecognized', 'Vision Disparity']"
76,"['Cardiovascular Diseases', 'Groups', 'risk factors', 'COVID19 (disease)', 'COVID19 (disease)', 'Clinical Research', 'Epidemiology', 'COVID19 (disease)', 'Patients']"
77,"['Guidelines', 'Hepatitis C', 'Screening for cancer', 'Age', 'Hepatitis C', 'Screening for cancer', 'Minority Groups', 'Child']"
78,"['Increasing (qualifier value)', 'Burden', 'Liver and Intrahepatic Biliary Tract Carcinoma', 'Europe', 'Investigates', 'Social Determinants of Health', 'Health', 'Liver and Intrahepatic Biliary Tract Carcinoma', 'risk factors', 'Health Services Accessibility', 'Improved', 'Health Outcomes', 'Evidence', 'Differential quality', 'Liver and Intrahepatic Biliary Tract Carcinoma', 'risk factors', 'Incidence', 'Health', 'Outcome Measures', 'United Kingdom', 'Social Determinants of Health', 'Time Perception', 'geographic population', 'Socioeconomic Status', 'Liver and Intrahepatic Biliary Tract Carcinoma', 'risk factors', 'Indication of (contextual qualifier)', 'Access', 'Administration of hepatitis B vaccine', 'Access', 'Alcoholic Liver Diseases', 'Prevalent', 'Persons', 'Economic Instability', 'Migrants', 'geographic population', 'Variant', 'Europe', 'Proportion', 'Liver diseases', 'geographical area', 'Gender', 'socioeconomic', 'Liver Cirrhosis', 'Mortality Vital Statistics', 'Highest', 'Death Rate', 'Persons', 'Disadvantaged Populations', 'Lower - spatial qualifier', 'Educational Status', 'Inadequate (qualifier)', 'Health care facility', 'geographic population', 'Primary', 'Influence', 'BARRIER', 'Fear (Mental Process)', 'Contribution', 'Health Inequities', 'Liver and Intrahepatic Biliary Tract Carcinoma', 'Biochemical Pathway', 'Scientific Study', 'Effect', 'Liver and Intrahepatic Biliary Tract Carcinoma', 'Incidence', 'Outcome Measures', 'Europe, Eastern', 'objective (goal)', 'Evidence-Based Medicine', 'Multilevel Analysis', 'public health medicine (field)', 'Social Determinants of Health', 'Impact food supplement', 'Precipitating Factors', 'Disproportionate', 'Burden', 'Liver and Intrahepatic Biliary Tract Carcinoma', 'Specific qualifier value', 'geographic population']"
79,"['COVID19 (disease)', 'COVID19 (disease)', 'Pandemics', 'Telemedicine', 'Delivery of Health Care', 'Telemedicine', 'care activity', 'Vision Disparity', 'Vulnerable Populations', 'geographic population', 'Patients', 'Practice Experience', 'Data']"
80,"['Americas Ethnicity', 'Diabetes', 'Mental association', 'Diabetes', 'Effectiveness', 'Changing', 'paradigm', 'Guidelines', 'Prophylactic treatment', 'Complication', 'Improving (qualifier value)', 'Quality', 'Life', 'Diabetes Mellitus', 'Administration occupational activities', 'Non-alcoholic Fatty Liver Disease', 'Weight Loss', 'sperm individualization', 'Social Determinants of Health', 'Overcome']"
81,"['Thalassemia', 'Patients', 'Heart', 'Complication', 'Iron Overload', 'High', 'Risk', 'Cardiac complication', 'Induce (action)', 'COVID19 (disease)', 'COVID19 (disease)', 'Normal', 'geographic population', 'Clinical Research', 'Evaluation', 'Early', 'Cardiovascular system', 'Complication', 'Patients', 'Early', 'Recovery - action', 'COVID19 (disease)', 'Stress Cardiac Magnetic Resonance Imaging', 'Magnetic Resonance Imaging']"
82,"['Social Determinants of Health', 'Drug Design', 'Effectiveness', 'Nursing interventions', 'Hepatitis B', 'Systematic Review', 'Social Determinants of Health', 'Hepatitis B', 'Nursing interventions', 'Effectiveness', 'Prophylactic treatment', 'Databases', 'Hepatitis B', 'Gender Equity', 'Social Determinants of Health', 'mental health organization', 'Organisation for Economic Co-Operation and Development', 'Country', 'Screening for cancer', 'Data Extraction', 'Reviewed By (qualifier)', 'Data', 'comparative study publication', 'Design', 'N36', 'Narration', 'Anabolism', 'Social Determinants of Health', 'Nursing interventions', 'Relevance', 'Health Outcomes', 'Social', 'Factor', 'Healthy Worker Effect', 'Effect', 'Health Outcomes', 'Anabolism', 'emergent', 'Heme', 'Prophylactic treatment', 'Screening for cancer', 'Immunization', 'therapeutic aspects', 'Prophylactic treatment', 'Heterogeneity', 'Relevance', 'Health Outcomes', 'Nursing interventions', 'tailor', 'Social Determinants of Health', 'Race:Type:Point in time:^Patient:Nominal', 'Languages', 'Drug usage', 'Socioeconomic Status', 'Heme', 'Nursing interventions', 'Comparative Effectiveness Research', 'Hepatitis B', 'Social', 'Factor', 'Health Outcomes', 'Scientific Study', 'Diversity', 'geographic population', 'Approach (spatial)', 'Interventional procedure', 'objective (goal)', 'Effectiveness', 'Nursing interventions', 'Prophylactic treatment']"
83,"['Vaccination', 'COVID19 (disease)', 'COVID19 (disease)', 'Pandemics', 'aspects of adverse effects', 'Widespread', 'Administration occupational activities', 'COVID19 (disease)', 'Vaccines', 'Evaluation', 'Safety', 'Potential', 'aspects of adverse effects', 'Clinical Research', 'Assessed', 'Incidence', 'aspects of adverse effects', 'AstraZeneca', 'Vaccination', 'Colicin Plasmids', 'Voluntary Workers', 'Male population group', 'Woman', 'Adverse reactions', 'ChAdOx1 nCoV-19', 'AstraZeneca', 'Vaccines', 'Questionnaires', 'findings aspects', 'Incidence', 'Adverse reactions', 'Nervous system structure', 'Signs and Symptoms, Respiratory', 'Dosage', 'second (number)', 'Dosage', 'systematic', 'Symptoms aspect', 'Prevalent', 'aspects of adverse effects', 'second (number)', 'Injection of therapeutic agent', 'Social survey', 'Participant', 'Persons', 'Age', 'Females', 'Adverse event', 'Vaccination', 'Significant', 'Relationships', 'occurrence characteristics', 'aspects of adverse effects', 'Recipient', 'Body mass index procedure', 'Adverse reactions', 'Recipient', 'Frequencies (time pattern)', 'aspects of adverse effects', 'Colicin Plasmids', 'Agender', 'Post vaccination fever', 'Adverse reactions', 'Tolerable']"
84,"['Limited (extensiveness)', 'Data', 'Mental association', 'Malignant neoplasm of urinary bladder', 'Smoking', 'Generalized', 'public health medicine (field)']"
85,"['Increased', 'Vulnerability', 'Physical Examination', 'Social', 'Cognitive', 'Greater', 'Risk', 'Negative', 'health related legal', 'Health Expenditures', 'United Kingdom', 'Frailty', 'Electronic Health Records', 'Data', 'chemical standardization', 'Screening for cancer', 'Canadian', 'Primary Health Care', 'Implementation', 'Canadian', 'Context', 'Acclimatization', 'Frailty', 'Terminology', 'Canada', 'Columbia (ethnic group)', 'Canada', 'Validation', 'research', 'Frailty', 'Primary Health Care', 'Clinician', 'Elderly (population group)', 'British Columbia']"
86,"['Non-alcoholic Fatty Liver Disease', 'Non-alcoholic Fatty Liver Disease', 'Systemic disease', 'Multifactorial', 'Heterogeneity', 'Pathogenesis', 'Chronic liver disease', 'Country', 'Scientific Study', 'Iran', 'Test Result', 'Statistical Prevalence', 'risk factors', 'Non-alcoholic Fatty Liver Disease', 'Clinical Research', 'Systematic Review', 'Meta Analysis (statistical procedure)', 'Estimated', 'Statistical Prevalence', 'risk factors', 'Disease', 'Iran', 'Peer', 'Review [Publication Type]', 'Reporting', 'Systematic Review', 'Meta Analysis (statistical procedure)', 'Statement', 'Science', 'PubMed', 'Scopus', 'Persian language', 'Science', 'Clinical Research', 'Particle', 'Review [Publication Type]', 'Statistical Prevalence', 'Non-alcoholic Fatty Liver Disease', 'Child', 'Confidence Intervals', 'Curie', 'Statistical Prevalence', 'High', 'Adult', 'Scientific Study', 'Curie', 'Scientific Study', 'Mental association', 'Non-alcoholic Fatty Liver Disease', 'Coitus', 'Relationships', 'Scientific Study', 'Non-alcoholic Fatty Liver Disease', 'Statistical Prevalence', 'Increased', 'Body mass index procedure', 'Scientific Study', 'Mental association', 'FBXO8 gene', 'Non-alcoholic Fatty Liver Disease', 'Iran', 'Non-alcoholic Fatty Liver Disease', 'Statistical Prevalence', 'Comparison', 'Area', 'Unfavorable', 'living situation', 'risk factors', 'Non-alcoholic Fatty Liver Disease', 'Nursing interventions', 'Control Groups', 'risk factors', 'PREVENT (product)', 'Non-alcoholic Fatty Liver Disease']"
87,"['Clinical Research', 'Investigates', 'Survival Rate', 'Malignant Neoplasms', 'Patients', 'Cancer Patient', 'Korea', 'Site', 'Liver', 'Vision Disparity', 'Measured', 'Impact food supplement', 'Overall Publication Type', 'Survival Rate', 'Assessed', 'Physical Strength', 'Cohort', 'Cancer Patient', 'Males', 'Main', 'Primary malignant neoplasm', 'Site', 'Stomach']"
88,"['Vision Disparity', 'Access', 'Living Donors', 'Transplantation of liver', 'United States', 'Mental association', 'Social Determinants of Health', 'Health', 'Established', 'Retrospective Cohort Study', 'Transplantation of liver', 'Recipient', 'Central', 'United Network for Organ Sharing', 'Databases', 'Patients', 'Zip Code', 'Social Determinants of Health', 'Measures', 'Data', 'Source', 'Temporal - Regional site descriptor', 'Central', 'Neighborhood', 'Social Deprivation Index', 'Disadvantaged Populations', 'Assessed', 'Mental association', 'Increasing (qualifier value)', 'selective dissemination of information', 'Receipt Date', 'Cessation of life', 'Transplantation of liver', 'Recipient', 'Clinical Research', 'Social Determinants of Health', 'Measures', 'selective dissemination of information', 'Transplantation', 'Recipient', 'Lower - spatial qualifier', 'selective dissemination of information', 'Midline (qualifier value)', 'selective dissemination of information', 'Midline (qualifier value)', 'selective dissemination of information', 'Decreased', 'Study models', 'selective dissemination of information', 'Quintile', 'Transplantation', 'Threshold', 'selective dissemination of information', 'Increasing (qualifier value)', 'selective dissemination of information', 'Reduced', 'Bibliographic Reference', 'Social Determinants of Health', 'Measures', 'selective dissemination of information', 'evaluation/testing', 'Vision Disparity', 'Context', 'Outreach', 'Reduced', 'Vision Disparity', 'Target', 'Ultrasonography', 'Zip Code']"
89,"['Malignant Neoplasms', 'Etiology aspects', 'Cessation of life', 'Malignant tumor of cervix', 'Malignant Neoplasms', 'Malignant Neoplasms', 'Woman', 'Survival Rate', 'Evaluation', 'Success', 'Assessed', 'Survival Rate', 'Malignant tumor of cervix', 'Asia']"
90,"['Liver function', 'Laboratory Procedures', 'Iranian (ethnic group)']"
91,"['Non-alcoholic Fatty Liver Disease', 'Non-alcoholic Fatty Liver Disease', 'Benign', 'Patients', 'Disease', 'Liver', 'Failure (biologic function)', 'Liver', 'Liver Cirrhosis', 'Liver carcinoma']"
92,"['Generalized', 'Liver', 'Community', 'Established', 'criteria', 'Liver diseases', 'SLC17A5 gene', 'Metabolic', 'Liver diseases', 'Metabolic', 'Alcoholic Liver Diseases', 'Metals', 'Estimated', 'Burden', 'SLC17A5 gene', 'Subtype (attribute)', 'Unfavorable', 'Social Determinants of Health', 'Health', 'Ultrasonography', 'Adult', 'Clinical', 'Social Factors', 'Vision Disparity', 'Subgroup A Nepoviruses']"
93,"['Social Determinants of Health', 'Quality', 'Transplantation of liver', 'care activity', 'Assessed', 'Mental association', 'Neighborhood', 'Transplantation', 'Outcome Measures', 'Mitigate']"
94,"['Vision Disparity', 'Waiting Lists (patient)', 'Mortality Vital Statistics', 'Transplantation of liver', 'Tumor Necrosis Factor-Beta', 'New', 'Social Determinants of Health']"
95,"['Hypertensive disease', 'Hypertensive disease', 'Primary', 'risk factors', 'Heart Diseases', 'Cerebrovascular accident', 'Meta Analysis (statistical procedure)', 'Systematic Review', 'Science of Statistics', 'Statistical Prevalence', 'Rating (action)', 'Hypertensive disease', 'Iranian (ethnic group)', 'Adolescent (age group)', 'Adult', 'Human Age Group']"
96,"['Changing', 'Genus: Coronavirus', 'Disease', 'COVID19 (disease)', 'Crisis', 'Restricted', 'Isolated', 'Vulnerable Populations', 'Patients', 'Liver carcinoma', 'altretamine/cisplatin/cyclophosphamide protocol', 'Medical care', 'COVID19 (disease)', 'Pandemics', 'Diagnosis', 'therapeutic aspects', 'altretamine/cisplatin/cyclophosphamide protocol']"
97,"['Independence', 'Predictor', 'Mortality Vital Statistics', 'removal technique', 'HCCS gene']"
98,"['Malignant Vaginal Neoplasm', 'Etiology aspects', 'Mortality Vital Statistics', 'Woman', 'Developing Countries', 'Continuance of life', 'Rating (action)', 'Malignant Vaginal Neoplasm', 'Essential', 'Investigates', 'Therapeutic procedure', 'Screening for cancer', 'Survival Rate', 'Malignant Vaginal Neoplasm', 'Asia']"
99,"['Safety', 'Hospitals', 'Dental Facilities', 'Healthcare services', 'Medical service', 'Underserved Populations', 'Burden', 'Chronic liver disease', 'Manifest', 'Liver Cirrhosis', 'Liver', 'High', 'geographic population', 'Poverty', 'Social Determinants of Health', 'Delayed Diagnosis', 'Presentation', 'High', 'Mortality Vital Statistics', 'Policy', 'Changing', 'Medicaid', 'Cell Growth', 'Access', 'Insurance', 'overview', 'Literature', 'care activity', 'Chronic liver disease', 'Liver diseases', 'Community', 'narrative review', 'controversy', 'definition - ActMoodCompletionTrack', 'Administration occupational activities', 'Condition', 'Liver and Intrahepatic Biliary Tract Carcinoma', 'chronic', 'Hepatitis A', 'Liver Cirrhosis', 'Transplantation of liver', 'Impact food supplement', 'Medicaid', 'Outcome Measures', 'Provider', 'Nursing interventions', 'ras GTPase-Activating Proteins', 'care activity', 'Vulnerable Populations', 'geographic population', 'Chronic liver disease']"
100,"['Primary sclerosing cholangitis', 'Primary sclerosing cholangitis', 'Infrequent', 'Autoimmune Diseases', 'physiopathological', 'Ulcerative Colitis', 'Ulcerative Colitis', 'Transplantation of liver', 'Curative - procedure intent', 'Patients', 'Astringents', 'Organ', 'Availability of', 'BARRIER', 'Insurance', 'Health Literacy', 'low', 'Worsening pattern', 'Overall Publication Type', 'Health care facility', 'Uninsured', 'Male population group', 'Did not receive therapy or drug for', 'Ulcerative Colitis', 'Diagnosis', 'Primary sclerosing cholangitis', 'BARRIER', 'Medical care', 'low', 'Health Literacy', 'Treating', 'Condition', 'Primary sclerosing cholangitis', 'research', 'Investigates', 'Alternative', 'Therapeutic procedure', 'Primary sclerosing cholangitis']"
101,"['Liver carcinoma', 'altretamine/cisplatin/cyclophosphamide protocol', 'Large nose', 'Anthropogenic Effects', 'Minority Groups', 'Patients', 'Lower - spatial qualifier', 'Socioeconomic Status', 'Social', 'Factor', 'Health', 'Hematoma, Subdural', 'Vision Disparity', 'Health Services Accessibility', 'Outcome Measures', 'Relationships', 'Hematoma, Subdural', 'Continuance of life', 'regional', 'altretamine/cisplatin/cyclophosphamide protocol']"
102,"['Social Determinants of Health', 'Contribution', 'Outcome Measures', 'Unmet', 'Social', 'Risk', 'Transplantation', 'Improved', 'Child', 'Provider', 'Social', 'Risk', 'Menstruation']"
103,"['Social Determinants of Health', 'Reusable Drivers', 'health disparity', 'American Indian or Alaska Native', 'geographic population', 'United States', 'High', 'Incidence Rate', 'LIVER/STOMACH', 'Colorectal Carcinoma', 'Racial Groups', 'Clinical Research', 'Incidence Rate', 'Malignant neoplasm of gastrointestinal tract', 'Social vulnerability', 'Score', 'Incident', 'Diagnosis', 'Identified', 'geographic population', 'Cancer Registry', 'Asian Indian', 'Corrected Age', 'Incidence Rate', 'geographic population', 'LIVER/STOMACH', 'Colorectal Carcinoma', 'Comparison', 'geographic population', 'Social Vulnerability Index', 'High', 'geographic population', 'Alaska', 'Incidence Rate', 'geographic population', 'High', 'geographic population', 'Social Vulnerability Index', 'High', 'Social vulnerability', 'High', 'Malignant Neoplasms', 'Incidence', 'geographic population', 'geographic population', 'Social Vulnerability Index', 'Social vulnerability', 'Drug Design', 'Effectiveness', 'Nursing interventions', 'geographic population']"
104,"['Non-alcoholic Fatty Liver Disease', 'Non-alcoholic Fatty Liver Disease', 'Widespread', 'Hand', 'Social', 'Unequal', 'Socioeconomic Status', 'Tomography, Emission-Computed, Single-Photon', 'Health', 'Clinical Research', 'Investigates', 'Relationships', 'Non-alcoholic Fatty Liver Disease']"
105,"['Clinical Research', 'Evaluation', 'regional', 'Social vulnerability', 'Geographic', 'Patients', 'Transplantation of liver', 'Liver carcinoma', 'altretamine/cisplatin/cyclophosphamide protocol', 'Study models', 'End Stage Liver Disease', 'exception - ResponseLevel']"
106,"['Non-alcoholic Fatty Liver Disease', 'Non-alcoholic Fatty Liver Disease', 'Prevalent', 'Chronic liver disease', 'Gene Expression', 'Predictor', 'Non-alcoholic Fatty Liver Disease', 'Disease susceptibility', 'protein expression', 'Non-alcoholic Fatty Liver Disease', 'Patients', 'Genetic Polymorphism', 'Viral Shedding', 'physiopathological', 'Disease', 'Clinical Research', 'Participant', 'Healthy Control', 'Persons', 'Non-alcoholic Fatty Liver Disease', 'Prescreen', 'objective (goal)', 'Genotype', 'Gene Frequency', 'Variation (Genetics)', 'Participant', 'Diagnosis', 'Non-alcoholic Fatty Liver Disease', 'High', 'Body mass index procedure', 'Body mass index procedure', 'Persons', 'Control Groups', 'Genetic Polymorphism', 'Non-alcoholic Fatty Liver Disease', 'Control Groups', 'With frequency', 'Non-alcoholic Fatty Liver Disease', 'Groups', 'Persons', 'cholecalciferol', 'CD55 gene', 'Decreased', 'High Risk Acute Leukemia', 'Alanine Transaminase', 'Aspartate Transaminase', 'TT genotype', 'Increased', 'High Risk Acute Leukemia', 'Alanine Transaminase', 'Aspartate Transaminase', 'Test Result', 'Increased', 'Risk', 'Non-alcoholic Fatty Liver Disease', 'Genetic Polymorphism', 'research', 'Molecular Mechanisms of Pharmacological Action', 'Up-Regulation (Physiology)', 'Persons', 'Non-alcoholic Fatty Liver Disease']"
107,"['Anabolism', 'degradation aspects', 'Endocannabinoids', 'Location', 'cannabinoid receptor', 'Cannabinoids', 'Clinical action', 'neuromuscular function', 'Digestive organ structure', 'Documented', 'cinobufotalin']"
108,"['Lip structure', 'Oral cavity', 'Malignant neoplasm of pharynx', 'Contribution', 'Cancer Burden', 'Comprehensive', 'Evaluation', 'Burden', 'Policy', 'Cognitive function: planning']"
109,"['Social Determinants of Health', 'Health Services Accessibility', 'Mental association', 'Persistent', 'Poverty', 'Pancreatic Polypeptide', 'Ethnicity', 'Opioids', 'Access', 'Patients', 'Malignant neoplasm of gastrointestinal tract', '1/3 meter (distance vision finding)']"
110,"['Liver Cirrhosis', 'North America', 'Epidemic', 'Non-alcoholic Fatty Liver Disease', 'Non-alcoholic Fatty Liver Disease', 'Reproduction', 'Colicin Plasmids', 'Impact food supplement', 'Perinatal period', 'Healthcare Utilization', 'Pregnant Women', 'Non-alcoholic Fatty Liver Disease', 'Liver Cirrhosis']"
111,"['Social Determinants of Health', 'cancer care', 'Health care facility', 'Data', 'Social', 'Factor', 'test health data', 'Liver carcinoma', 'Groups', 'Patients', 'Malignant Neoplasms', 'Treating']"
112,"['Glycemic Control', 'Liver function', 'Mechanism (attribute)', 'Clinical Research', 'Quantitation', 'Effect', 'Dietary Supplementation', 'Outcome Measures']"
113,"['Pancreatic carcinoma', 'CP protocol', 'Fatal', 'Malignant Neoplasms', 'Incidence', 'Mortality Vital Statistics', 'research', 'Investigates', 'trends qualifier', 'Disease Hotspot', 'year', 'Global Burden of Disease', 'Data']"
114,"['Cardiovascular Diseases', 'Cardiovascular Diseases', 'public health medicine (field)', 'risk factors', 'Cardiovascular Diseases', 'Arteriosclerosis', 'Hypertensive disease', 'Diabetes', 'Dyslipidemias', 'Inflammation', 'MET Gene Alteration Positive', 'research', 'Correlation', 'Metabolic', 'Intestinal Microbiome', 'Diet', 'risk factors', 'Intestinal Microbiome', 'Homo sapiens', 'Functional', 'Metabolic Pathway', 'Enzymes', 'Homo sapiens', 'Genome', 'Catabolism', 'Polysaccharides', 'trimethyloxamine', 'Intestinal Microbiome', 'Corticosterone', 'Immunologic Adjuvants', 'Inflammatory', 'choline', 'carnitine', 'Diet, High-Fat', '5-Trimethoxyamphetamine', 'Bacteria', 'Liver', 'Metabolism', 'Changing', '5-Trimethoxyamphetamine', 'trimethyloxamine', 'trimethyloxamine', 'Macrophage Activation', 'Tissue damage', 'Endothelium, Vascular', 'Decreasing', 'Bile Acids', 'Permeability', 'Intestines', 'Extravasation', 'Heart failure', 'Colicin Plasmids', 'Induce (action)', 'Systemic autoinflammation', 'Increasing (qualifier value)', 'Intestines', 'Extravasation', 'High', 'trimethyloxamine', 'Levels (qualifier value)', 'Promotion (action)', 'development aspects', 'Arteries', 'Arteriosclerosis', 'Coronary heart disease', 'Healthy', 'Symbiosis', 'Intestinal Microbiome', 'Host (organism)', 'Diet', 'Intestines', 'Epithelial', 'Mucous Membrane', 'Reduced', 'Inflammation', 'Controlling (action)', 'Blood Pressure']"
115,"['Data', 'Hepatitis A', 'Liver carcinoma', 'altretamine/cisplatin/cyclophosphamide protocol', 'Impact food supplement', 'Patients', 'Lower - spatial qualifier', 'Socioeconomic Status', 'altretamine/cisplatin/cyclophosphamide protocol', 'Cell cluster', 'Poverty', 'Area', 'New York City']"
116,"['Statistical Prevalence', 'Glaucoma, Primary Open Angle', 'Relationships', 'Smoking', 'Potential', 'risk factors', 'Glaucoma, Primary Open Angle']"
117,"['Transplantation of liver', 'Tumor Necrosis Factor-Beta', 'Hepatitis, Alcoholic', 'acetylene hydratase activity', 'Practice Experience', 'Social', 'Factor', 'Health', 'Evaluation', 'Languages', 'Patients', 'Social Interaction', 'Health Care Systems', 'Characteristics', 'Patients', 'acetylene hydratase activity', 'Evaluation', 'Tumor Necrosis Factor-Beta']"
118,"['Social Determinants of Health', 'Social Determinants of Health', 'Alkalemia', 'Homo sapiens', 'Liver diseases', 'Literature', 'Social Determinants of Health', 'Persons', 'risk factors', 'Social Determinants of Health']"
119,"['Epidemiology', 'Evidence', 'Effect', 'Ambient', 'Air (substance)', 'Pollution', 'Brain', 'Relationships', 'Injury due to exposure to external cause', 'Air (substance)', 'Pollution', 'Incidence', 'Brain Neoplasms']"
120,"['altretamine/cisplatin/cyclophosphamide protocol', 'Primary', 'Liver and Intrahepatic Biliary Tract Carcinoma', 'Related to Cancer', 'Cessation of life', 'United States', 'altretamine/cisplatin/cyclophosphamide protocol', 'Large nose', 'Minority Groups', 'Organized', 'Patients', 'Provider', 'Health System', 'Societal Factors', 'Minority Groups', 'narrative review', 'National Center on Minority Health and Health Disparities', 'altretamine/cisplatin/cyclophosphamide protocol', 'care activity', 'Rural-Urban Continuum Code', 'Literature', 'Relationships', 'Vision Disparity', 'Ethnicity', 'Metal-Organic Frameworks', 'Pleckstrin Homology Domains', 'biology (field)', 'Behavior', 'Health Care Systems', 'Interpersonal', 'Community', 'Social Norms', 'Influence', 'research', 'Promotion (action)', 'Health Equity', 'altretamine/cisplatin/cyclophosphamide protocol', 'care activity', 'Clinician', 'Research Personnel', 'Mitigate', 'altretamine/cisplatin/cyclophosphamide protocol', 'care activity', 'altretamine/cisplatin/cyclophosphamide protocol', 'research', 'Patients', 'Practice Experience', 'altretamine/cisplatin/cyclophosphamide protocol', 'care activity', 'Race:Type:Point in time:^Patient:Nominal', 'Ethnicity', 'Health', 'Ethnicity', 'Priorities', 'development aspects', 'Programs - Publication Format', 'Nursing interventions', 'Experience', 'Racial Groups']"
121,"['Clinical Research', 'Investigates', 'Malignant neoplasm of stomach', 'Gas Chromatography', 'Abnormal', 'Body mass index procedure', 'Body mass index procedure', 'Groups', 'systematic', 'Scopus', 'January', 'January', 'Pooled Sample', 'Odds Ratio', 'Confidence Intervals', 'Curie', 'Assessed', 'Scientific Study', 'Participant', 'Systematic Review', 'RR genotype', 'Gas Chromatography', 'Curie']"
122,"['Life Style', 'Changing', 'low', 'Range of Motion, Articular', 'Increased', 'Statistical Prevalence', 'Metabolic Syndrome X', 'ETV3 gene', 'Cardiovascular Diseases', 'Relationships', 'Exercise', 'ETV3 gene', 'Statistical Technique', 'Clinical Research']"
123,"['Policy', 'Transplantation of liver', 'Tumor Necrosis Factor-Beta', 'Influence', 'Preceptorship', 'Monitor Device', 'trends qualifier', 'Access', 'Outcome Measures', 'Patients', 'Review [Publication Type]', 'findings aspects', 'Health Equity', 'research', 'year', 'evaluation/testing', 'Health Inequities', 'Stage', 'Tumor Necrosis Factor-Beta', 'Outcome Measures']"
124,"['ovarian neoplasm', 'Malignant Neoplasms', 'Woman', 'Cancer-Related Death', 'Poverty', 'Forecast of outcome', 'Mortality Vital Statistics', 'Absent', 'Signs and Symptoms', 'Late stage', 'Late Diagnosis', 'Survival Rate', 'Patients', 'Diagnosis', 'ovarian neoplasm', 'Assessed', 'Standard of Care', 'Clinical Research', 'Evaluation', 'Survival Rate', 'ovarian neoplasm', 'Patients', 'Asia']"
125,"['Oxidative Stress', 'Contribution', 'Injury of liver', 'Antioxidants', 'Improved', 'Liver function', 'Hepatoprotective Agent', 'Antioxidants', 'Clinical Research', 'Mental association', 'Antioxidants', 'Clinical Enzyme Tests (procedure)', 'Cross-Sectional Studies', 'Cohort Studies', 'ARPP21 gene', 'Data', 'Epidemiologic Studies', 'Persian language', 'Participant', 'Age', 'year', 'Clinical Research', 'geographic population', 'Males', 'Woman', 'Dietary Intake', 'Frequencies (time pattern)', 'Aspartate Transaminase', 'Aspartate Transaminase', 'Alanine Transaminase', 'Alanine Transaminase', 'Glutamyl transferase', 'Gamma-glutamyl transferase', 'Alkaline Phosphatase', 'Alkaline Phosphatase', 'Measured', 'Analyzer, device', 'Investigates', 'Mental association', 'High', 'Finding of liver enzyme levels', 'Intake', 'Antioxidants', 'Study models', 'High', 'Consumption of goods', 'selenium', 'VIT gene', 'Carotene', 'Cryptoxanthins', 'Odds Ratio', 'High', 'Alkaline Phosphatase', 'Decreased', 'Bibliographic Reference', 'Groups', 'ORALIT', 'Research Subject', 'High', 'Consumption of goods', 'selenium', 'Vitamins', 'Carotenoids', 'Carotene', 'Carotene', 'Cryptoxanthins', 'Decreased', 'Odds Ratio', 'High', 'Alkaline Phosphatase', 'findings aspects', 'Hypothesis', 'Vitamins', 'Carotenoids', 'Improvement', 'Alkaline Phosphatase', 'Suppressor Device', 'development aspects', 'Injury of liver']"
126,"['Clinical Research', 'Evaluation', 'Hepatotoxicity', 'buprenorphine', 'Lactating (finding)', 'Rattus norvegicus', 'buprenorphine', 'COMMD3 gene', 'Opioids', 'Safety', 'Effectiveness', 'Analgesics, Opioid', 'Scientific Study', 'Safety', 'COMMD3 gene', 'Maintenance', 'therapeutic aspects', 'addict', 'Patients']"
127,"['Usually Need Help from Another Person for Arising', 'Hepatitis C', 'Hepatitis C', 'Cure (remedy)', 'Persons', 'Homelessness', 'APEH gene', 'Critical', 'Social Determinants of Health', 'Health', 'Housing', 'Mental disorders', 'Alcohol or Other Drugs use']"
128,"['Sentinel node (disorder)', 'SLN gene', 'Biopsy', 'Recommendation', 'Interventional procedure', 'Axilla', 'Clinical', 'Negative Lymph Node', 'Early', 'Malignant neoplasm of breast', 'Diagnosis', 'Clinical Research', 'Genes', 'Prediction', 'Malignant neoplasm of breast', 'Patients', 'Tumor tissue sample', 'Malignant neoplasm of breast', 'Patients', 'Analysis', 'Gene Expression', 'Genes', 'Quantitative (qualifier value)', 'Mammary Gland Parenchyma', 'Patients', 'Partial', 'Simple mastectomy', 'Gene Signature', 'Tumor stage', 'Estrogen Receptors', 'Endoplasmic Reticulum', 'Status', 'findings aspects', 'Negative', 'lymph nodes', 'Neoplasm Metastasis', 'Neoplasm Micrometastasis', 'KRT19 gene', 'Relationships', 'LINC01194 gene', 'Characteristics', 'Signs and Symptoms', 'LINC01194 gene']"
129,"['Indication of (contextual qualifier)', 'Geographic', 'Vision Disparity', 'Mortality Vital Statistics', 'Ultrasonography', 'Investigates', 'Impact food supplement', 'travel', 'Distance', 'Transplantation of liver', 'Tumor Necrosis Factor-Beta', 'Programs - Publication Format', 'Social vulnerability', 'age differences', 'Mortality Vital Statistics']"
130,"['Overlap syndrome', 'Oral region', 'Presentation', 'Numerous', 'Liver diseases', 'Characteristics', 'Patients', 'Providing presence (regime/therapy)', 'Autoimmune Chronic Hepatitis', 'Insemination, Artificial, Homologous', 'Protein Domain', 'Primary sclerosing cholangitis', 'Primary sclerosing cholangitis', 'Primary', 'Primary Biliary Cholangitis', 'Primary Biliary Cholangitis', 'Standard of Care', 'Therapeutic immunosuppression', 'ursodiol', 'preference', 'therapeutic aspects', 'Primary Biliary Cholangitis', 'Transplantation of liver', 'Tumor Necrosis Factor-Beta', 'Severe (severity modifier)', 'Case (situation)', 'Hispanics', 'High', 'Statistical Prevalence', 'Chronic liver disease', 'Complication', 'Portal Hypertension', 'Probability', 'Tumor Necrosis Factor-Beta', 'with issues', 'Social Determinants of Health', 'Social Determinants of Health', 'Hispanics', 'Transplantation', 'Report (document)', 'Woman', 'Immigrant (person)', 'Latin American', 'Symptoms aspect', 'Worsening pattern', 'Liver diseases', 'year', 'Inappropriate', 'Late Diagnosis', 'BARRIER', 'Health Care Systems', 'Patient History', 'Worsening pattern', 'Previous', 'Symptoms aspect', 'Abdomen distended', 'Diagnosis', 'Insemination, Artificial, Homologous', 'Primary sclerosing cholangitis', 'Syndrome', 'Patients', 'Steroids', 'ursodiol', 'Improvement', 'Migratory (qualifier value)', 'Status', 'Diagnosis', 'Increased', 'Risk', 'Complication', 'Medication Management', 'Probability', 'Transplantation of liver', 'Patients', 'Transplantation of liver', 'Evaluation', 'High', 'End Stage Liver Disease', 'Model for end-stage liver disease score:Score:Pt:^Patient:Qn', 'Score', 'Policy', 'Reduced', 'Vision Disparity', 'Hispanics', 'Patients', 'High', 'Risk', 'Removed', 'Clinical Deterioration', 'Daily', 'Hispanics', 'Highest', 'Percent (qualifier value)', 'Ethnicity', 'Overall Publication Type', 'Tumor Necrosis Factor-Beta', 'Etiology aspects', 'Phenomenon', 'Essential', 'Increasing (qualifier value)', 'Awareness', 'Problem', 'research', 'Tumor Necrosis Factor-Beta', 'Vision Disparity']"
131,"['Colorectal Carcinoma', 'Colorectal Carcinoma', 'France', 'Social', 'Unequal', 'Health', 'Disadvantaged Populations', 'Patients', 'Characterization', 'Reduced', 'Incidence', 'Colorectal Carcinoma', 'Explanation', 'survivin complex', 'Multidimensional', 'Variable (uniformity)', 'Health Care Systems', 'Patients', 'Lower - spatial qualifier', 'Participation', 'Screening for cancer', 'Colorectal Carcinoma', 'Diagnosis', 'Frequently', 'therapeutic aspects', 'Disadvantaged Populations', 'Patients', 'Risk', 'Open approach', 'Severe (severity modifier)', 'Postoperative Period', 'Pharmacotherapy', 'Clinical Research', 'Social Deprivation', 'Within', 'Health care facility', 'Territoriality', 'Individualized', 'France', 'Social Determinants of Health', 'Malignant Neoplasms', 'Registries', 'Social Deprivation', 'Aggregate', 'Measures', 'Social Environment', 'Persons', 'Identification (Psychology)', 'Comprehension', 'Mechanism (attribute)', 'Social Deprivation', 'Programs - Publication Format', 'Practice Experience']"
132,"['Chronic liver disease', 'Hispanic or Latino', 'Highest', 'Non-alcoholic Fatty Liver Disease', 'Liver diseases', 'Persons', 'Asian Americans', 'Black Caribbean', 'Highest', 'Hepatitis C', 'American Indians', 'alaskan', 'Native (qualifier value)', 'Vision Disparity', 'Disease', 'Burden', 'Minority Groups', 'Therapeutic procedure', 'Transplantation of liver', 'Vision Disparity', 'Geography', 'Alcoholic Liver Diseases', 'Health Equity', 'Root Cause Analysis', 'Health Inequities', 'Social', 'Factor', 'Health', 'Health Outcomes', 'Physical Strength', 'Collaboration', 'Patients', 'Community', 'REMS Stakeholder', 'Health Personnel', 'Health Care', 'Institution (social concept)', 'Entity Name Part Qualifier - professional', 'Review [Publication Type]', 'Strategy', 'Potential', 'Improved', 'Quality', 'Promotion (action)', 'Gender Equity', 'Liver']"
133,"['Liver carcinoma', 'altretamine/cisplatin/cyclophosphamide protocol', 'High', 'Prevalent', 'Asian Americans', 'Pacific Islander Americans', 'alpha 1-antitrypsin', 'Heterogenous', 'Subgroup A Nepoviruses', 'Knowledge', 'altretamine/cisplatin/cyclophosphamide protocol', 'Outcome Measures', 'Subgroup A Nepoviruses', 'alpha 1-antitrypsin', 'Medical Surveillance', 'Surveillance, Epidemiology, and End Results (SEER) Program', 'Databases', 'altretamine/cisplatin/cyclophosphamide protocol', 'Patients', 'alpha 1-antitrypsin', 'Ethnicity', 'Data', 'Demography', 'Socioeconomic Status', 'Neoplasms', 'Characteristics', 'therapeutic aspects', 'Continuance of life', 'ROC Curve', 'Performed', 'Asian Americans', 'Ethnicity', 'Secondary Data Analysis', 'Patients', 'Subgroup A Nepoviruses', 'Asian Americans', 'Ethnicity', 'Pacific Islander Americans', 'Groups', 'Age', 'year', 'Asian Americans', 'Income', 'Proportion', 'Rural Area', 'Asian Americans', 'Statistical Significance', 'age differences', 'Tumor size', 'Pretreatment (substance)', 'alpha-Fetoproteins', 'Levels (qualifier value)', 'Operative Surgical Procedures', 'Groups', 'Asian Americans', 'Midline (qualifier value)', 'month', 'month', 'Secondary Data Analysis', 'Subgroup A Nepoviruses', 'Asian Americans', 'Ethnicity', 'age differences', 'Tumor size', 'With staging', 'Continuance of life', 'alpha 1-antitrypsin', 'Neoplasms', 'Characteristics', 'therapeutic aspects', 'Asian Americans', 'High', 'Continuance of life', 'socioeconomic', 'Health Services Accessibility', 'Clinical Research', 'Continuance of life', 'Vision Disparity', 'alpha 1-antitrypsin', 'Ethnicity']"
134,"['Hepatitis B, Chronic', 'Hepatitis B', 'Virus Diseases', 'Early', 'Life', 'Failure (biologic function)', 'Prophylactic treatment', 'Administration occupational activities', 'Liver Cirrhosis', 'Malignant Neoplasms', 'Hepatitis B', 'Persons', 'Africa South of the Sahara', 'Psychophysiology', 'Social', 'Anthropogenic Effects', 'Hepatitis B', 'Influence', 'Coitus', 'Gender', 'Health Inequities', 'Access', 'Timely', 'Sensitive', 'Diagnosis', 'Effectiveness', 'Administration occupational activities', 'Social Interaction', 'Structure', 'Unequal', 'Race:Type:Point in time:^Patient:Nominal', 'Biomedicine', 'Hepatitis B', 'Prophylactic treatment', 'Diagnosis', 'therapeutic aspects', 'Affecting', 'Community', 'Explanation', 'Study models', 'Biomedicine', 'Affecting', 'Persons', 'Community', 'Integrated', 'Biomedicine', 'Practice Experience', 'Social Environment', 'Shapes', 'Personal Attribute', 'Clinical', 'public health medicine (field)', 'Response process', 'Hepatitis B', 'Conscious', 'Effectiveness', 'Response process', 'Hepatitis B', 'Hepatitis B', 'Hepatitis', 'Associated with', 'Mortality Vital Statistics']"
135,"['Vision Disparity', 'Tumor Necrosis Factor-Beta', 'Waiting Lists (patient)', 'Social Determinants of Health', 'Health', 'Colicin Plasmids', 'Automobile Driving', 'Health Inequities', 'Tumor Necrosis Factor-Beta', 'Social Determinants of Health', 'Potential', 'Characterization', 'Drug Design', 'cellular targeting', 'Nursing interventions', 'Promotion (action)', 'Problem', 'Social Determinants of Health', 'Vision Disparity', 'Reporting', 'Nursing interventions', 'Retrospective Studies', 'Process', 'Data Mapping', 'County', 'Tract', 'Censuses', 'Groups', 'Spatial Distribution', 'Potential', 'Vision Disparity', 'Patient referral', 'Community', 'Numerous', 'Pleckstrin Homology Domains', 'Social Determinants of Health', 'Evaluation', 'Genetic Selection', 'Variability', 'Large nose', 'low', 'Patient referral', 'County', 'Highest', 'Liver diseases', 'Mortality Vital Statistics', 'Neighborhood', 'Quintile', 'Quartile', 'Black Populations', 'Persons', 'Expected (qualifier)', 'Demography', 'geographic population', 'Evaluation', 'Tumor Necrosis Factor-Beta', 'Identified', 'Poverty', 'Educational Status', 'Social Determinants of Health', 'Demonstrates', 'Study models', 'Evaluation', 'cellular targeting', 'Nursing interventions', 'Tumor Necrosis Factor-Beta', 'Access']"
136,"['Asthma', 'Chronic disease of respiratory system', 'Persons', 'Clinical Research', 'Statistical Prevalence', 'Asthma', 'East', 'Azerbaijan', 'Investigates', 'Mental association', 'Asthma', 'Exogenous Factors']"
137,"['Acre USA Survey', 'Cessation of life', 'Suicide', 'ethanol', 'Alcoholic Liver Diseases', 'Drug Overdose', 'Veterans', 'Large nose', 'Impacted tooth', 'Limited (extensiveness)', 'research', 'Relationships', 'Community', 'Community', 'Economics', 'Condition', 'Providing presence (regime/therapy)', 'TBATA gene', 'statistical cluster', 'Suicide', 'Alcohol Related Disorders', 'Cessation of life', 'Colorado', 'Veterans', 'Death Rate', 'Colorado', 'geographic population', 'Veterans']"
138,"['Clinical Research', 'Detected (finding)', 'Gene Signature', 'RNA Sequence', 'Data', 'Identification (Psychology)']"
139,"['Social Determinants of Health', 'Access', 'Cancer Death Rate', 'parent deprivation', 'Associated with', 'Mortality Vital Statistics', 'altretamine/cisplatin/cyclophosphamide protocol', 'Cholangiocarcinoma', 'Controlling (action)', 'Persons', 'Social Determinants of Health']"
140,"['Administration occupational activities', 'Invasive infections', 'Substance Use Disorders', 'Parenteral Nutrition', 'Microbicides', 'Treatment outcome', 'Patient Non-Compliance', 'Complete', 'Parenteral Nutrition', 'Microbicides']"
141,"['Evaluation', 'evaluation/testing', 'Relationships', 'Metabolic Syndrome X', 'Alanine Transaminase', 'Alanine Transaminase', 'Aspartate Transaminase', 'Gamma-glutamyl transferase', 'Gamma-glutamyl transferase', 'Alkaline Phosphatase', 'Cohort Studies', 'ARPP21 gene', 'Data', 'ARPP21 gene', 'Epidemiologic Studies', 'Iran', 'Participant', 'BaseLine dental cement', 'Phase', 'ARPP21 gene', 'Questionnaires', 'Metabolic Syndrome X', 'ETV3 gene', 'High', 'Levels (qualifier value)', 'Metabolic Syndrome X', 'Logistic Regression', 'Statistical Prevalence', 'ETV3 gene', 'Participant', 'Aspartate Transaminase', 'Alanine Transaminase', 'Alkaline Phosphatase', 'Gamma-glutamyl transferase', 'Increased', 'Increasing (qualifier value)', 'ETV3 gene', 'Component object', 'Alanine Transaminase', 'Aspartate Transaminase', 'Gamma-glutamyl transferase', 'Alkaline Phosphatase', 'Odds Ratio', 'ETV3 gene', 'ETV3 gene', 'Increased', 'Levels (qualifier value)', 'High', 'Biological Markers', 'ETV3 gene']"
142,"['Patients', 'Surgical Stoma', 'Impaired', 'Acclimatization', 'Self Efficacy', 'Nursing Process', 'nursing therapy', 'Investigates', 'Knowledge acquisition', 'Nursing Process', 'Self-care interventions', 'Knowledge', 'Performance', 'Elderly (population group)', 'Patients', 'Intestinal stoma']"
143,"['Metabolic Syndrome X', 'ETV3 gene', 'Metabolic Diseases', 'Increasing (qualifier value)', 'Statistical Prevalence', 'Extension', 'Life Expectancy', 'Clinical Research', 'Investigates', 'ETV3 gene', 'Statistical Prevalence', 'Factor', 'Azerbaijan', 'geographic population']"
144,"['Listeria monocytogenes', 'Reservoir device', 'foodborne', 'Pathogenic organism', 'Infection', 'Impact food supplement', 'Pregnancy Outcome', 'leucine', 'Listeriosis', 'Groups', 'Woman']"
145,"['HIV', 'Primary immune deficiency disorder', 'Etiology aspects', 'Disease', 'Burden', 'Mortality Vital Statistics', 'Africa South of the Sahara', 'Epidemic', 'Joints', 'United Nations', 'Sustainable Development', 'objective (goal)', 'HIV', 'Burden', 'control act - information', 'Effectiveness', 'Epidemiology', 'Prophylactic treatment', 'Nursing interventions', 'Age', 'Specific qualifier value', 'HIV', 'Statistical Prevalence', 'Estimated', 'Local', 'Publishing', 'Dimensionality', 'ROC Curve', 'HIV', 'Statistical Prevalence', 'Stratified', 'Specific qualifier value', 'Human Age Group', 'Adult', 'Glycation End Products, Advanced', 'year', 'anti-Ro (SSA) measurement']"
146,"['Persian language', 'prednimustine', 'Individualized', 'concept', 'Persons', 'criteria', 'Result', 'Organ', 'Liver brand of Vitamin B 12', 'Standard (qualifier)', 'Diagnosis', 'Physical Examination', 'Methods', 'Physical Examination', 'Data Analysis', 'Elderly (population group)', 'Health', 'Aging', 'Iran', 'Phase', 'Healthy Aging', 'Evaluation', 'Clinical', 'Elderly (population group)']"
147,"['Transplantation of liver', 'Effectiveness', 'Therapeutic procedure', 'Liver Failure, Acute', 'Chronic liver disease', 'Liver Cirrhosis', 'Liver carcinoma', 'Clinical Research', 'Evaluation', 'Survival Rate', 'Transplantation of liver', 'Asia']"
148,"['Hematuria', 'Symptoms aspect', 'Nephrology Speciality', 'Urology', 'Lacking', 'Urinalysis', 'Epidemiology', 'Clinical Research', 'Epidemiology', 'Hematuria', 'Iran']"
149,"['Intrahepatic biliary atresia', 'Data', 'Social Determinants of Health', 'Health', 'Influence', 'therapeutic aspects', 'Liver carcinoma', 'altretamine/cisplatin/cyclophosphamide protocol', 'Investigates', 'Mental association', 'Social Determinants of Health', 'Health care facility', 'Community Health Education', 'Economic Stability', 'Surgery specialty']"
150,"['Hepatitis C', 'Hepatitis C', 'Excessive (qualifier value)', 'Alcohol consumption', 'Etiology aspects', 'Liver diseases', 'Antiviral Agents', 'Therapeutic procedure', 'Infection', 'Virologic Response', 'Sustained Virologic Response', 'Data', 'Influence', 'Alcohol consumption', 'Uptake', 'Cure (remedy)']"
151,"['Incidence', 'Cessation of life', 'Extrinsic', 'Poisoning', 'Suicide', 'Alcoholic Liver Diseases', 'Increased', 'Country', 'United States', 'Canada', 'Social', 'geographic population', 'Data', 'Data', 'Canadian', 'public health medicine (field)', 'Mental association', 'Age', 'Marital Status', 'Health', 'Illicit Substance', 'Analgesics, Opioid', 'Prescription procedure', 'Substance', 'Fraction of', 'Hypersensitivity', 'Males', 'year', 'Childbirth', 'Mood Disorders', 'High', 'Persons', 'Multiple substances', 'year', 'Social Determinants of Health', 'Portion of cell substance', 'Illicit Substance', 'Statistical Prevalence', 'Marital Status', 'Opioids', 'Statistical Prevalence', 'Substance', 'Morbidity - disease rate', 'Mortality Vital Statistics', 'findings aspects', 'Social', 'Factor', 'Shapes', 'geographic population', 'Cessation of life', 'Feeling despair']"
152,"['Impact food supplement', 'Social Determinants of Health', 'Health', 'Outcome Measures', 'Patients', 'Resectable Hepatocellular Carcinoma', 'altretamine/cisplatin/cyclophosphamide protocol']"
153,"['Oxidative Stress', 'Thyroid Diseases', 'Clinical Research', 'gallic acid', 'General Anesthesia', 'Gene Expression', 'Antioxidants', 'Thioredoxins', 'ATXN1 gene', 'TXN2 gene', 'Thioredoxins', 'Oxidoreductase', 'TXNRD1 gene', 'Hyperthyroidism', 'Study models', 'Forty Nine', 'Males', 'Rats, Wistar', 'Groups', 'Control Groups', 'Hypothyroidism', 'Hyperthyroidism', 'Groups', 'Induce (action)', 'propylthiouracil', 'Groups', 'Groups', 'Treating', 'General Anesthesia', 'Daily', 'Thyroid Hormones', 'Serum', 'Oxidative Stress', 'Markers (device)', 'Evaluation', 'week', 'Gene Expression', 'TXNRD1 gene', 'Measured', 'Mealtimes', 'Antioxidants', 'Truncus Arteriosus, Persistent', 'malondialdehyde', 'Hypothyroidism', 'Increased', 'Truncus Arteriosus, Persistent', 'Levels (qualifier value)', 'Control Groups', 'Hypothyroidism', 'Treating', 'General Anesthesia', 'Hypothyroidism']"
154,"['Review [Publication Type]', 'Cohort Studies', 'Mental association', 'Chronic disease', 'Severe (severity modifier)', 'COVID19 (disease)', 'Complication']"
155,"['Lacking', 'Consensus', 'Social', 'Factor', 'Cessation of life', 'Increase', 'Mortality Vital Statistics', 'Drug Overdose', 'Alcoholic Liver Diseases', 'Suicide', 'United States', 'Acre USA Survey', 'Clinical Research', 'Science in Literature', 'PIN1 gene', 'Relevance', 'Social Determinants of Health', 'Unequal', 'Mortality Vital Statistics', 'trends qualifier']"
156,"['Comparison', 'Continuance of life', 'Outcome Measures', 'Small', 'Liver carcinoma', 'HCCS gene', 'Ablation', 'Antibodies', 'removal technique', 'SNCG gene', 'Differential quality', 'Transplantation of liver', 'Tricuspid Valve Insufficiency', 'Comparison', 'SNCG gene', 'Antibodies']"
157,"['Inflammatory', 'Documented', 'Nutritional', 'Induce (action)', 'Inflammation', 'Mental association', 'Cholelithiasis', 'Disease', 'Gerstmann-Straussler-Scheinker Disease', 'Clinical Research', 'Mental association', 'Gerstmann-Straussler-Scheinker Disease']"
158,"['Persons', 'Energy, Physics', 'Solid', 'Solid', 'Air Pollution', 'Associated with', 'Cessation of life', 'Patterns', 'trends qualifier', 'Solid', 'Analyzer, device', 'Estimated', 'Statistical Prevalence', 'physiologic resolution', 'Unequal', 'Progress', 'Healthy Worker Effect', 'Poverty', 'Developing Countries', 'Developing Countries', 'Access']"
159,"['Therapeutic procedure', 'Liver diseases', 'Failed', 'Preceptorship', 'Radiotherapy, Adjuvant', 'Mesenchymal Stem Cells', 'Feces', 'silymarin', 'Traditional origin', 'therapeutic aspects', 'Mesenchymal Stem Cells', 'New', 'Therapeutic procedure', 'Potential', 'Liver Failure', 'Lassa Fever', 'therapeutic aspects']"
160,"['Medical center', 'urban area', 'Los Angeles', 'Diversity', 'initial patient population', 'Clinical Research', 'Genetic', 'Social Determinants of Health', 'Cervical Atlas', 'Community', 'Diversity', 'Biorepository', 'Electronic Health Records', 'Patients']"
161,"['Opium Use', 'Homo sapiens', 'Carcinogens', 'International Agency for Research on Cancer', 'Multicenter Study', 'Mental association', 'Risk', 'Malignant neoplasm of lung', 'Case (situation)', 'Cost Control', 'Unconditional', 'Regression Analysis', 'Confidence Intervals', 'Curie', 'Measured', 'Mental association', 'Risk', 'Malignant neoplasm of lung', 'ORALIT', 'Gender', 'Socioeconomic Status', 'Waterpipe', 'Smoking', 'Risk', 'Malignant neoplasm of lung', 'System User -- individual', 'Comparison', 'Curie', 'Response process', 'Cumulative', 'Risk', 'High', 'Small cell carcinoma of lung', 'Histology', 'Curie', 'Malignant neoplasm of lung', 'System User -- individual', 'High', 'Females', 'Curie', 'Males', 'Curie', 'System User -- individual', 'Tobacco', 'Curie', 'Risk', 'Malignant neoplasm of lung', 'Regular', 'System User -- individual', 'Conclusion', 'Carcinogenicity', 'opium', 'Mental association', 'Small cell carcinoma of lung', 'Case (situation)', 'Histology']"
162,"['Indexes', 'Cancellous Bone', 'Townes syndrome', 'Bone Density', 'Associated with', 'Electromagnetic Spectrum', 'Exercise', 'Vitamins', 'Liver', 'Enzymes', 'Biochemical', 'Measurement', 'Mental disorders', 'Quality', 'Life', 'Colicin Plasmids', 'Townes syndrome', 'Vitelliform Macular Dystrophy', 'Data Set']"
163,"['Syndemic', 'Hazardous Substances', 'Alcohol consumption', 'Opioids', 'Obesity', 'Changing', 'Liver diseases', 'Epidemiology', 'Symptom aggravating factors', 'health disparity', 'health disparity', 'Disadvantaged Populations', 'geographic population', 'Light', 'health disparity', 'Source', 'Consequence of', 'Chronic liver disease', 'Improving (qualifier value)', 'Health', 'Outcome Measures', 'Increased', 'Alcohol Use Disorder', 'Woman', 'Minority Groups', 'Poverty', 'Context', 'Increasing (qualifier value)', 'Alcoholic Liver Diseases', 'Non-alcoholic Fatty Liver Disease', 'Fibrosis', 'Hispanic or Latino', 'Woman', 'Age', 'Persons', 'Food Insecurity', 'Access', 'Hepatitis A', 'Average Linkage Cluster Analysis', 'therapeutic aspects', 'Suboptimal', 'Minority Groups', 'Persons', 'Uninsured', 'Mortality Vital Statistics', 'Diagnosis', 'altretamine/cisplatin/cyclophosphamide protocol', 'Data', 'Cohort', 'Autoimmune Diseases', 'Lacking', 'Clinical Research', 'Transitory', 'Epidemiology', 'Review [Publication Type]', 'Gender', 'socioeconomic', 'Vision Disparity', 'Chronic liver disease', 'Social Determinants of Health', 'Social Factors', 'health disparity', 'Chronic liver disease', 'Outcome Measures', 'Potential', 'Solutions', 'Health Policy', 'Health system plans', 'Community', 'Persons', 'Solutions', 'Promotion (action)', 'Gender Equity', 'Improved', 'Health Outcomes']"
164,"['Health Care', 'COVID19 (disease)', 'Pandemics', 'Health', 'Unequal', 'Ethnicity', 'Metal-Organic Frameworks', 'Implementation', 'Nursing interventions', 'Metal-Organic Frameworks', 'Study models', 'Theory', 'Taxonomy', 'Implementation', 'Digital X-ray', 'Nursing interventions']"
165,"['Background', 'Transplantation of liver', 'Standard of Care', 'End Stage Liver Disease', 'Patients', 'Transplantation of liver', 'List', 'Scientific Study', 'Vision Disparity', 'Gender', 'Numerous', 'Socioeconomic Factors', 'Evaluation', 'Recent', 'Vision Disparity', 'Patients', 'Transplantation of liver', 'Specimen', 'SLC5A5 gene', 'Hospitalization', 'Databases', 'United States', 'Body Fluid Discharge', 'SLC5A5 gene', 'Adult', 'Patients', 'Chronic liver disease', 'Transplantation of liver', 'International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10)', 'Gender', 'socioeconomic', 'Status', 'Comorbidity', 'Transplantation of liver', 'Test Result', 'Transplantation of liver', 'Clinical Research', 'Menstruation', 'Females', 'Associated with', 'Decreased', 'Transplantation', 'Odds Ratio', 'Analyzers, Physiologic, Middle Ear, Acoustic Reflectometry', 'Confidence Intervals', 'Curie', 'Comparison', 'Caucasian', 'Patients', 'Black Populations', 'Patients', 'Decreased', 'Transplantation', 'Analyzers, Physiologic, Middle Ear, Acoustic Reflectometry', 'Curie', 'American Indian or Alaska Native', 'Analyzers, Physiologic, Middle Ear, Acoustic Reflectometry', 'Curie', 'Hispanic Americans', 'Increased', 'Transplantation of liver', 'Analyzers, Physiologic, Middle Ear, Acoustic Reflectometry', 'Curie', 'Curie', 'Increase', 'Quartile', 'Increment', 'Increase', 'Transplantation', 'High', 'Transplantation', 'Medicare', 'Analyzers, Physiologic, Middle Ear, Acoustic Reflectometry', 'Curie', 'Patients', 'Insurance', 'Transplantation', 'Analyzers, Physiologic, Middle Ear, Acoustic Reflectometry', 'Curie', 'Analysis of substances', 'Race:Type:Point in time:^Patient:Nominal', 'Gender', 'Social', 'Factor', 'Significant', 'Anthropogenic Effects', 'Probability', 'Transplantation of liver', 'Clinical Research', 'Vision Disparity', 'Transplantation of liver', 'Scientific Study', 'Transplantation of liver']"
166,"['Texas', 'Liver carcinoma', 'altretamine/cisplatin/cyclophosphamide protocol', 'Incidence', 'Geographical continent', 'United States', 'Ethnicity', 'Vision Disparity', 'Analysis of substances', 'Social Determinants of Health']"
167,"['Inflammatory Bowel Diseases', 'Inflammatory Bowel Diseases', 'Groups', 'chronic', 'Inflammatory disorder', 'National origin', 'Disease', 'With frequency', 'Chronic disease', 'Patients', 'Inflammatory Bowel Diseases']"
168,"['Serum', 'CA-125 Antigen', 'WFDC2 protein, human', 'Optimum', 'Cytoreductive Surgery', 'Eligible', 'Woman', 'Diagnosis', 'ovarian neoplasm', 'Diagnostic Imaging', 'AST serum measurement', 'Patients', 'Complete', 'Pathological staging', 'Data', 'Version', 'Persons', 'Clinical Research', 'Case (situation)', 'Stage level 3', 'Serum', 'WFDC2 protein, human', 'pmol', 'Optimum', 'Cytoreductive Surgery', 'Operative Surgical Procedures', 'Sensitivity and Specificity', 'AST serum measurement', 'Optimum', 'Cytoreductive Surgery', 'Operative Surgical Procedures', 'Sensitivity and Specificity', 'Negative Predictive Value of Diagnostic Test', 'WFDC2 protein, human', 'Case (situation)', 'Clinical', 'Radiology Specialty', 'findings aspects', 'Evaluation', 'Tumor Markers', 'Prediction', 'Optimum', 'Surgery specialty']"
169,"['Societal Factors', 'Influence', 'Social Determinants of Health', 'Social Determinants of Health', 'Transplantation']"
170,"['Transplantation of liver', 'Child', 'Liver', 'Failure (biologic function)', 'Survival Rate', 'Assessed', 'Success', 'Transplantation of liver', 'Clinical Research', 'Assessed', 'Survival Rate', 'Transplantation of liver', 'Child', 'Analysis of substances', 'year', 'Clinical Study Population Subgroup', 'Analysis of substances', 'TitleStyles', 'Review [Publication Type]', 'Test Result', 'Particle', 'Meta Analysis (statistical procedure)', 'Established', 'Survival Rate', 'Disease regression', 'Relationships', 'Clinical Research', 'Survival Rate', 'year', 'Clinical Research', 'Documented', 'Comprehensive', 'Evidence', 'Policy', 'Decision', 'Sector', 'Fetal Health and Development', 'evaluation/testing', 'treatment options', 'Nursing interventions']"
171,"['Malignant Neoplasms', 'Age', 'Awareness', 'Accurate (qualifier)', 'Malignant Neoplasms', 'Incidence', 'Estimated', 'Malignant Childhood Neoplasm', 'Incidence', 'Iran']"
172,"['Hematoma, Subdural, Chronic', 'SDSL gene', 'Clinical Research', 'Investigates', 'Colicin Plasmids', 'Associated with', 'Result', 'Craniotomy']"
173,"['Hypertensive disease', 'Cardiovascular Diseases', 'Cerebrovascular accident', 'Chronic Kidney Diseases', 'socioeconomic', 'Unequal', 'Colicin Plasmids', 'Statistical Prevalence', 'Awareness', 'therapeutic aspects', 'Control Groups', 'Ataxia Telangiectasia', 'Hypertensive disease', 'Hypertensive disease', 'Iran']"
174,"['Health Services Research', 'Inflammatory Bowel Diseases', 'Inflammatory Bowel Diseases', 'Patients', 'geographic population', 'Northern European', 'Incidence', 'Inflammatory Bowel Diseases', 'Crohn Disease', 'Ulcerative Colitis', 'Increasing (qualifier value)', 'geographic population', 'Comprehensive', 'Examined', 'Epidemiology', 'Presentation', 'Phenotype', 'therapeutic aspects', 'Outcome Measures', 'Social Determinants of Health', 'Pathogenesis', 'Inflammatory Bowel Diseases', 'Black Populations', 'Hispanics', 'Patients', 'United States', 'Improved', 'Health Equity', 'Minority Groups', 'Inflammatory Bowel Diseases', 'Priority', 'Health Services Accessibility', 'Accurate (qualifier)', 'Physical Examination', 'therapeutic aspects', 'Therapeutic procedure', 'Clinical Trials', 'Evaluation', 'Exogenous Factors', 'Increase', 'Disease', 'Incidence']"
175,"['Prophylactic treatment', 'Liver carcinoma', 'altretamine/cisplatin/cyclophosphamide protocol', 'Reduction (chemical)', 'Vision Disparity', 'research', 'Social and Contextual Areas', 'Social Determinants of Health', 'Health', 'Empiric', 'Social and Contextual Areas', 'Colicin Plasmids', 'Neighborhood', 'Social Environment', 'Vision Disparity', 'Clinical Research', 'Contribution', 'Poverty', 'Social Deprivation Index', 'altretamine/cisplatin/cyclophosphamide protocol', 'Vision Disparity', 'Scientific Study', 'findings aspects']"
176,"['Incidence', 'Inflammatory Bowel Diseases', 'Inflammatory Bowel Diseases', 'Increasing (qualifier value)', 'Minority Groups', 'Groups', 'Acre USA Survey', 'Minority Groups', 'Inflammatory Bowel Diseases', 'care activity', 'Outcome Measures', 'History of previous events', 'Health Inequities', 'Social Determinants of Health']"
177,"['Cross-Sectional Studies', 'Potential', 'Colicin Plasmids', 'Mental association', 'Metabolic Syndrome X', 'ETV3 gene', 'Obesity', 'Observation parameter', 'Finding of liver enzyme levels', 'Blood Pressure', 'Sociodemographic Factors', 'Colicin Plasmids', 'Elderly (population group)', 'CD48 gene']"
178,"['Investigates', 'Clinical', 'Electrocardiographic monitors', 'findings aspects', 'colchicine', 'Evaluation', 'Correlation', 'Outcome Measures', 'Toxicity aspects', 'Cessation of life']"
179,"['Filipino Americans', 'Fetal Alcohol Syndrome', 'Asian Americans', 'Subgroup A Nepoviruses', 'United States', 'Case Study', 'Fetal Alcohol Syndrome', 'Practice Experience', 'Metabolic Syndrome X', 'Disease', 'Asian Americans', 'Subgroup A Nepoviruses', 'Hispanic or Latino', 'Caucasian', 'Increased', 'Statistical Prevalence', 'Congenital muscular dystrophy (disorder)', 'Fetal Alcohol Syndrome', 'Science of genetics', 'Life Style', 'Fetal Alcohol Syndrome', 'Asian Americans', 'Groups', 'Body Burden', 'Congenital muscular dystrophy (disorder)', 'Adverse event', 'Social Determinants of Health', 'Health', 'Asian Americans', 'Subgroup A Nepoviruses', 'Scientific Study', 'Fetal Alcohol Syndrome', 'Congenital muscular dystrophy (disorder)', 'Pharmaceutical Preparations', 'manager', 'Congenital muscular dystrophy (disorder)', 'Potential', 'Mechanism (attribute)', 'Reduced', 'Congenital muscular dystrophy (disorder)', 'Burden', 'Fetal Alcohol Syndrome', 'Therapeutic Index, Drug', 'Evaluation procedure', 'Cardiovascular system', 'health disparity', 'Fetal Alcohol Syndrome']"
180,"['Mammography', 'Methods', 'Early', 'Detection', 'Malignant neoplasm of breast', 'BC Original Formula', 'Low Level', 'Clinical Research', 'Investigates', 'Iran']"
181,"['Evidence', 'Mental association', 'Serum', 'carnitine', 'Levels (qualifier value)', 'Changing', 'Left', 'Heart Ventricle', 'Clinical Research', 'Evaluation', 'Mental association', 'Observation parameter']"
182,"['Iran', 'Seroprevalence', 'General Population', 'Seroprevalence', 'COVID19 (disease)', 'Communicable Diseases', 'Iranian (ethnic group)']"
183,"['Evaluation', 'Relative (related person)', 'Alanine Transaminase', 'Aspartate Transaminase', 'Gamma-glutamyl transferase', 'Diabetes Mellitus', 'Cohort Studies']"
184,"['year', 'Seminal', 'Bisexuality', 'Hermaphroditism', 'Female Homosexuality', 'Bisexuality', 'Genderqueer', 'Hermaphroditism', 'Sexual and Gender Disorders', 'Minority Groups', 'US Military enlisted E9', 'Persons', 'Discrimination (process of differentiation)', 'harassment', 'Sexual Orientation', 'United States National Institutes of Health', 'Vision Disparity', 'US Military enlisted E9', 'Community', 'Health Disparate Populations', 'High', 'Sexually Transmitted Diseases', 'Alcohol or Other Drugs use', 'Drug abuse', 'mental health', 'Condition', 'Obesity', 'Eating Disorders', 'Malignant Neoplasms', 'US Military enlisted E9', 'Community', 'Transsexual (finding)', 'Patients', 'Color', 'Practice Experience', 'Discrimination (process of differentiation)', 'Denied (qualifier)', 'Health Care', 'Patients', 'US Military enlisted E9', 'Persons', 'Twice (Numerical Qualifier)', 'Lifetime', 'Injury due to exposure to external cause', 'Emotions', 'Physical Examination', 'Sexual Trauma', 'Comparison', 'Heterosexuality', 'Colicin Plasmids', 'Negative', 'Digestion', 'Health', 'Effect', 'Social Determinants of Health', 'Digestive System Disorders', 'US Military enlisted E9', 'geographic population', 'Solutions', 'Improved', 'Health', 'Community', 'gastrointestinal']"
185,"['Documented', 'Transplantation of liver', 'Recipient', 'Household composition', 'Donor for liver transplant (person)']"
186,"['Report (document)', 'Poisoning', 'Persons', 'utilization qualifier', 'opium', 'Exposure to', 'Investigates', 'Mental association', 'Cohort Studies']"
187,"['Hypertensive disease', 'risk factors', 'Cardiovascular Diseases', 'Etiology aspects', 'Cessation of life', 'Hypertensive disease', 'Scientific Study', 'Report (document)', 'Iran', 'Evaluation', 'evaluation/testing', 'Relative (related person)', 'Alanine Transaminase', 'Aspartate Transaminase', 'Gamma-glutamyl transferase', 'Hypertensive disease']"
188,"['Liver and Intrahepatic Biliary Tract Carcinoma', 'Fatal', 'Condition', 'American Indians', 'geographic population', 'Literature', 'Prophylactic treatment', 'Asian Indian', 'Literature', 'Liver and Intrahepatic Biliary Tract Carcinoma', 'Asian Indian', 'geographic population', 'Arizona', 'Colicin Plasmids', 'Structure', 'Unequal', 'Affecting', 'Groups', 'PubMed', 'Americas Ethnicity', 'Asian Indian', 'Adult', 'Liver diseases', 'Outcome Measures', 'Particle', 'Inclusion', 'Scientific Study', 'Observational Study', 'Secondary Data Analysis', 'Article', 'Methods', 'Purchased Services, Consulting, Business, Management', 'Test Result', 'Empiric', 'Liver and Intrahepatic Biliary Tract Carcinoma', 'Prophylactic treatment', 'therapeutic aspects', 'Nursing interventions', 'geographic population', 'research', 'Evaluation', 'Liver diseases', 'Malignant Neoplasms', 'Reporting', 'Anthropological Culture', 'Relevance', 'Nursing interventions', 'Liver and Intrahepatic Biliary Tract Carcinoma', 'Prophylactic treatment', 'Structure', 'Improved', 'Health Inequities', 'Liver and Intrahepatic Biliary Tract Carcinoma', 'Asian Indian', 'Persons']"
189,"['Clinical Research', 'Mental association', 'Social Determinants of Health', 'Health', 'Social Determinants of Health', 'Transplantation of liver', 'Tumor Necrosis Factor-Beta', 'Liver Cirrhosis', 'Access']"
190,"['Clinical Research', 'Behavior Therapy', 'Questionnaires', 'Measures', 'Iranian (ethnic group)', 'parent', 'Perception', 'Behavior']"
191,"['Cohort Studies', 'Etiology aspects', 'Clinical Trial [Publication Type]', 'Epidemiologic Studies', 'Investigates', 'Health', 'Consequence of', 'Road', 'Traffic', 'trauma qualifier']"
192,"['BaseLine dental cement', 'Data', 'Prospective Tissue Collection', 'Epidemiologic Studies', 'Cohort Studies', 'Proportion', 'Awareness', 'therapeutic aspects', 'Guidelines', 'Report (document)', 'Committee', 'Participant', 'Age', 'year', 'Woman', 'Curie', 'Guidelines', 'Guidelines', 'Participant', 'Newly Diagnosed', 'Guidelines', 'Comparison', 'Adult', 'Diagnosis', 'Hypertensive disease', 'Guidelines', 'Diagnosis', 'Participant', 'Young', 'Literacy', 'Males', 'low', 'Levels (qualifier value)', 'risk factors', 'Free of (attribute)', 'Conventional', 'geographic population', 'Eligible', 'Pharmacologic Actions', 'SEND Implementation Guide', 'Guidelines', 'Burden', 'Health system plans', 'Early Diagnosis', 'Administration occupational activities', 'Hypertensive disease', 'Hypertensive disease', 'Iran']"
193,"['Malignant neoplasm of urinary bladder', 'BC Original Formula', 'Malignant Neoplasms', 'Iran', 'Opium Use', 'risk factors', 'BC Original Formula', 'Assessed', 'Mental association', 'Observation parameter', 'Opium Use', 'Iran', 'Risk', 'BC Original Formula']"
194,"['Organ Transplantation', 'preference', 'therapeutic aspects', 'Terminal illness', 'Patients', 'Terminal illness', 'Transplantation', 'Waiting Lists (patient)', 'Water Scarcity', 'Organ', 'Environmental pool', 'Result', 'Cessation of life', 'Annual', 'United States', 'Patients', 'Unique', 'BARRIER', 'Social Determinants of Health', 'Health', 'Patients', 'Disenfranchised Grief', 'Groups', 'Transplantation', 'Review Literature', 'Vision Disparity', 'Social Determinants of Health', 'research']"
195,"['Serious', 'Completed Suicide', 'Treatment intent', 'Colorectal Carcinoma', 'Decade', 'Effectiveness', 'therapeutic aspects', 'Discover', 'Etiology aspects']"
196,"['Low Back Pain', 'Hypotension', 'Condition', 'geographic population', 'Statistical Prevalence', 'Predictor', 'Hypotension', 'Developing Countries', 'Clinical Research', 'Evaluation', 'Statistical Prevalence', 'Associated with', 'Hypotension', 'Iranian (ethnic group)', 'geographic population']"
197,"['Comprehensive', 'Scientific Study', 'Assessed', 'Burden', 'Anemia', 'Iran', 'Clinical Research', 'Data', 'Epidemiologic Studies', 'Persian language']"
198,"['Humidity', 'Estrus', 'Storage area', 'Condition', 'Substance', 'Homo sapiens', 'Adjudication', 'Aflatoxin M1', 'Microscopy, Atomic Force', 'Levels (qualifier value)', 'Airway Resistance Test', 'Sterilizing Units', 'Clinical Research', 'Evaluation', 'Consumption of goods', 'Geographic Locations', 'Sampling - Surgical action', 'Cold Temperature', 'Seasons', 'Analysis', 'Methods', 'vincristine', 'Assessed', 'Microscopy, Atomic Force', 'Specimen', 'Microscopy, Atomic Force', 'Toxin', 'Mental concentration', 'Sampling - Surgical action', 'ERBB2 gene', 'ERBB2 gene', 'Levels (qualifier value)', 'Toxin', 'Pasteuria', 'Sampling - Surgical action', 'Airway Resistance Test', 'Milk (body substance)', 'Data', 'Assessed', 'Values', 'vincristine', 'geographic population', 'findings aspects', 'Specimen', 'Contaminated', 'Recommendation', 'Calculated', 'Indicators', 'Risk', 'Liver and Intrahepatic Biliary Tract Carcinoma', 'Consumer', 'Milk (body substance)']"
199,"['Global Burden of Disease', 'trauma qualifier', 'risk factors', 'systematic', 'Estimated', 'Incidence', 'Morbidity - disease rate', 'International', 'Reduced', 'Cancer Burden']"
200,"['Liver carcinoma', 'altretamine/cisplatin/cyclophosphamide protocol', 'Cessation of life', 'Patients', 'Liver Cirrhosis', 'Mortality Vital Statistics', 'United States']"
201,"['Patients', 'Non-alcoholic Fatty Liver Disease', 'Non-alcoholic Fatty Liver Disease', 'status - In progress', 'Nonalcoholic Steatohepatitis', 'Nonalcoholic Steatohepatitis', 'Increase', 'Liver Cirrhosis', 'Cancer-Related Death', 'Predictor', 'Nonalcoholic Steatohepatitis', 'Disease Progression', 'Factor', 'Disease Progression', 'Patients', 'Nonalcoholic Steatohepatitis', 'United States', 'Clinical Research', 'Demography', 'Clinical', 'Nonalcoholic Steatohepatitis', 'Diagnosis', 'Comorbidity', 'therapeutic aspects', 'Logistic Models', 'Diagnosis', 'Sociodemographic Factors', 'Clinical Variant', 'Likelihood Ratio Test', 'Patients', 'Gain', 'Ultrasonography', 'Cohort', 'Woman', 'Non-alcoholic Fatty Liver Disease', 'Fibrosis stage:Finding:Point in time:Serum/Plasma:Ordinal', 'Diagnosis', 'Dog Age in Years', 'Diagnosis', 'Obesity', 'Fibrosis stage:Finding:Point in time:Serum/Plasma:Ordinal', 'Diagnosis', 'vitamin E', 'Transplantation of liver', 'Concept Status - Proposed', 'Diagnosis', 'Disease Progression', 'Odds Ratio', 'Curie', 'Nonalcoholic Steatohepatitis', 'Diagnosis', 'Woman', 'Male population group', 'Smoker', 'Non-smoker', 'Obesity', 'Disease Progression', 'Part-time employment (finding)', 'Nonalcoholic Steatohepatitis', 'Status', 'Concept Status - Proposed', 'communicable disease diagnosis (procedure)', 'Duration (temporal concept)', 'Morbid obesity', 'Smoking', 'Factor', 'Fibrosis', 'Disease Progression', 'findings aspects', 'Decision', 'Nonalcoholic Steatohepatitis', 'Administration occupational activities', 'Ultrasonography']"
202,"['Estimated', 'Cancer Burden']"
203,"['Kidney Failure, Chronic', 'Impaired', 'Renal function', 'Permanent', 'Alternative', 'Therapeutic procedure', 'Hemodialysis', 'Peritoneum', 'Physical Dialysis', 'Kidney Transplantation', 'Investigates', 'Survival Rate', 'Patients', 'Kidney Transplantation', 'Colicin Plasmids', 'Iran']"
204,"['Cancer Registry', 'Data', 'Analysis', 'Vision Disparity', 'Liver carcinoma', 'altretamine/cisplatin/cyclophosphamide protocol', 'Incidence', 'Neighborhood', 'Socioeconomic Status', 'Asian Americans', 'Pacific Islander Americans', 'Hispanic or Latino', 'California']"
205,"['Male population group', 'Mobile', 'High risk of', 'Clinical Research', 'Investigates', 'Statistical Prevalence', 'HIV', 'Behavior', 'Reusable Drivers']"
206,"['Statistical Prevalence', 'Relationships', 'Obesity', 'Diabetes Mellitus', 'Non-alcoholic Fatty Liver Disease', 'Non-alcoholic Fatty Liver Disease', 'Chronic liver disease', 'Health', 'Unequal', 'Non-alcoholic Fatty Liver Disease', 'Spatial Distribution', 'Analyzer, device', 'Health', 'Unequal', 'Non-alcoholic Fatty Liver Disease', 'Spatial Distribution', 'Assessed', 'health disparity', 'Outcome Measures', 'Review [Publication Type]', 'Generalized', 'Health', 'Unequal', 'Non-alcoholic Fatty Liver Disease', 'Spatial Distribution', 'Outcome Measures', 'Gender', 'Ethnicity', 'Particle', 'Review [Publication Type]', 'United States', 'Males', 'High', 'Non-alcoholic Fatty Liver Disease', 'Statistical Prevalence', 'Particle', 'Evidence', 'Woman', 'High', 'Burden', 'Advanced phase', 'Liver diseases', 'Complication', 'Particle', 'Hispanic or Latino', 'Non-alcoholic Fatty Liver Disease', 'Statistical Prevalence', 'Outcome Measures', 'Particle', 'Caucasian', 'Complication', 'Ethnicity', 'Particle', 'Patients', 'low', 'Socioeconomic Status', 'High', 'Non-alcoholic Fatty Liver Disease', 'Statistical Prevalence', 'Particle', 'Probability', 'Disease Progression', 'Complication', 'Particle', 'Non-alcoholic Fatty Liver Disease', 'Statistical Prevalence', 'Outcome Measures', 'Unequal', 'Review [Publication Type]', 'Ultrasonography', 'geographic population', 'Evidence', 'Non-alcoholic Fatty Liver Disease', 'Spatial Distribution', 'Outcome Measures', 'Unequal', 'Social', 'Groups', 'research']"
207,"['Pediatric gastroenterologist', 'Genus: Coronavirus', 'Disease', 'Pandemics', 'Knowledge acquisition', 'New', 'Disease', 'manager', 'Spreading (qualifier value)', 'Patients', 'Health Occupations', 'Decision', 'Patients', 'chronic', 'gastrointestinal', 'threat', 'Practice Experience', 'Decreased', 'Numbers', 'Telemedicine', 'Technology', 'Protocols documentation', 'Performed', 'Endoscopy (procedure)', 'Impact food supplement', 'research', 'Occupations', 'Search - action']"
208,"['Social Determinants of Health', 'Hematoma, Subdural', 'Healthy People Programs', 'Social', 'Community', 'Context', 'Health', 'Neighborhood', 'Environment', 'Pediatric brand name', 'geographic population', 'Hematoma, Subdural', 'Healthcare Disparities', 'Pediatric brand name', 'gastroenterology (field)', 'Review [Publication Type]', 'Inflammatory Bowel Diseases', 'Endoscopy (procedure)', 'Bariatric Surgery', 'Transplantation of liver', 'Telemedicine', 'Genus: Coronavirus', 'Disease']"
209,"['Diabetes', 'Comorbidity', 'COVID19 (disease)', 'Clinical', 'Epidemiological Factors', 'Mortality Vital Statistics', 'COVID19 (disease)', 'diabetic', 'Patients', 'Iran', 'Impact food supplement', 'Prescribed', 'Antibiotics, Antineoplastic', 'Patients']"
210,"['Gout Suppressants', 'Class', 'Pharmaceutical Preparations', 'Increased', 'Risk', 'Infections of musculoskeletal system', 'Pharmaceutical Preparations', 'Reversible', 'risk factors', 'COVID19 (disease)', 'Conflict (Psychology)', 'Impact food supplement', 'chronic', 'Visual Suppression', 'COVID19 (disease)', 'Communicable Diseases', 'Risk', 'evaluation/testing', 'Influence', 'Social Determinants of Health', 'Health', 'Validation', 'Discover', 'New', 'risk factors', 'Assessed', 'Mental association', 'Incident', 'COVID19 (disease)', 'Case-Control Studies', 'Patients', 'Testing', 'Academic Medical Centers', 'California', 'Medical service', 'chronic', 'Visual Suppression', 'Manually', 'health records', 'Protocols documentation', 'Mapping (action)', 'Data', 'Patients', 'Zip Code', 'Evidence', 'Mental association', 'chronic', 'Visual Suppression', 'COVID19 (disease)', 'Odds Ratio', 'Curie', 'Medical service', 'Positive', 'Ethnicity', 'Presenile dementia', 'public entity', 'Transportation', 'Monthly (qualifier value)', 'Alcohol Use Disorder', 'Predictor', 'Communicable Diseases', 'findings aspects', 'Databases', 'Medical service', 'Data', 'Communicable Diseases', 'Disease']"
211,"['Colicin Plasmids', 'Affecting', 'Dynamics', 'Surgical lengthening - action', 'Symptoms aspect', 'Virologic Response', 'Virologic Response', 'Clinical', 'Groups', 'Adult', 'immunoglobulin G', 'HIV Infections', 'Assessed', 'COVID19 (disease)', 'History of Medicine', 'month', 'Research Subject', 'Asymptomatic (finding)', 'BaseLine dental cement', 'Research Subject', 'Symptomatic', 'follow-up', 'Research Subject', 'Persisting', 'Symptoms aspect', 'BaseLine dental cement', 'Levels (qualifier value)', 'Folded structure', 'Blood Group (classification)', 'Sustained', 'gastrointestinal', 'gastroenterology (field)', 'Respiratory rate', 'BaseLine dental cement', 'Immunoglobulin M', 'gastroenterology (field)', 'Symptoms aspect', 'Liver Cirrhosis', 'BaseLine dental cement', 'Age', 'Males', 'Lung', 'Involvement with', 'Chest CT', 'Comparison', 'Antibodies']"
212,"['Clinical Research', 'Maternal Deprivation', 'Italy', 'Stage IV Hepatocellular Carcinoma AJCC v7', 'altretamine/cisplatin/cyclophosphamide protocol', 'Diagnosis', 'Chance']"
213,"['Liver carcinoma', 'altretamine/cisplatin/cyclophosphamide protocol', 'Malignant Neoplasms', 'Liver', 'Patients', 'Gender', 'Races (activity)', 'Ethnicity', 'Socioeconomic Status', 'altretamine/cisplatin/cyclophosphamide protocol', 'Etiology aspects', 'Liver Cirrhosis', 'Non-alcoholic Fatty Liver Disease', 'United States', 'Infectious agent', 'Hepatitis B and hepatitis C', 'Patients', 'altretamine/cisplatin/cyclophosphamide protocol', 'Screening for cancer', 'Vulnerable Populations', 'Patients', 'Persons', 'BARRIER', 'Insurance Coverage', 'Health care facility', 'Limited (extensiveness)', 'Screening for cancer', 'Minority Groups', 'Electromagnetic Spectrum', 'altretamine/cisplatin/cyclophosphamide protocol', 'care activity', 'Inadequate (qualifier)', 'Screening for cancer', 'Delayed Diagnosis', 'Health Services Accessibility', 'Improved', 'Multilevel Analysis', 'Colicin Plasmids', 'lead', 'Screening for cancer', 'therapeutic aspects', 'Vision Disparity', 'Health Insurance', 'Access', 'Challenge', 'Patients', 'Lower - spatial qualifier', 'Socioeconomic Status', 'Reduced', 'Health care facility', 'Reduced', 'Morbidity - disease rate', 'Mortality Vital Statistics', 'Patients', 'Community', 'Collaboration', 'Health care facility', 'Attenuation', 'Health Inequities', 'Collaboration', 'Interdisciplinary Studies', 'status - In progress', 'Vision Disparity', 'Vulnerable Populations', 'Health Equity']"
214,"['Prospective Studies', 'risk factors', 'Noncommunicable Diseases', 'Participant', 'Health Status', 'Socioeconomic Status', 'Behavior', 'Colicin Plasmids', 'Nutritional status', 'Environmental Exposure', 'Collected', 'Analysis', 'Storage', 'Blood', 'Urine', 'Nail plate', 'Hair Specimen', 'Genetic Association Studies', 'Biological Markers', 'Adult', 'Age', 'General Population', 'Woman', 'follow-up', 'Participant', 'control act - information', 'Nutritional status', 'Behaviorial Habits', 'Physical Examination', 'findings aspects', 'medication use', 'Medical History', 'Variable (uniformity)', 'Body mass index procedure', 'Metabolic', 'Score', 'Nutritional study of macronutrients', 'Micronutrients', 'Disease', 'Hypertensive disease', 'Fatty Liver', 'Diastolic hypertension', 'Coded Data and Samples', 'Measurement', 'Interval', 'Examined', 'Conditional', 'Changing', 'risk factors', 'Clinical Research', 'Relationships', 'Socioeconomic Status', 'Environment', 'risk factors', 'Prevalent', 'Cohort Studies', 'Research Infrastructure', 'Research Personnel']"
215,"['Decade', 'Statistical Prevalence', 'Diabetes', 'Increased', 'Country', 'Update', 'Statistical Prevalence', 'Diabetes', 'Prediabetes syndrome', 'Iran', 'Sociodemographic Factors', 'risk factors', 'Diabetes', 'Awareness', 'Control Groups']"
216,"['Severe (severity modifier)', 'Episode of', 'Poisoning', 'opium', 'Iran', 'Patients', 'Injury due to exposure to external cause', 'Treating', 'Chelating Agents', 'Patients', 'Follow-Up Studies', 'Evaluation', 'Treatment Effectiveness', 'Patients', 'Result']"
217,"['COVID19 (disease)', 'COVID19 (disease)', 'Pandemics', 'Crisis', 'Large nose', 'Affecting', 'geographic population', 'Disadvantaged Populations', 'Access', 'Health Care Systems', 'Sufficient', 'Medical care', 'Therapeutic procedure', 'Health Care', 'Vision Disparity', 'Contracting', 'Mitigate', 'Vision Disparity', 'initial patient population', 'Liver diseases', 'Overlearning', 'Impact food supplement', 'Pandemics', 'United States', 'United Kingdom', 'Canada', 'Disproportionate', 'Communicable Diseases', 'Cessation of life', 'Ethnic Minorities', 'Disadvantaged Populations', 'density', 'Work', 'Health Care', 'Liver diseases', 'Liver diseases', 'Viable', 'Solutions', 'Health Services Accessibility', 'Vaccination', 'Patients', 'COVID19 (disease)', 'Reduced', 'Healthcare Disparities', 'Health', 'Disadvantaged Populations', 'geographic population', 'Community', 'Solutions', 'Personalized', 'Nursing interventions', 'Community', 'Diversity', 'Cultural Sensitivity', 'initial patient population']"
218,"['Non-alcoholic Fatty Liver Disease', 'Non-alcoholic Fatty Liver Disease', 'Chronic liver disease', 'Estimated', 'Approximate', 'World', 'geographic population', 'Statistical Prevalence', 'Incidence', 'Non-alcoholic Fatty Liver Disease', 'Africa', 'Statistical Prevalence', 'Estimated', 'General Population', 'Increasing (qualifier value)', 'Burden', 'Noncommunicable Diseases', 'Statistical Prevalence', 'Obesity', 'Diabetes Mellitus, Non-Insulin-Dependent', 'Food Insecurity', 'Increased', 'Consumption of goods', 'Statistical Prevalence', 'Non-alcoholic Fatty Liver Disease', 'public entity', 'Awareness', 'risk factors', 'Increase', 'Non-alcoholic Fatty Liver Disease', 'Component object', 'Metabolic Syndrome X', 'Silent']"
219,"['Clinical Research', 'Burden', 'Tumor stage Tis', 'Cessation of life']"
220,"['Protective Factors', 'Communicable Diseases', 'research', 'Vitamins', 'Disease Progression', 'Prophylactic treatment', 'COVID19 (disease)', 'Case-Control Studies', 'Patients', 'Healthy', 'Persons', 'Blood specimen', 'Laboratory Procedures', 'Albumins', 'Vitamin measurement', 'Mental association', 'Avitaminosis', 'COVID19 (disease)', 'Severities', 'findings aspects', 'Patients', 'COVID19 (disease)', 'Clinical Research', 'Avitaminosis', 'Albumin level - finding', 'Decreased', 'Infected', 'Patients', 'Signs and Symptoms, Respiratory', 'Clinical Research', 'Negative', 'Correlation', 'Levels (qualifier value)', 'COVID19 (disease)', 'Communicable Diseases', 'Biological Response Modifiers', 'Virus Replication']"
221,"['Social Determinants of Health', 'Health', 'Condition', 'Live - Specimen Condition', 'Learning', 'Impact food supplement', 'Health Outcomes', 'Life Course', 'Consequence of', 'Adulthood', 'Adversity', 'Adverse Event Outcome', 'Child', 'Transplantation of liver', 'Child', 'Socioeconomic Factors', 'Neighborhood', 'Burden', 'Transplant-Related Mortality', 'Social', 'Child', 'Laboratory Procedures', 'Nursing interventions', 'Social', 'Child', 'Transplantation of liver', 'Granular', 'Data', 'Specific qualifier value', 'Social Risk Factor', 'Food Insecurity', 'Impact food supplement', 'Outcome Measures', 'Transplantation of liver', 'Transplantation of liver', 'Community', 'Knowledge', 'Pressing Pain', 'Problems - What subject filter', 'Medical care', 'Health System', 'Laboratory Procedures', 'Health System', 'Nursing interventions', 'Attending (provider role)', 'Patients', 'Adversity', 'Outcome Measures', 'Child', 'Transplantation of liver']"
222,"['Africa', 'Drug Component Mass', '3,4-Methylenedioxyamphetamine', 'Implementation', 'International Unit', 'Africa', 'International Unit', 'Location', 'Environment', 'Receiver Operating Characteristic', 'receptor operated channel', 'Analysis of substances', 'Optimum', 'Threshold', 'System Suitability', 'Concordance', 'Location', 'Onchocerciasis', 'Detected (finding)', 'Threshold', 'International Unit', 'Location', 'Uveitis, Intermediate', 'Prediction', 'Estimated', 'Africa, Central', 'Africa, Eastern', 'Amenable', 'Providing presence (regime/therapy)', 'Control Groups', 'Lactation transmission', 'receptor operated channel', 'Analysis of substances', 'Identified', 'Threshold', 'Classification', 'Location', 'Prediction', 'Uveitis, Intermediate', 'International Unit', 'Threshold', 'System Suitability', 'kilometer', 'Location', 'Weight measurement scales', 'Data Collection', 'Onchocerciasis', 'African', 'Continent (qualifier value)', 'Spatial Analysis', 'consider', 'International Unit', 'Homo sapiens', 'Resources', 'Laboratory', 'Surveys', 'Implementation', '3,4-Methylenedioxyamphetamine', 'Cognitive function: initiation']"
223,"['Vitamin supplementation', 'PREVENT (product)', 'Avitaminosis', 'Colicin Plasmids', 'Response process', 'Dietary Supplementation', 'Data Mining', 'Statistical Technique', 'control act - information', 'Databases', 'Evaluation', 'Colicin Plasmids', 'Influence', 'Serum', 'Dietary Supplementation', 'Vitamins', 'Random Forest', 'Extraction', 'Surveys', 'Ultra-violet', 'Intake', 'Nutritional', 'Vitamin measurement', 'Evaluation', 'Relationships', 'Potential', 'Influence', 'Colicin Plasmids', 'response to vitamin', 'RF', 'Correlation', 'Serum', 'Dietary Supplementation', 'Anthropogenic Effects', 'Body mass index procedure', 'Fat Mass', ""Stargardt's disease"", 'Ratio', 'Gamma-glutamyl transferase', 'Total protein measurement', 'Hematologic Tests', 'Observation parameter', 'Mean Corpuscular Volume (result)', 'cisplatin/methotrexate/vinblastine protocol', 'Mean corpuscular hemoglobin concentration determination', 'MCHC - raised', 'Measurement', 'Insulin Sensitivity', 'Physical Examination', 'Insulin Resistance', 'Total', 'Bilirubin', ""Stargardt's disease"", 'Gamma-glutamyl transferase', 'Positive', 'Physical Examination', 'Insulin Resistance', 'cisplatin/methotrexate/vinblastine protocol', 'MCHC - raised', 'Negative', 'Correlation', 'Vitamins', 'Mental concentration', 'Response process', 'Dietary Supplementation', 'RF', 'Response process', 'Evaluation', 'Data Set', 'Serum']"
224,['Intestines']
225,"['Coordinated', 'Patient Transition', 'Liver Cirrhosis', 'Hospitals', 'Hospital admission', 'Inadequate (qualifier)', 'Quality of Health Care', 'Models, Mental', 'Primary Care Physicians', 'Tooth root structure', 'care activity']"
226,"['Allocation', 'Transplantation of liver', 'Tumor Necrosis Factor-Beta', 'Mitosporic Fungi', 'Periodic', 'Review [Publication Type]', 'Programs - Publication Format', 'Evaluation', 'Transplantation', 'Social Determinants of Health', 'Cessation of life', 'Charitable contribution', 'Colicin Plasmids', 'Adult', 'Tumor Necrosis Factor-Beta', 'Hospitals, General', 'Review [Publication Type]', 'ROC Curve', 'Performed', 'Tumor Necrosis Factor-Beta', 'Cessation of life', 'Donor for liver transplant (person)', 'Transplantation of liver', 'Patients', 'Transplantation', 'Recipient', 'Data', 'Censuses', 'univariate statistics', 'Recipient', 'Midline (qualifier value)', 'Midline (qualifier value)', 'Persons', 'Reside', 'Households', 'Canadian', 'U.S. Dollar', 'Comparison', 'Recipient', 'findings aspects', 'Population Density', 'Liver diseases', 'Liver diseases', 'Statistical Significance', 'Multivariate Analysis', 'Tumor Necrosis Factor-Beta', 'Patients', 'Patients', 'Autoimmune Diseases', 'Patients', 'Review [Publication Type]', 'Transplantation', 'North American origin (finding)', 'Transplantation of liver', 'Programs - Publication Format', 'Patients', 'Social Determinants of Health', 'Etiology aspects', 'Transplantation']"
227,"['COVID19 (disease)', 'Pandemics', 'Social Justice', 'Impact food supplement', 'Social Determinants of Health', 'Health', 'Systemic Racism', 'United States', 'Health Services Accessibility', 'Social Determinants of Health', 'Vulnerable Populations', 'Patients', 'Methods', 'Antisense Orientation', 'Bias (Epidemiology)', 'Telemedicine', 'Improved', 'Community Outreach']"
228,"['melatonin', 'Effect', 'Controlling (action)', 'status - In progress', 'Non-alcoholic Fatty Liver Disease', 'Non-alcoholic Fatty Liver Disease', 'Non-alcoholic Fatty Liver Disease', 'therapeutic aspects', 'Clinical Research', 'Evaluation', 'melatonin', 'Plasma', 'Levels (qualifier value)', 'Gamma-glutamyl transferase', 'Transaminases', 'Non-alcoholic Fatty Liver Disease', 'Patients', 'Non-alcoholic Fatty Liver Disease', 'melatonin', 'Databases', 'Initially', 'Identified', 'Scientific Study', 'Trial Inclusion Exclusion Criteria Version', 'Particle', 'Assessed', 'Alanine Transaminase', 'Levels (qualifier value)', 'Lower - spatial qualifier', 'melatonin', 'therapeutic aspects', 'week', 'Aspartate Transaminase', 'Levels (qualifier value)', 'Alteration', 'week', 'Alkaline Phosphatase', 'Changing', 'week', 'follow-up', 'Decreased', 'Refused', 'Detected (finding)', 'Triglyceride level - finding', 'melatonin', 'therapeutic aspects', 'Reduction (chemical)', 'Cholesterol measurement test', 'Gamma-glutamyl transferase', 'Levels (qualifier value)', 'Administration occupational activities', 'melatonin', 'status - In progress', 'Non-alcoholic Fatty Liver Disease', 'Liver function', 'Observation parameter', 'Management procedure', 'Non-alcoholic Fatty Liver Disease', 'Treatment Plan', 'Patients', 'Non-alcoholic Fatty Liver Disease']"
229,"['Autoimmune liver disease', 'Complex', 'biology (field)', 'Exogenous Factors', 'Increased', 'Statistical Prevalence', 'Presentation', 'Standard of Care', 'Transplantation', 'Vision Disparity', 'Minority Groups', 'Black Populations', 'Patients', 'Autoimmune liver disease', 'biology (field)', 'Hereditary', 'Genetic Predisposition to Disease', 'Vision Disparity', 'Universal', 'Variation (Genetics)', 'Outcome Measures', 'Environment', 'Societal Factors', 'Bias, Implicit', 'Bias (Epidemiology)', 'Patients', 'Mitigate', 'Colicin Plasmids', 'Health Inequities', 'Autoimmune liver disease', 'Review [Publication Type]', 'therapeutic aspects', 'Response process', 'Autoimmune liver disease', 'Minority Groups', 'geographic population', 'Vision Disparity', 'Health Equity']"
230,"['Neisseria', 'Causative_agents', 'Sexually Transmitted Diseases', 'Gonorrhea', 'Bacteria', 'Infected', 'Epithelial Cells', 'Cervix Uteri', 'Woman', 'Male population group', 'Metastatic Bone Disease', 'Genitalia', 'Comparison', 'With frequency', 'Neisseria gonorrhoeae', 'Genital infection', 'Groups', 'Pregnant Women', 'Spontaneous', 'Unspecified Abortion', 'Clinical Research', 'West (direction)', 'Woman', 'Spontaneous', 'Unspecified Abortion', 'Home Childbirth', 'Infertility', 'Specific qualifier value', 'DNA', 'Endocervix', 'Polymerase Chain Reaction', 'Detected (finding)', 'Data Analysis', 'Statistical Significance', 'Average', 'Glycation End Products, Advanced', 'Woman', 'Woman', 'Spontaneous abortion', 'Woman', 'Woman', 'year', 'With frequency', 'Gonorrhea', 'Statistical Prevalence', 'Gonorrhea', 'Spontaneous abortion', 'Infertility']"
231,['Anti-Inflammatory Agents']
232,"['Genus: Coronavirus', 'Disease Outbreaks', 'Spreading (qualifier value)', 'Public Health Systems Research', 'To Be Marketed', 'Pharmaceutical Preparations', 'Testing', 'favipiravir', 'Investigates', 'Effectiveness', 'Safety', 'COVID19 (disease)', 'Patients', 'Systematic Review', 'Systematic Review', 'Meta Analysis (statistical procedure)', 'Statement', 'Prospero', 'Clinical Trials', 'Safety', 'Effectiveness', 'favipiravir', 'Comparison', 'Control Groups', 'therapeutic aspects', 'Patients', 'Confirmed by', 'Communicable Diseases', 'Databases', 'Assessed', 'Scientific Study', 'Comprehensive', 'Laboratory Procedures', 'Publications', 'Bias (Epidemiology)', 'Scientific Study', 'Meta Analysis (statistical procedure)', 'Meta Analysis (statistical procedure)', 'Clinical', 'Improvement', 'favipiravir', 'Control Groups', 'Hospitalization', 'RR genotype', 'Curie', 'Renal clearance diagnostic test', 'day', 'Hospitalization', 'Control Groups', 'Curie', 'Mineral supplementation', 'favipiravir', 'Control Groups', 'Curie', 'Groups', 'Mortality Vital Statistics', 'favipiravir', 'Control Groups', 'Statistical Significance', 'favipiravir', 'Mortality Vital Statistics', 'Patients', 'Mild Severity of Illness Code', 'COVID19 (disease)', 'Antiviral Agents', 'Symptoms aspect', 'Effectiveness', 'Clinical setting']"
233,"['Sociodemographic Factors', 'Colicin Plasmids', 'Presentation', 'Disease', 'COVID19 (disease)', 'Severities', 'Administration occupational activities', 'Factor', 'risk factors', 'Disease', 'Severities', 'Patients', 'Infected', 'COVID19 (disease)']"
234,"['Bibliographic Reference', 'Interval', 'RASL12 gene', 'Biological Markers', 'Inflammatory', 'Oxidative Stress', 'Biological Markers', 'Liver function', 'Healthy', 'Adult']"
235,"['COVID19 (disease)', 'COVID19 (disease)', 'public health medicine (field)', 'Signs and Symptoms', 'Antinuclear IgG Antibody Measurement', 'Research Personnel', 'Diagnosis', 'Therapeutic procedure', 'Measures', 'immunoglobulin G', 'Suspected diagnosis', 'COVID19 (disease)', 'Voluntary Workers', 'Measures', 'Duration (temporal concept)', 'Symptoms aspect', 'Sampling - Surgical action', 'Participant', 'Clinical Research', 'Healthy', 'Genetic Carriers', 'Cure (remedy)', 'Borderline', 'Research Subject', 'Diagnosis', 'COVID19 (disease)', 'gastrointestinal', 'gastroenterology (field)', 'Symptoms aspect', 'gastroenterology (field)', 'Asymptomatic (finding)', 'findings aspects', 'Diagnosis', 'COVID19 (disease)', 'Boost', 'research', 'Diagnosis']"
236,"['Marriage, life event', 'Woman', 'Health', 'Homo sapiens', 'Clinical Research', 'Systematic Review', 'Scientific Study', 'Child', 'Marriage, life event']"
237,"['Statistical Prevalence', 'Metabolic Syndrome X', 'Increased', 'Decade', 'World', 'Epidemic', 'public entity', 'Clinical', 'Clinical Research', 'Evaluation', 'Statistical Prevalence', 'Metabolic Syndrome X', 'Demographic Factors', 'Clinical Research']"
238,"['Failure (biologic function)', 'Liver carcinoma', 'altretamine/cisplatin/cyclophosphamide protocol', 'Medical Surveillance', 'altretamine/cisplatin/cyclophosphamide protocol', 'Diagnosis', 'Worsening pattern', 'Forecast of outcome', 'Estimated', 'Statistical Prevalence', 'Medical Surveillance', 'risk factors', 'Patients', 'altretamine/cisplatin/cyclophosphamide protocol', 'Country of Argentina', 'Recognition, Psychology', 'Patients', 'Implementation', 'altretamine/cisplatin/cyclophosphamide protocol', 'surveillance aspects', 'Success', 'altretamine/cisplatin/cyclophosphamide protocol', 'surveillance aspects']"
239,"['Inflammation', 'Inflammation Mediators', 'Players', 'Pathology', 'Irritable Bowel Syndrome', 'chemokine', 'CCL28 gene', 'Inflammatory cell', 'Mucous Membrane', 'Levels (qualifier value)', 'Patients']"
240,"['Chronic liver disease', 'Chloride Anion Exchanger', 'Affect (mental function)', 'Approximate', 'Ultrasonography', 'geographic population', 'Hospitalization', 'Financial cost', 'Cancer Burden', 'Financial Hardship', 'Persons', 'Chloride Anion Exchanger']"
241,"['Menopause', 'Associated with', 'Changing', 'Profiling (action)', 'risk factors', 'Oxidative Stress', 'Control Groups', 'Menopause', 'Complication', 'vitamin E', 'Antioxidants', 'Lipid Peroxidation', 'Menopause', 'Evaluation', 'Effect', 'Deciduous maxillary right central incisor tooth', 'Dietary Supplementation', 'Menopause', 'Woman']"
242,"['Malignant neoplasm of gastrointestinal tract', 'Persons', 'Primary Prevention', 'Nursing interventions', 'Healthy', 'Negative', 'Effect', 'Reduced', 'Financial Stress', 'Probability', 'gastrointestinal', 'Cancer Prevention', 'Policy']"
243,"['Clinical Trials, Randomized', 'resveratrol', 'Menstruation', 'physiopathological', 'Clinical', 'Acne Vulgaris', 'Hair', 'Biochemical', 'Evidence', 'Hyperandrogenism', 'Woman', 'Polycystic Ovary Syndrome']"
244,"['Cholangiocarcinoma', 'Liver and Intrahepatic Biliary Tract Carcinoma', 'Early', 'Diagnosis', 'Success', 'therapeutic aspects', 'Clinical Research', 'Comparison', 'Biopsy', 'Cholangiocarcinoma', 'Prospective Studies', 'Patients', 'Endoscopic Retrograde Cholangiopancreatography', 'Endoscopic Retrograde Cholangiopancreatography', 'Performed', 'Persons', 'Sampling - Surgical action', 'Narrow', 'Biopsy', 'Fluoroscopy', 'Age', 'Patients', 'year', 'Forceps', 'Diagnosis', 'Cholangiocarcinoma', 'Statistical Significance', 'Cholangiocarcinoma', 'Case (situation)', 'Diagnosis', 'Biopsy forceps, device']"
245,"['Mechanism (attribute)', 'Parkinson Disease', 'Inflammation', 'Colicin Plasmids', 'Inflammatory', 'Colicin Plasmids', 'leptin', 'Mechanism (attribute)', 'Inflammation', 'Contribution', 'Symptoms aspect', 'Possible diagnosis', 'Meta Analysis (statistical procedure)', 'Accurate (qualifier)', 'estimation <subjective>', 'Relationships']"
246,"['Oxidative Stress', 'saliva', 'Antioxidants', 'Protection', 'Dental caries', 'superoxide dismutase', 'superoxide dismutase', 'catalase', 'glutathione']"
247,"['COVID19 (disease)', 'COVID19 (disease)', 'Severe (severity modifier)', 'Respiratory Distress Syndrome, Adult', 'Genus: Coronavirus', 'China']"
248,"['Colorectal Carcinoma', 'Impact food supplement', 'Patients', 'Psychophysiology', 'Social Aspects of Cancer', 'Gender', 'Mixed anxiety and depressive disorder', 'Relationships', 'Characteristics', 'Disease', 'Demography']"
249,"['Clinical Research', 'Average', 'Mental concentration', 'Metals', 'cadmium', 'Hamartoma Syndrome, Multiple', 'chromium', 'copper', 'nickel', 'nickel', 'lead', 'Chickens', 'Intake', 'Target', 'Carcinogenic Metal', 'Cross-Sectional Studies', 'Specimen', 'Chickens', 'Measurement', 'Hamartoma Syndrome, Multiple', 'Creatinine measurement', 'copper', 'nickel', 'lead', 'Inductively-Coupled Plasma Optical Emission Spectrometer', 'Metals', 'Detected (finding)', 'Spatial Distribution', 'Mental concentration', 'Hamartoma Syndrome, Multiple', 'copper', 'Creatinine measurement', 'nickel', 'Highest', 'lead', 'Mental concentration', 'Highest', 'Creatinine measurement', 'nickel', 'lead', 'Liver', 'Muscle Tissue', 'Acceptable', 'Levels (qualifier value)', 'Highest', 'Daily', 'Intake', 'Muscle Tissue', 'Creatinine measurement', 'Highest', 'Meat', 'Hawaii', 'Chickens', 'Creatinine measurement', 'Neglecta', 'Hamartoma Syndrome, Multiple', 'lead', 'Creatinine measurement', 'nickel', 'Consumption of goods', 'Adult', 'Child']"
250,"['Clinical Research', 'Mental association', 'Social Interaction', 'Social Vulnerability Index', 'Ethnicity', 'Probability', 'Liver carcinoma']"
251,"['Malignant neoplasm of breast', 'Malignant Neoplasms', 'Woman', 'Asia', 'Health Problems in Pregnancy', 'Country', 'Extensive', 'therapeutic aspects', 'Early Diagnosis', 'Methods', 'Increasing (qualifier value)', 'Survival Rate', 'Evaluation', 'Screening for cancer', 'Societies', 'BARRIER', 'Mammography', 'Asia']"
252,"['Rapid', 'Increased', 'Case (situation)', 'COVID19 (disease)', 'Numerous', 'Cities', 'Iran', 'Pandemics', 'Communicable Diseases', 'Rating (action)', 'Assessed', 'Seroprevalence', 'Respiratory Distress Syndrome, Adult', 'Genus: Coronavirus', 'Cities', 'Iran', 'Indicator', 'Rating (action)']"
253,"['Oxidative Stress', 'Increased', 'Deposition', 'Fatty Liver', 'Clinical Research', 'Hypolipidemic Agents']"
254,"['Patients', 'Diabetes Mellitus, Insulin-Dependent', 'High', 'Celiac Disease', 'Hamartoma Syndrome, Multiple', 'Genetic Background', 'Social Interaction', 'Environment', 'Immunologic Factors', 'Systematic Review', 'Meta Analysis (statistical procedure)', 'Estimated', 'Statistical Prevalence', 'Hamartoma Syndrome, Multiple', 'Iranian (ethnic group)', 'Patients', 'Diabetes Mellitus, Insulin-Dependent', 'Celiac Disease', 'Celiac Disease', 'Diabetes', 'Iran', 'Combinations (Undergarment)', 'Databases', 'Databases, Genetic', 'Sudden infant death syndrome', 'PubMed', 'Heterogeneity', 'Scientific Study', 'Assessed']"
255,"['control act - information', 'Social Determinants of Health', 'Health', 'Transplantation of liver', 'Tumor Necrosis Factor-Beta', 'Outcome Measures', 'Health', 'Recipient', 'County', 'residence', 'Influence', 'Outcome Measures']"
256,"['Burden', 'Chronic disease', 'Manuscripts', 'Comprehensive', 'Morbidity - disease rate', 'Burden', 'Ethnic Groups', 'New Zealand']"
257,"['Cystic Echinocccosis', 'Zoonoses', 'Homo sapiens', 'Herbivory', 'Animals', 'World Health', 'Echinococcus granulosus', 'leucine', 'Herbals (publications)', 'Therapeutic procedure', 'Property (attribute)', 'Antioxidants', 'Antineoplastic Agents', 'Microbicides', 'Potential', 'Plants', 'Traditional origin', 'Medicine, Modern', 'ex vivo']"
258,"['Metabolic Syndrome X', 'Factor', 'Clinical Research', 'Colicin Plasmids', 'Variant', 'Metabolic Syndrome X', 'ETV3 gene', 'Component object', 'Clinical Research']"
259,"['Malignant neoplasm of stomach', 'Gas Chromatography', 'Malignant Neoplasms', 'Iran', 'Prevention Study', 'Investigates', 'Epidemiology', 'Malignant neoplasm of stomach', 'Statistical Prevalence', 'Incidence', 'Mortality Vital Statistics', 'risk factors', 'Iran']"
260,"['COVID19 (disease)', 'Pandemics', 'Health Inequities', 'Acre USA Survey', 'Social Conditions', 'Shapes', 'Health Personnel', 'Dermatology field', 'Social Determinants of Health', 'Health', 'Vision Disparity', 'Liver diseases', 'Statistical Prevalence', 'Outcome Measures', 'Health Services Accessibility', 'Physical Distancing', 'COVID19 (disease)', 'Pandemics', 'Symptom aggravating factors', 'Vision Disparity', 'Health', 'Consequence of', 'Patients', 'Chronic liver disease', 'Type of bridge device', 'GTPase-Activating Proteins', 'Health Equity', 'Social Determinants of Health', 'Persons', 'Community', 'Social Norms', 'Nursing interventions', 'Implementation', 'Screening for cancer', 'hepatology (field)', 'care activity', 'Cascade Device', 'Community', 'Social Norms', 'Nursing interventions', 'Collaboration', 'Partnership', 'public entity', 'Health Personnel', 'Health Services Accessibility', 'Community', 'Increasing (qualifier value)', 'research', 'Investigates', 'Mental association', 'Social Determinants of Health', 'health disparity', 'Advocacy', 'Upstream', 'Social Determinants of Health', 'Racism', 'Bias (Epidemiology)', 'hepatology (field)', 'Normal', 'Patients', 'Social', 'Context', 'Health care facility', 'Obstetric Delivery', 'care activity', 'Vulnerable Populations', 'Patients', 'Liver diseases', 'COVID19 (disease)', 'historical period']"
261,"['Weight Gain', 'Disease', 'Comorbidity', 'Patients', 'COVID19 (disease)', 'beneficiary', 'Comprehensive', 'Administration occupational activities', 'Post-Treatment Lyme Disease Syndrome', 'Statistical Prevalence', 'Disease', 'Comorbidity', 'COVID19 (disease)', 'Patients', 'Systematic Review', 'Meta Analysis (statistical procedure)']"
262,"['Clinical Research', 'Evaluation', 'Statistical Prevalence', 'Signal Pathways', 'Mutation Rate', 'Malignant neoplasm of gastrointestinal tract', 'Systematic Review', 'Meta Analysis (statistical procedure)', 'Clinical Research', 'criteria', 'Study models', 'Confidence Intervals', 'Curie', 'Calculation', 'Pooled Sample', 'Estimated', 'Statistical Prevalence', 'Pooled Sample', 'Signal Transduction', 'Mutation', 'Malignant neoplasm of stomach', 'Liver and Intrahepatic Biliary Tract Carcinoma', 'Colorectal Carcinoma', 'Pancreatic carcinoma', 'Curie', 'Curie', 'Curie', 'Curie', 'Mutation Rate', 'Wnt Signaling Pathway', 'Mitogen-Activated Protein Kinases', 'Biochemical Pathway', 'Curie', 'Curie', 'Genes', 'Biochemical Pathway', 'PIK3CA gene', 'Biochemical Pathway', 'Colorectal Carcinoma', 'beta catenin', 'CTNNB1 gene', 'Liver and Intrahepatic Biliary Tract Carcinoma', 'Changing', 'Biochemical Pathway', 'Wnt Signaling Pathway', 'Mitogen-Activated Protein Kinases', 'Biochemical Pathway', 'Pancreatic carcinoma', 'High', 'Pressure- physical agent', 'Pooled Sample', 'Antigen-Presenting Cells', 'Mutation', 'Colorectal Carcinoma', 'Malignant neoplasm of stomach', 'Pancreatic carcinoma', 'Gene Alterations']"
263,"['Colorectal Carcinoma', 'Colorectal Carcinoma', 'second (number)', 'Cancer-Related Death', 'Survival Rate', 'Colicin Plasmids', 'Quality', 'Physical Examination', 'Treatment Protocols', 'Clinical Research', 'Assessed', 'Survival Rate', 'Colorectal Carcinoma', 'Clinical Research', 'International', 'Scopus', 'Internet', 'Publishing', 'Evaluation', 'Quality', 'Scientific Study', 'Heterogeneity', 'Paper', 'Assessed', 'Publication Year', 'Specimen', 'Human Development', 'Heterogeneity Diffusion Imaging', 'Clinical Research', 'TitleStyles', 'systematic', 'Scientific Study', 'Meta Analysis (statistical procedure)', 'Survival Rate', 'Patients', 'Colorectal Carcinoma', 'Curie', 'Curie', 'Curie', 'Disease regression', 'Correlation', 'Survival Rate', 'Specimen', 'Human Development', 'Survival Rate', 'Survival Rate', 'European (ethnic group)', 'Country', 'Acre USA Survey', 'Documented', 'Comprehensive', 'Evidence-Based Medicine', 'Meta Analysis (statistical procedure)', 'Enhance (action)', 'Policy', 'Outcome Measures', 'Medical service', 'Prophylactic treatment', 'Colorectal Carcinoma']"
264,"['diabetic', 'Patients', 'High', 'COVID19 (disease)', 'Colicin Plasmids', 'Prediction', 'Patients', 'COVID19 (disease)']"
265,"['solidarity', 'Clinical action', 'Persons', 'Supportive care', 'Groups', 'Standing position', 'solidarity', 'Literature', 'Advocacy', 'Persons', 'Gene Expression', 'View', 'No Concerns', 'Thinking, function', 'solidarity', 'Reusable Drivers', 'Stimulation (motivation)', 'solidarity', 'Decision', 'solidarity', 'World', 'COVID19 (disease)', 'World', 'COVID19 (disease)']"
266,"['Blood Pressure', 'Dimensional Measurement Accuracy', 'Diagnosis', 'Administration occupational activities', 'Hypertensive disease', 'Clinical Research', 'Blood Pressure', 'Medical Devices', 'American Medical Association', 'Iranian (ethnic group)', 'Adult']"
267,"['Evaluation', 'Anabolism', 'copper', 'Artificial nanoparticles', 'Aqueous Humor', 'extract - ActClassContainer']"
268,"['Statistical Prevalence', 'Helicobacter pylori', 'Communicable Diseases', 'Country', 'Socioeconomic Status', 'Mental association', 'Persons', 'Levels (qualifier value)', 'Characteristics', 'Europe', 'Country', 'High', 'Statistical Prevalence', 'Communicable Diseases', 'Clinical Research', 'risk factors', 'Communicable Diseases', 'Adult', 'Clinical Trials']"
269,"['Clinical Research', 'Comparison', 'Quality', 'Life', 'Perceived quality of life', 'Patients', 'Diabetes Mellitus, Non-Insulin-Dependent', 'Questionnaires', 'Iran']"
270,"['Research Methodology', 'Electromagnetic Spectrum', 'Traumatic AND/OR non-traumatic injury', 'Estimated', 'Demography', 'Policy Makers', 'Global Burden of Disease', 'Methods', 'Estimated', 'Burden', 'criteria']"
271,"['Clinical Research', 'Unequal', 'Decayed, Missing, and Filled Teeth Index', 'Disintegration (morphologic abnormality)', 'Fill', 'Adult', 'Iran']"
272,"['Follow', 'Healthy People Programs', 'Disconnection', 'Animals', 'Environment', 'Rodent', 'Reservoir (environment)', 'Cryptosporidiosis', 'Homo sapiens', 'Animals', 'Intrahepatic biliary atresia', 'Cryptosporidium', 'Systematic Review', 'Meta Analysis (statistical procedure)', 'Estimated', 'Statistical Prevalence', 'Cryptosporidiosis', 'Associated with', 'risk factors', 'Rodent', 'International', 'PubMed', 'Science', 'Scientific Study', 'Meta Analysis (statistical procedure)', 'Estimated', 'Overall Publication Type', 'Statistical Prevalence', 'Deprecated Cryptosporidium sp Ag [Presence] in Unspecified specimen by Immunofluorescence', 'Variance', 'Heterogeneity']"
273,"['Province', 'New Brunswick', 'Patients', 'Infected', 'Hepatitis C', 'geographic population', 'Clinical Research', 'Colicin Plasmids', 'Patients']"
274,"['TBATA gene', 'control act - information', 'Contribution', 'Preventive monitoring', 'Brucellosis', 'Sentinel Surveillance', 'Diagnosis', 'Brucellosis']"
275,"['Disease Outbreaks', 'Respiratory Distress Syndrome, Adult', 'China', 'December', 'Pandemics', 'Nature of disorder', 'Specific qualifier value', 'Pharmaceutical Preparations', 'Potential', 'Therapeutic procedure', 'Patients', 'Systematic Review', 'Meta Analysis (statistical procedure)', 'Evaluation', 'Scientific Study', 'favipiravir', 'COVID19 (disease)', 'Pneumonia']"
276,"['Malaria', 'Homo sapiens', 'Health Problems in Pregnancy', 'Decade']"
277,"['Hepatitis C', 'HIV', 'Morbidity - disease rate', 'Mortality Vital Statistics', 'Clinical Research', 'Evaluation', 'Statistical Prevalence', 'Hepatitis B', 'Coinfection', 'Persons', 'Woman', 'Sex Workers', 'Live - Specimen Condition', 'Data', 'Source', 'Databases', 'PubMed', 'Analysis', 'Computer software', 'Statistical Prevalence', 'Hepatitis C', 'Curie', 'Curie', 'Statistical Prevalence', 'Hepatitis B', 'Curie', 'Curie', 'Statistical Prevalence', 'Statistical Prevalence', 'Hepatitis C', 'Asia, Southeastern', 'Highest', 'Africa', 'Statistical Prevalence', 'High', 'Statistical Prevalence', 'Hepatitis C', 'Coinfection', 'Hearing problem', 'Nursing interventions', 'geographic population', 'Hepatitis C', 'Excretory function', 'Recommendation', 'Harm Reduction', 'Hepatitis B', 'Vaccination']"
278,"['Clinical Research', 'Evaluation', 'Oxidative Stress', 'Non-alcoholic Fatty Liver Disease', 'Non-alcoholic Fatty Liver Disease', 'Patients', 'Diagnosis', 'month', 'therapeutic aspects']"
279,"['Heart failure', 'Fatal', 'Cardiac Arrhythmia', 'Cardiac dilatation', 'Anemia', 'Thalassemia', 'Effect', 'Echocardiographs', 'Changing', 'Thalassemia', 'Candida intermedia', 'Patients', 'Iran']"
280,"['Investigates', 'Liver carcinoma', 'altretamine/cisplatin/cyclophosphamide protocol', 'Characteristics', 'Relationships', 'Result', 'Transplantation of liver', 'Tumor Necrosis Factor-Beta']"
281,"['Hepatitis C', 'Hepatitis C', 'Case (situation)', 'Persons', 'Inject - dosing instruction imperative', 'Pharmaceutical Preparations', 'Study models', 'Hepatitis C', 'therapeutic aspects', 'Success', 'therapeutic aspects', 'Positive', 'Anthropogenic Effects', 'Evaluation', 'Changing', 'Health Care', 'Programs - Publication Format']"
282,"['Clinical Research', 'Evaluation', 'Statistical Prevalence', 'HIV', 'HIV', 'Hepatitis C', 'hepatitis B virus', 'Coinfection', 'Persons', 'Woman', 'Sex Workers', 'Data', 'Source', 'Databases', 'Data', 'Computer software']"
283,"['zinc phosphide', 'Release (procedure)', 'phosphine', 'Toxic effect', 'phosphine', 'Interferes with', 'Manifest', 'Toxicity aspects', 'Prodromal Symptoms', 'Symptoms aspect', 'Abdominal Pain', 'Nausea', 'Metabolic acidosis', 'Increased', 'Liver function', 'Male population group', 'History', 'Ingestion', 'Mild Severity of Illness Code', 'Have Abdominal Discomfort', 'Structure of right upper quadrant of abdomen', 'therapeutic aspects', 'polyethylene glycols', 'Laboratory Procedures', 'Sudden Cardiac Arrest', 'Hospital admission', 'Autopsy', 'Myopathy', 'Fibrosis', 'Ischemia', 'Congestion', 'Heart tissue', 'Pulmonary Edema', 'Bilateral', 'Kidney', 'Nutmeg - dietary', 'Providing presence (regime/therapy)', 'phosphine', 'Liquid substance', 'Patients', 'Worse', 'Cardiovascular system', 'Cardiopulmonary', 'Early Fetal Death', 'Checking (action)', 'Cardiac enzymes', 'Cardiac monitoring', 'Early Diagnosis', 'Efficient', 'Administration occupational activities', 'Patients']"
284,"['cadmium chloride', 'Industry', 'Application procedure', 'Industry', 'Environment', 'Environmental Pollutants', 'Clinical Research', 'Evaluation', 'Effect', 'atorvastatin', 'cadmium', 'Hepatotoxicity', 'Males', 'Rattus norvegicus']"
285,"['mental health', 'Iran', 'Clinical Research', 'Assessed', 'mental health', 'Iranian (ethnic group)', 'Adult']"
286,"['Abdominal Pain', 'Symptoms', 'Poisoning', 'Diagnosis', 'Clinical Research', 'Abdominal Pain', 'Patients', 'Erectile dysfunction', 'Ambulatory Care Facilities', 'Disease']"
287,"['trends qualifier', 'trauma qualifier', 'Health', 'Regular', 'Traumatic AND/OR non-traumatic injury', 'Burden', 'Evaluation procedure', 'Critical', 'Global Burden of Disease', 'Morbidity - disease rate']"
288,"['Animal bite', 'Rabies (disorder)', 'public health medicine (field)', 'Fatalities']"
289,"['India', 'Antihypertensive Agents', 'Hypertensive disease', 'Clinical Research', 'Predictor', 'Transition Mutation', 'Stage', 'Hypertensive disease', 'Incidence', 'Prehypertension', 'Hypertensive disease']"
290,"['Background', 'Overweight', 'Serious', 'Country', 'Fatty Liver', 'Statistical Prevalence', 'Obesity', 'Overweight', 'Iranian (ethnic group)', 'student', 'Meta Analysis (statistical procedure)', 'Sudden infant death syndrome', 'Scopus', 'PubMed', 'Eligible', 'Publications', 'Particle', 'Statistical Prevalence', 'Overweight', 'Data', 'Heterogeneity', 'Science of Statistics', 'Data', 'Version', 'Scientific Study', 'Persons', 'year', 'Statistical Prevalence', 'Obesity', 'Iranian (ethnic group)', 'student', 'Body mass index procedure', 'Confidence Intervals', 'Curie', 'Woman', 'Curie', 'Curie', 'Statistical Prevalence', 'Overweight', 'Body mass index procedure', 'Curie', 'Woman', 'Curie', 'Curie', 'Obesity', 'Curie', 'elementary school students', 'Curie', 'Schools, Secondary', 'Curie', 'high school students', 'Statistical Prevalence', 'Rating (action)', 'Overweight', 'Statistical Prevalence', 'Obesity', 'High', 'Statistical Prevalence', 'Overweight', 'High', 'Woman', 'Statistical Prevalence', 'Obesity', 'Schools, Secondary', 'Statistical Prevalence', 'Schools, Secondary', 'high school students']"
291,"['Unequal', 'Oral cavity', 'Behavior', 'Iran', 'Clinical Research', 'Unequal', 'Oral cavity', 'Middle Aged', 'Elderly (population group)', 'Iran']"
292,"['Drowning', 'International Classification of Diseases', 'ICD9 - Coding system', 'Global Burden of Disease', 'Clinical Research', 'Unintentional', 'Estimated']"
293,"['Overweight', 'Obesity', 'Health', 'No Concerns', 'Adverse event', 'Consequence of', 'Life Span', 'Clinical Research', 'socioeconomic', 'Unequal', 'Overweight', 'Obesity', 'Iranian (ethnic group)', 'Adult']"
294,"['Liver carcinoma', 'Liver and Intrahepatic Biliary Tract Carcinoma', 'Liquid Chromatography', 'Malignant Neoplasms', 'Cessation of life', 'Comprehensive', 'Survival Rate', 'Patients', 'Liquid Chromatography', 'Asia', 'Clinical Research', 'Evaluation', 'Survival Rate', 'Patients', 'Liquid Chromatography', 'Asian country', 'Methodology aspects', 'Clinical Research', 'Research Personnel', 'International', 'Internet', 'Gray Literature', 'Evaluation', 'Quality', 'Paper', 'TitleStyles', 'Scientific Study', 'Inclusion', 'Liquid Chromatography', 'Curie', 'Curie', 'Curie', 'Clinical Research', 'Liquid Chromatography', 'Continuance of life', 'Rating (action)', 'Asian country', 'Lower - spatial qualifier', 'Europe', 'North America']"
295,"['Neighborhood', 'Poverty', 'Adverse event', 'Health Outcomes', 'Neighborhood', 'Poverty', 'Adherence (attribute)', 'Immunosuppressive Agents', 'Pharmaceutical Preparations', 'Transplantation of liver']"
296,"['Malignant neoplasm of prostate', 'Male population group', 'Incidence', 'Malignant neoplasm of prostate', 'Increasing (qualifier value)']"
297,"['research', 'Homeless persons', 'Infected', 'Hepatitis C', 'therapeutic aspects', 'Uptake', 'Marginal']"
298,"['Article', 'Characteristics', 'Health System', 'HCCAT5 gene', 'Iran', 'Documents', 'Report (document)', 'Guidelines', 'HCCAT5 gene', 'Publishing', 'HCCAT5 gene', 'Iran', 'Assessed', 'Technology', 'Improved', 'Decision Making', 'HCCAT5 gene', 'Iran', 'Face', 'Pressing Pain', 'Problems - What subject filter', 'HCCAT5 gene', 'Iran', 'Research Personnel', 'Absent', 'Lymphatic System', 'Technology', 'HCCAT5 gene', 'Test Result', 'High Level', 'Policy', 'Maker (occupation)', 'Extrinsic']"
299,"['Malignant neoplasm of breast', 'Problems - What subject filter', 'public health medicine (field)', 'World', 'Continuance of life', 'Anura', 'Indicators', 'Quality', 'Cancer Control']"
300,"['Scientific Study', 'Assessed', 'Statistical Prevalence', 'Diabetes', 'Prediabetes syndrome', 'Systematic Review', 'Meta Analysis (statistical procedure)', 'Estimated', 'Statistical Prevalence', 'Undiagnosed', 'Diabetes Mellitus, Non-Insulin-Dependent', 'Variant', 'Publications']"
301,"['Article', 'Analyzer, device', 'Potential']"
302,"['Central Nervous System Stimulants', 'methamphetamine', 'Increasing (qualifier value)', 'Iran', 'Assessed', 'Drug usage', 'Behavior', 'Statistical Prevalence', 'HIV', 'Hepatitis C', 'hepatitis B virus', 'geographic population', 'methamphetamine', 'Iran']"
303,"['Levels (qualifier value)', 'Unequal', 'Exercise', 'Iran', 'Clinical Research', 'Unequal', 'Exercise', 'phenylpropanolamine', 'Iranian (ethnic group)', 'Adult']"
304,"['Country', 'Success', 'Improving (qualifier value)', 'child survival', 'Localized', 'status - In progress', 'United Nations', 'Sustainable Development Goals', 'Death of child', 'Data', 'Child', 'Mortality Vital Statistics', 'trends qualifier', 'Number of Late Fetal Deaths', 'Infant, Newborn', 'Infant', 'Child', 'Age', 'low', 'Developing Countries', 'Models, Statistical', 'Child', 'Country', 'Death of child', 'Live Birth', 'Death of child', 'Country', 'Identification (Psychology)', 'Patterns', 'status - In progress', 'Geographic', 'Unequal', 'Investments', 'Implementation', 'Improved', 'Population Health']"
305,"['Noncommunicable Diseases', 'threat', 'Global developmental delay', 'United Nations', 'Observation in research', 'status - In progress', 'Budgets', 'Global Burden of Disease', 'Data']"
306,"['Clinical Research', 'Statistical Prevalence', 'Hepatitis B Surface Antigens', 'Health Personnel', 'Mediterranean Region', 'Middle Eastern']"
307,"['Organochlorine pesticide', 'Persistent', 'PLP1 protein, human', 'Insecticides', 'Clinical Research', 'Evaluation', 'Residue', 'Meat', 'hepato-renal', 'Cattle', 'Sheep', 'Specimen', 'Residual', 'Contents', 'Aldrin', 'Dieldrin', 'DDT (Insecticide)', 'Metabolite', 'Isomerism (chemical phenomenon)', 'lindane', 'Heptachlor', 'Chlordan', 'methoxychlor', 'Hexachlorobenzene', 'Analysis', 'Specimen', 'Ocular Cicatricial Pemphigoid', 'Residue', 'Techniques', 'Gas Chromatography-Mass Spectrometry', 'Gas Chromatography-Mass Spectrometry', 'Analysis', 'Lower - spatial qualifier', 'findings aspects', 'Meat', 'Organ', 'Status', 'Residue', 'Ocular Cicatricial Pemphigoid', 'Preventive monitoring', 'Pesticide Residues', 'Organ', 'public health medicine (field)']"
308,"['Mortality Vital Statistics', 'Patients', 'Illness (finding)', 'low', 'Transplantation', 'Clinical Reasoning', 'Illness (finding)', 'Social Determinants of Health', 'Influence', 'Decision', 'Illness (finding)', 'Social Determinants of Health', 'Characteristics', 'Adjudication', 'Transplantation']"
309,"['Evidence', 'Transplantation of liver', 'Tumor Necrosis Factor-Beta', 'Outcome Measures', 'Indication of (contextual qualifier)', 'Community', 'Characteristics', 'Risk', 'Transplantation', 'Quality', 'Metric (substance)', 'Consistency', 'Tumor Necrosis Factor-Beta', 'Outcome Measures', 'County']"
310,"['Blastocystis', 'Tuberculosis', 'public health medicine (field)', 'Replication Origin', 'Clinical Research', 'Investigates', 'Blastocystis', 'Subtype (attribute)', 'Alleles', 'Spatial Distribution', 'Tuberculosis', 'Patients']"
311,"['Osteoarthritis, Knee', 'Collagen Diseases', 'Problems - What subject filter', 'Investigates', 'risk factors', 'Osteoarthritis, Knee', 'Case (situation)', 'Diagnosis', 'Community', 'Orientation (spatial)', 'Control Groups', 'Rheumatism', 'Phase']"
312,"['objective (goal)', 'Diabetes', 'Administration occupational activities', 'Enhance (action)', 'Performance', 'Colicin Plasmids', 'Therapeutic procedure', 'Target', 'Achievement', 'Control Groups', 'Complication', 'Diabetes']"
313,"['Clinical Research', 'Evaluation', 'Effectiveness', 'Poisoning', 'Outpatients', 'Clinical Research', 'Epidemic', 'Poisoning', 'Iran', 'Patients', 'Ambulatory Care Facilities', 'Treating', 'penicillamine', 'Having administered', 'day', 'Availability of', 'Recommendation', 'week', 'Withholding Treatment', 'Ambulatory Care Facilities', 'Test Result', 'Patients', 'Poisoning', 'Symptoms aspect', 'Encephalopathies', 'Presentation', 'Midline (qualifier value)', 'therapeutic aspects', 'day', 'Statistical Significance', 'Treatment Protocols', 'Complication', 'Recovery - action', 'therapeutic aspects', 'Midline (qualifier value)', 'Reduced', 'Patients', 'penicillamine', 'Bone Substitutes', 'Poisoning', 'Sample Size', 'Limited (extensiveness)', 'Detected (finding)', 'Serious', 'aspects of adverse effects', 'penicillamine', 'Acceptable', 'Recovery - action', 'Epidemic', 'Limitation', 'Access']"
314,"['Statistical Prevalence', 'IL13 gene', 'Chronic disease', 'Child', 'Science of Statistics', 'Statistical Prevalence', 'IL13 gene', 'Iranian (ethnic group)', 'Child', 'Systematic Review', 'Meta Analysis (statistical procedure)', 'Evaluation', 'Statistical Prevalence', 'IL13 gene', 'Iranian (ethnic group)', 'Child']"
315,"['Colorectal Carcinoma', 'Etiology aspects', 'Cessation of life', 'World Health', 'Scientific Study', 'Anabolism', 'therapeutic aspects', 'year', 'Colicin Plasmids', 'Anabolism', 'Cancer Therapeutic Procedure', 'Microorganism', 'Intestines']"
316,"['Mortality Vital Statistics', 'Mexico', 'Decreased', 'year', 'geographic population', 'Practice Experience', 'Social Deprivation']"
317,"['Premature Birth', 'Gestational Age', 'Fetus Small for Gestational Age', 'Contribution', 'Infant, Newborn', 'Mortality Vital Statistics', 'Social', 'Premature Birth', 'Fetus Small for Gestational Age', 'geographic population', 'Data', 'Demography', 'risk factors', 'Premature Birth', 'Fetus Small for Gestational Age', 'Pregnant Women', 'Analysis of substances', 'Pregnancy', 'Premature Birth', 'High', 'Mother (person)', 'year', 'Reduced', 'Fetus Small for Gestational Age', 'Quintile', 'Decreased', 'Effectiveness', 'coverage - financial contract', 'Fetus Small for Gestational Age', 'Nursing interventions', 'Woman', 'Socioeconomic Status', 'Fetus Small for Gestational Age']"
318,"['Clinical Research', 'Evaluation', 'Statistical mean', 'Mental concentration', 'cadmium', 'Hamartoma Syndrome, Multiple', 'chromium', 'copper', 'nickel', 'nickel', 'lead', 'Meat', 'Sheep', 'Daily', 'Intake', 'Analysis of substances', 'Metals', 'Inductively-Coupled Plasma', 'Specimen', 'Principal Component Analysis', 'Passive Cutaneous Anaphylaxis', 'Cell Differentiation process', 'Sheep', 'Kidney', 'hepato-renal', 'Levels (qualifier value)', 'Hamartoma Syndrome, Multiple', 'copper', 'lead', 'Positive', 'Target', 'Hazard', 'Quotient', 'Calculated', 'lead', 'Hamartoma Syndrome, Multiple', 'Levels (qualifier value)', 'Kidney', 'Carcinogenic Metal', 'Creatinine measurement', 'Hazard', 'Hawaii', 'Consumption of goods', 'Child', 'International', 'High', 'Levels (qualifier value)', 'Hawaii']"
319,"['Liver carcinoma', 'Liver and Intrahepatic Biliary Tract Carcinoma', 'Liquid Chromatography', 'Malignant Neoplasms', 'Report (document)', 'Liquid Chromatography', 'Incidence', 'Iranian (ethnic group)', 'Location', 'Clinical Research', 'Systematic Review', 'Estimated', 'Accurate (qualifier)', 'Incidence', 'Rating (action)', 'Liquid Chromatography', 'Iranian (ethnic group)', 'Persons']"
320,"['Malignant Neoplasms', 'Cessation of life', 'Malignant neoplasm of gastrointestinal tract', 'Primary', 'Mortality Vital Statistics', 'Malignant Neoplasms', 'trend', 'Different', 'Malignant neoplasm of gastrointestinal tract', 'Iran']"
321,"['Generalized', 'public health medicine (field)', 'Hepatitis C', 'Hepatitis C', 'Relevance', 'Financial cost', 'Speaking (activity)', 'Midline (qualifier value)', 'Financial cost', 'Complication of transplanted liver', 'Effectiveness', 'Therapeutic procedure', 'Hepatitis C', 'Patients', 'Increased', 'Improving (qualifier value)', 'bony process', 'Patients', 'Adherence (attribute)', 'Patients', 'Pharmacotherapy', 'Effectiveness', 'drug management', 'Disease', 'Health Policy', 'Insurance', 'Patients', 'Hepatitis C', 'Sufficient', 'Patients', 'Insurance', 'Problem', 'Economic Conditions', 'Effectiveness', 'therapeutic aspects', 'Assisted (qualifier value)', 'Hepatitis C', 'therapeutic aspects', 'Reduced', 'Patients', 'Cell Growth', 'Private Room', 'Positive', 'Insurance Carriers', 'Increasing (qualifier value)', 'Interested', 'Increase', 'Social status', 'Patients', 'Disease', 'Policy', 'Insurance']"
322,"['Coinfection', 'Tuberculosis', 'Tuberculosis', 'Intestines', 'Parasites', 'Infections of musculoskeletal system', 'public health medicine (field)', 'low', 'Developing Countries', 'Data', 'Iran', 'Investigates', 'Statistical Prevalence', 'Patients', 'Tuberculosis', 'Iran']"
323,"['Cessation of life', 'Feeling despair', 'PIN1 gene', 'public health medicine (field)', 'Cessation of life', 'Liver diseases', 'Pharmaceutical Preparations', 'Etiology aspects', 'Cessation of life', 'Additional', 'Mortality Vital Statistics', 'Data', 'Rating (action)', 'Drug Overdose', 'Cessation of life', 'Suicide', 'Cessation of life', 'Rating (action)', 'Economics', 'Social Determinants of Health', 'Health', 'Hematoma, Subdural', 'Increase', 'PIN1 gene', 'Neoplasm Metastasis', 'Hematoma, Subdural', 'PIN1 gene', 'PIN1 gene', 'Hematoma, Subdural', 'Income', 'Age', 'High', 'Average', 'Health Personnel', 'Florida', 'PIN1 gene', 'High', 'Reduced', 'PIN1 gene', 'Explanation']"
324,"['Chronic disease', 'Followed by', 'High', 'Lower - spatial qualifier', 'Socioeconomic Status', 'research', 'Cancer Progression', 'Groups', 'Diversity', 'socioeconomic', 'Body Patterning', 'Antisense Orientation', 'Malignant Neoplasms', 'Investigates', 'German language', 'socioeconomic', 'Unequal', 'Malignant Neoplasms', 'Incidence', 'Germany', 'Malignant Neoplasms', 'Specific qualifier value', 'Malignant Neoplasms', 'Diagnosis', 'Assessed', 'District', 'German language', 'Socioeconomic Factors', 'Absolute', 'Relative (related person)', 'socioeconomic', 'Unequal', 'Malignant Neoplasms', 'Incidence', 'Analysis', 'Logarithm', 'Offset', 'Male population group', 'socioeconomic', 'Unequal', 'Malignant Neoplasms', 'Incidence', 'High', 'District', 'Malignant Neoplasms', 'Specific qualifier value', 'Malignant Neoplasms', 'Large nose', 'Malignant Neoplasms', 'Lung', 'Oral cavity', 'Respiratory System', 'Woman', 'High', 'Kidney', 'Urinary Bladder', 'Malignant tumor of cervix', 'Hematopoietic and Lymphoid Cell', 'Neoplasms', 'Unequal', 'Malignant Neoplasms', 'Gradient', 'High', 'Less Than', 'melanoma', 'Malignant neoplasm of thyroid', 'Woman', 'Woman', 'ovarian neoplasm', 'Male population group', 'Incident', 'Malignant Neoplasms', 'cancer location', 'Incidence', 'Malignant Neoplasms', 'Antisense Orientation', 'socioeconomic', 'Gradient', 'Minority Groups', 'Woman', 'Federal Government', 'socioeconomic', 'Unequal', 'Malignant Neoplasms', 'Incidence', 'findings aspects', 'socioeconomic', 'Body Patterning', 'Malignant Neoplasms', 'Diversity', 'Directions', 'cancer location', 'Malignant Neoplasms', 'Unequal', 'Potential', 'Cancer Prevention', 'Strategy', 'Cancer Prevention']"
325,"['Clinical Research', 'Estimated', 'Statistical Prevalence', 'Sambucus', 'ABUSE NEGLECT', 'Iran']"
326,"['Neighborhood Disadvantage', 'Increased', 'diabetes risk', 'risk factors', 'Childhood', 'Adulthood', 'High', 'socioeconomic', 'socioeconomic', 'Neighborhood Disadvantage', 'Incidence', 'geographic population']"
327,"['Hepatitis B', 'public entity', 'Liver Cirrhosis', 'Liver carcinoma', 'altretamine/cisplatin/cyclophosphamide protocol', 'Clinical Research', 'Evaluation', 'Effect', 'Educational Intervention', 'Prophylactic behavior', 'Health behavior', 'Hepatitis B', 'Vaccination', 'Woman', 'Marriage, life event', 'Marriage, life event', 'Marriage, life event', 'Participant', 'Knowledge', 'Health Belief Model', 'LRP5 gene', 'Intention - mental process', 'Hemoglobin', 'Vaccination', 'Questionnaires', 'Distress Score Visual Analogue Scale', 'Educational Intervention', 'pretesting', 'follow-up', 'Levels (qualifier value)', 'Statistical Significance', 'Score', 'Groups', 'Statistical Significance', 'Case Study', 'Positive', 'Participant', 'LRP5 gene', 'Intention - mental process', 'Hemoglobin', 'Vaccination', 'Educational Intervention', 'LRP5 gene', 'Improved', 'Prophylactic behavior', 'Hemoglobin', 'Vaccination']"
328,"['Accurate (qualifier)', 'Estimated', 'Statistical Prevalence', 'Hepatitis', 'Colicin Plasmids', 'Prisoners', 'Iran']"
329,"['Problem', 'chronic', 'Illness (finding)', 'Liver Cirrhosis']"
330,"['Chlamydia trachomatis', 'Connecticut', 'Reproductive tract infection', 'Woman', 'Evidence', 'Communicable Diseases', 'Connecticut', 'With frequency', 'Communicable Diseases', 'Iranian (ethnic group)', 'Woman']"
331,"['Influence', 'Health-Related Quality Of Life', 'Health-Related Quality Of Life', 'Fatigue', 'Clinical Research', 'Relationships', 'Demography', 'Health-Related Quality Of Life', 'Fatigue']"
332,"['Communicable Diseases', 'Disease', 'Highest', 'Mortality Vital Statistics', 'Improvement', 'Socioeconomic Status', 'Access', 'Drinking Water', 'Patterns', 'Decreasing', 'Spreading (qualifier value)', 'Cessation of life', 'Communicable Diseases', 'incidence and prevalence', 'Noncommunicable Diseases', 'Spondyloenchondrodysplasia', 'Increased', 'Iran', 'Cessation of life', 'Nursing interventions', 'Spondyloenchondrodysplasia', 'Homo sapiens', 'Financial Stress', 'Health System', 'Policy', 'Growth', 'year', 'Education, Medical', 'Cohort', 'Prospective Studies', 'Epidemiologic Studies', 'Assessed', 'Burden', 'Spondyloenchondrodysplasia', 'Investigates', 'risk factors', 'Ethnicity', 'Iran', 'Persian language', 'Cohort', 'Participant', 'Component object', 'Adult', 'Birth', 'Adolescence', 'Elderly (population group)', 'Replication Origin', 'Iran', 'Blood Banks', 'Urine', 'Hair', 'Nail plate', 'Specimen', 'Persian language', 'Cohort', 'Research Infrastructure', 'Implementation', 'research', 'Evidence', 'Health Policy', 'Control Groups', 'Spondyloenchondrodysplasia']"
333,"['Prophylactic treatment', 'Inflammatory', 'Milieu Therapy', 'Anti-Inflammatory Agents', 'Modality', 'Hemodialysis', 'Patients', 'Rating (action)', 'Inflammatory', 'Markers (device)', 'Inflammation', 'Uremia', 'Morbidity - disease rate', 'Mortality Vital Statistics', 'Hemodialysis', 'Patients', 'Clinical Research', 'Evaluation', 'Reduction (chemical)', 'Inflammatory', 'Markers (device)', 'Hemodialysis', 'Patients']"
334,"['Hepatitis C', 'Hepatitis C', 'Liver diseases', 'Potential', 'Comprehensive', 'Evidence', 'Hepatitis C', 'Iranian (ethnic group)', 'Hemodialysis', 'Hodgkin Disease', 'Patients', 'Systematic Review']"
335,"['Clinical Research', 'Evaluation', 'Effect', 'Lactobacillus', 'Dietary Supplementation', 'trends qualifier', 'Milk (body substance)', 'Antioxidants', 'Observation parameter']"
336,"['Earthquakes', 'Fukushima Nuclear Accident', 'Government', 'Requirement', 'Evacuation procedure', 'Radioactivity', 'Fukushima Nuclear Accident', 'Life Style', 'Diet', 'Exercise', 'Cardiovascular Diseases', 'Mental association', 'Evacuation procedure', 'Changing', 'Cardiovascular Diseases', 'risk factors', 'Fukushima Nuclear Accident', 'Health Surveys', 'Clinical Research', 'Longitudinal Studies', 'health and clinical management', 'Surveys', 'Proportion', 'Overweight', 'Hypertensive disease', 'Diabetes Mellitus', 'Dyslipidemias', 'Liver Dysfunction', 'Atrial Fibrillation', 'Polycythemia', 'Increased', 'Evacuation procedure', 'Increase', 'Heart Disease Risk Factors', 'Myocardial Infarction', 'Cerebrovascular accident', 'Prophylactic behavior', 'Diabetes Mellitus', 'Dyslipidemias', 'Collaboration', 'Community']"
337,"['Contribution', 'Nervous System Physiological Phenomena', 'Hepatic Encephalopathy', 'Electrophysiological Phenomena', 'Mechanism (attribute)', 'Damage', 'Hyperammonemia (disorder)', 'Impaired cognition', 'Bile duct structure', 'Tape Recording', 'CA1 Pyramidal Cell Area', 'Neurons', 'Hippocampus (Brain)', 'Males', 'Rats, Wistar', 'salicylhydroxamic acid', 'Surgery specialty', 'Electrophysiological Phenomena', 'Hippocampus (Brain)', 'Neurons', 'Clinical Research', 'Potential', 'ampicillin', 'Accountable Health Plans', 'Increased', 'Significantly low', 'Animals', 'salicylhydroxamic acid', 'Groups', 'Internal', 'Hippocampus (Brain)', 'Neurons', 'Contribution', 'Congenital Abnormality', 'Hepatic Encephalopathy', 'Therapeutic procedure']"
338,"['Musculoskeletal Diseases', 'public entity', 'Statistical Prevalence', 'Persian language', 'Adult', 'Cohort', 'Research Subject', 'Age', 'Complete', 'Community', 'Orientation (spatial)', 'Control Groups', 'Rheumatism', 'Electronic Supplementary Materials', 'Research Subject', 'Physical Examination', 'Research Subject', 'day', 'Frequently', 'Complaint (finding)', 'Site', 'Complaint (finding)', 'Degenerative polyarthritis', 'Rheumatism', 'Affecting', 'Low Back Pain', 'Degenerative polyarthritis', 'Osteoarthritis, Knee', 'Females', 'Males', 'Low Back Pain', 'Males', 'Females', 'Periarthritis', 'Prevalent', 'Males', 'Fibromyalgia', 'Psychological Tests (procedure)', 'Prevalent', 'Females', 'Rheumatoid Arthritis', 'Males', 'Females', 'Statistical Prevalence', 'Geographic Locations', 'prevention program', 'Administration occupational activities', 'Societies']"
339,"['Dermatologic disorders', 'Frequently', 'Relapse', 'Numerous', 'Atopy', 'Contact Dermatitis', 'Administration occupational activities', 'Complex', 'Pathogenesis', 'Effectiveness', 'Therapeutic procedure', 'Patients', 'Quality', 'Life']"
340,"['Obesity', 'Overweight', 'Obesity', 'risk factors', 'Series', 'Noncommunicable Diseases', 'year', 'Epidemiologic Studies', 'Obesity', 'Associated with', 'Increased', 'Risk', 'Malignant Neoplasms', 'Endometrium', 'Epidemiology', 'Mental association', 'Obesity', 'Potential', 'Mechanism (attribute)', 'Chronic inflammation', 'Social Interaction', 'Endocrine system', 'Adiponectin', 'Somatomedins', 'Colicin Plasmids', 'progesterone and estrogen', 'Cell metabolism', 'Alteration', 'Obesity', 'Participation', 'Biologic Development', 'Disease Progression', 'Pharmacotherapy', 'cellular targeting', 'Therapeutic procedure']"
341,"['Response process', 'Result', 'Costimulatory and Inhibitory T-Cell Receptors', 'Signal Transduction', 'Apoptosis', 'Cessation of life', 'Ligands', 'Molecule', 'soluble', 'Homo sapiens', 'Serum', 'soluble', 'CD274 protein, human', 'Patients', 'Autoimmune Diseases', 'Social Role', 'Evaluation', 'Mental association', 'Severities', 'IL13 gene', 'Arkansas', 'Patients']"
342,"['Clinical Research', 'Investigates', 'Hepatoprotective Agent', 'Physical activity', 'extract - ActClassContainer', 'Carbon Tetrachloride', 'Induce (action)', 'Hepatotoxicity', 'Rattus norvegicus']"
343,"['Changing', 'Blood', 'Markers (device)', 'BaseLine dental cement', 'Daily', 'day', 'Race:Type:Point in time:^Patient:Nominal', 'Blood Indices', 'Patterns', 'Changing', 'objective (goal)', 'Race:Type:Point in time:^Patient:Nominal', 'Erythrocyte Indices', 'Gamma-glutamyl transferase', 'Tumor necrosis', 'Patterns', 'Markers (device)', 'High', 'Race:Type:Point in time:^Patient:Nominal', 'Race:Type:Point in time:^Patient:Nominal', 'Observation parameter', 'BaseLine dental cement', 'Markers (device)', 'Ferritin', 'Muscle Tissue', 'Tissue damage', 'Observation parameter', 'Renal function', 'Markers (device)', 'creatinine', 'Blood', 'Alanine Transaminase', 'Lipid Metabolism', 'Nonesterified Fatty Acids', 'Reactive Oxygen Species', 'Inflammation', 'Observation parameter', 'Leukocytes', 'Interleukins', 'C-reactive protein', 'production', 'Catecholamines', 'norepinephrine', 'dopamine', 'Lipid Metabolism', 'Marker', 'Triglycerides', 'Decreased', 'Race:Type:Point in time:^Patient:Nominal', 'Menstruation', 'Return to Work', 'BaseLine dental cement', 'Hormonal', 'Markers (device)', 'Insulin', 'Unique', 'Patterns', 'findings aspects', 'Athletes', 'Optimum', 'Exercise', 'Exercise', 'Physical performance', 'Preventive monitoring', 'Exercise', 'Prophylactic treatment']"
344,"['Evaluation', 'Burden', 'Iran', 'Global Burden of Disease']"
345,"['omega-3 fatty acids', 'Fetal Alcohol Syndrome', 'Fetal Alcohol Syndrome', 'Health', 'Clinical Research', 'Evaluation', 'Effect', 'Oils', 'Dietary Supplementation', 'Profiling (action)', 'Participant', 'Pregnant Women', 'Age', 'year', 'fish oils', 'Dietary Supplements', 'Daily', 'Docosahexaenoic Acids', 'docosahexaenoic acid', 'eicosapentaenoic acid', 'eicosapentaenoic acid', 'Placebos', 'week', 'Obstetric Delivery', 'Primary', 'eicosapentaenoic acid', 'Proportion', 'Pregnancy', 'Groups', 'Consumption of goods', 'Serum', 'fish oils', 'Dietary Supplementation', 'Increased', 'docosahexaenoic acid', 'Interventional procedure', 'Placebos', 'Groups', 'week', 'Curie', 'eicosapentaenoic acid', 'Proportion', 'Fetal Alcohol Syndrome', 'Increased', 'Intervention Group', 'Curie', 'fish oils', 'Dietary Supplements', 'Pregnancy', 'Serum']"
346,"['Post-transplant lymphoproliferative disorder', 'Post-transplant lymphoproliferative disorder', 'Complication', 'Organ Transplantation', 'Therapeutic immunosuppression', 'risk factors', 'Post-transplant lymphoproliferative disorder', 'Involvement with', 'Organ', 'Unusual', 'Presentation', 'Extranodal', 'Woman', 'Transplantation of liver', 'month', 'Pharmaceutical Preparations', 'tacrolimus', 'prednisolone', 'Presentation', 'Symptoms aspect', 'Upper', 'Respiratory Tract Infections', 'Respiratory distress', 'Therapeutic procedure', 'Respiratory arrest', 'Emergency Situation', 'Tracheostomy procedure', 'Biopsy', 'paratracheal mass', 'Lymphoma, Non-Hodgkin', 'Post-transplant lymphoproliferative disorder', 'Adenoma, Monomorphic', 'Presentation', 'Persistent', 'Structure of upper respiratory tract cavity', 'Symptoms aspect', 'Transplantation of liver', 'Evaluation', 'Physicians', 'Levels (qualifier value)', 'Clinical']"
347,"['Home environment', 'Tobacco', 'System User -- individual', 'Smokeless Tobacco', 'Smoker', '1000000', 'System User -- individual', 'Smokeless Tobacco', 'Examined', 'Socioeconomic Factors', 'Associated with', 'Tobacco Type Used', 'Rural', 'Asian Indian', 'geographic population']"
348,"['Evaluation', 'Hepatoprotective Agent', 'Property (attribute)', 'Rydingia persica', 'ethanol', 'Carbon', 'Liver damage', 'Rattus norvegicus']"
349,"['socioeconomic', 'Unequal', 'Affecting', 'Social', 'Factor', 'Health', 'socioeconomic', 'Characteristics', 'Health Equity', 'Mental association', 'Social Determinants of Health', 'Clinical Research', 'metropolitan area', 'Laryngeal Masks', 'Science of Statistics', 'Mental association', 'Mortality Vital Statistics', 'Risk', 'Mortality Vital Statistics']"
350,"['Hepatitis C', 'Chronic liver disease', 'Liver Cirrhosis', 'Liver carcinoma', 'Genotype', 'Hepatitis C', 'Acquisition (action)', 'Clinical', 'Disease Outcome or Response', 'therapeutic aspects']"
351,"['Gastroesophageal reflux disease', 'Gastrointestinal Diseases', 'Range', 'Europe', 'North America', 'Clinical Research', 'Estimated', 'Burden', 'Gastroesophageal reflux disease', 'Iran']"
352,"['socioeconomic', 'Unequal', 'public health medicine (field)', 'Etiology aspects', 'Mortality Vital Statistics', 'Europe', 'Data', 'Analyzer, device', 'Unequal', 'Specific qualifier value', 'Mortality Vital Statistics', 'European (ethnic group)', 'Cities']"
353,"['Chronic Kidney Diseases', 'Hearing problem', 'El Salvador', 'Increase', 'Case (situation)', 'Traditional origin', 'risk factors', 'Cessation of life', 'Male population group', 'Age', 'year', 'Male population group']"
354,"['No Concerns', 'Evidence', 'Potential', 'Consequence of']"
355,"['Malignant neoplasm of gastrointestinal tract', 'Esophageal and Gastric Varices', 'Pancreas', 'Iran', 'Opiates', 'Examined', 'Mental association', 'Consumption of goods', 'Optical density units', 'Incidence', 'Upper', 'Malignant Neoplasms']"
